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ABSTRACT 
 
Increased respiratory muscle work is encountered during strenuous whole-
body exercise, and at rest in older adults and those with pulmonary limitations such 
as chronic obstructive pulmonary disease (COPD). When sufficiently strenuous it 
can result in diaphragmatic fatigue, increased blood lactate concentrations, and an 
alteration in respiratory muscle recruitment patterns. Increased respiratory muscle 
work also elevates cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β) within 
the respiratory muscles and systemically. There is mounting evidence that 
inflammation contributes significantly to the ageing process and age related diseases. 
Enhanced oxidative stress, glycogen depletion and diaphragmatic fatigue are all 
potential stimuli for this production. Whole-body exercise training can attenuate 
systemic inflammation and oxidative stress in younger adults during exercise, and in 
older adults who experience this at rest. An attenuation of muscle glycogen or 
increases in antioxidant enzymes may explain such reductions. Inspiratory muscle 
training (IMT) may also elicit similar adaptations in the inspiratory muscles, and thus 
also attenuate these markers. Accordingly, this thesis evaluated in younger adults 
whether: (I) the respiratory muscles contribute to exercise-induced increases in 
plasma cytokines and/or systemic oxidative stress measured by DNA damage to 
peripheral blood mononuclear cells (PBMC) during 1 h of steady-state cycling 
exercise (EX) and volitional hyperpnoea at rest which mimicked the breathing and 
respiratory muscle recruitment patterns achieved during EX (HYPEX) and heavy 
exercise (VH); (II) an increase in these inflammatory markers was related to 
diaphragmatic fatigue; (III) IMT attenuates these markers during EX, HYPEX and 
EX; and (IV) IMT changes an estimation of the maximum lactate steady-state and 
respiratory muscle recruitment patterns during the lactate minimum test. This thesis 
V 
 
also evaluated in older adults at rest whether: (V) IMT attenuates plasma cytokines 
and DNA damage to PBMC.  
It was found in younger adults that: (I) plasma IL-6 concentrations increased 
during EX, HYPEX and VH and plasma IL-1β increased during VH. Plasma 
interleukin-1 receptor antagonist concentration and oxidative DNA damage to PBMC 
remained unchanged during VH; (II) the increase in IL-6 and IL-1β during VH was 
not related to the induction of diaphragmatic fatigue; (III) following IMT, plasma IL-
6 concentrations were reduced by 33% during EX, 24% during VH, but were 
unchanged during HYPEX; and (V) following IMT, an estimation of the maximum 
lactate steady-state and respiratory muscle recruitment patterns remained unchanged 
during the lactate minimum test. It was found in older adults that: (IV) following 
IMT, nine plasma cytokines and DNA damage to PBMC remained unchanged. This 
thesis provides novel evidence that the respiratory muscles contribute to exercise-
induced increases in plasma IL-6 and IL-1β concentration and that this increase is not 
related to diaphragmatic fatigue. IMT attenuates plasma IL-6 concentration during 
exercise, but not in a range of plasma cytokines in older adults at rest. It is attractive 
to speculate that the respiratory muscles contribute to the systemic inflammation 
observed in COPD patients and IMT may reduce the dysregulated cytokine response 
observed during exercise of COPD patients.  
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CHAPTER 1 ‒ GENERAL INTRODUCTION 
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1.0 THE RESPIRATORY SYSTEM 
 The respiratory system is comprised of two interdependent components; the 
lung parenchyma which is responsible for gas exchange, and the respiratory muscles 
which act as the ventilatory pump. The primary function of the respiratory system is 
to preserve the partial pressure of arterial blood gases oxygen (O2) and carbon 
dioxide (CO2). During exercise there is an increased consumption of O2 by the 
working muscles that must be maintained, and an increased CO2 production that must 
be eliminated. Thus, the primary reason for increased ventilation during exercise is to 
increase alveolar ventilation in proportion to O2 consumption and CO2 production 
and maintain acid-base homeostasis. The respiratory system achieves this with 
remarkable precision and at minimal energy cost to the body through the co-
ordination of the lung parenchyma, airways, respiratory control systems and 
respiratory muscles.  
 
1.1 THE RESPIRATORY MUSCLES 
The respiratory muscles are morphologically and functionally skeletal 
muscles. However, they only weigh ~960 g (Freedman et al. 1983), and represent 
only ~3% of total body mass (Robertson et al. 1977). The primary inspiratory 
muscles comprise the diaphragm, external intercostals, parasternal, sternomastoid 
and scalene muscles (Figure 1.1). The primary expiratory muscles comprise the 
internal intercostal, rectus abdominis, external and internal oblique and transverse 
abdominis muscles (Figure 1.1). The mechanical and kinematic analysis of the 
respiratory muscles during exercise has demonstrated that ventilation is made 
possible by highly coordinated actions of the respiratory muscles. 
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Figure 1.1 Schematic illustration of the anatomy of human respiratory muscles. 
Adapted from www.concept2.co.uk/training/breathing.php. 
 
1.2 RESPIRATORY MECHANICS AND KINEMATICS DURING EXERCISE 
1.2.1 RESPIRATORY MECHANICS AND KINEMATICS MEASUREMENT TECHNIQUES 
The measurement of respiratory mechanics during exercise can be inferred 
from a balloon pressure catheter system. Thin walled balloon catheters are passed 
intranasally into participants with either two different balloon catheters, or two 
balloons sealed over a single catheter as shown in Figure 1.2. Pleural pressure is 
estimated from a catheter positioned in the oesophagus (oesophageal pressure; Pe). 
Abdominal pressure is estimated from a catheter positioned in the stomach (gastric 
pressure; Pg). The difference between pleural and abdominal pressure is termed 
transdiaphragmatic pressure (Pdi).   
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Figure 1.2 Balloon pressure catheter system with two balloons sealed over a single 
catheter. Note that internal organs are not to scale.   
 
 
A limitation of the balloon catheter system is that it assumes that the chest 
wall moves with only two degrees of freedom. To overcome this limitation more 
recent studies have used a geometric optical reference system termed optoelectronic 
plethysmography (OEP; Figure 1.3). This system measures respiratory kinematics, 
and allows volume variations of the entire chest wall and its different compartments 
to be obtained breath by breath. 
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Figure 1.3 Optoelectronic plethysmography (OEP) uses a number of small reflective 
markers that are placed on the participant’s trunk. A motion analysis system captures 
the three-dimensional coordinates of these markers and the enclosed volume is 
computed by connecting the points to form triangles. The chest wall can be modelled 
as being composed of three different compartments: pleural rib cage (blue), 
abdominal rib cage (green) and the abdomen (yellow). Adapted from Aliverti et al. 
(2009).  
 
 
1.2.2 RESPIRATORY MECHANICS AND KINEMATICS DURING EXERCISE 
Aliverti et al. (1997) have combined the kinematic measures from OEP with 
simultaneous measurement of pleural and abdominal pressure using a balloon 
pressure catheter system, enabling the measurement of the relative contributions of 
the chest wall muscles, the diaphragm and the abdominal muscles to the changes in 
compartmental volumes and pressures. Measurements were taken at rest and during 
sub-maximal cycling exercise at intensities of 0, 30, 50 and 70% maximum power 
output ( ̇max). Their findings are summarised as follows: At rest, diaphragm 
shortening accounts for most of the increase in lung volume. At the onset of exercise 
(and with progressive intensities) end-inspiratory lung volume increases as a result of 
an increase in the volume of the pleural rib cage and to a lesser extent the volume of 
the abdomen. End-expiratory lung volume decreased as a result of a reduction in 
abdominal volume. As exercise progressed there was a gradual increase in the 
recruitment of rib cage and abdominal muscles. Throughout exercise there is a 
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gradual relaxation of the abdominal muscles during inspiration which causes a 
decrease in abdominal pressure and reduces Pdi, whilst decreasing the expiratory 
action of the abdominal muscles on the volume of the abdomen. These findings 
suggest that during exercise the diaphragm acts primarily as a flow generator 
whereas the ribcage muscles generate the pressure to displace the abdomen and 
decrease end-inspiratory lung volume. The abdominal muscles generate the pressure 
to displace the abdomen and decrease end-expiratory lung volume. During 
inspiration the progressive increase in end-inspiratory lung volume acts to prevent 
ribcage distortion and simultaneously minimise Pdi. This precise coordination of the 
respiratory muscles minimises the work of breathing (WOB) during exercise. 
 
 
1.2.3 WORK OF BREATHING DURING EXERCISE  
The WOB reflects the metabolic and/or energetic cost of the respiratory 
muscles to pulmonary ventilation and can be divided into two main categories: (i) 
elastic work - the energy required to alter the shape of the anatomical structures 
involved with breathing; and (ii) resistive work - the energy required to overcome the 
resistance to airflow in the airways. During exercise the respiratory muscles must 
perform both elastic and resistive work. Elastic work is performed to expand the lung 
and chest wall and overcome the elastic recoil force. Resistive work increases when 
the air entering the airways becomes more turbulent during high airflow rates.  
The principle of ‘minimal effort’ is thought to govern the WOB during 
exercise. This principle has been supported by experimental data with mathematical 
modelling and demonstrates that the naturally occurring ventilatory response to 
exercise is associated with the minimal energy requirement from the respiratory 
muscles (Mead 1963; Otis et al. 1950; Yamashiro and Grodins 1973). Furthermore, 
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during exercise, ventilation occurs within a range of lung volumes that give the 
greatest total lung compliance (the change in pressure required to get a change in 
volume; ∆Pressure / ∆Volume). The combination of the increase in tidal volume (VT) 
and breathing frequency (fB) occurs at a level that minimises dead space ventilation. 
Lastly, the respiratory muscles shorten at an optimal length so that force production 
is maximised.  
 Experimentally the WOB can be decreased using a proportional assist 
ventilator (PAV) or increased using inspiratory flow-resistive or pressure-threshold 
loading (IRL). The PAV partially unloads the inspiratory muscles by generating a 
positive pressure in proportion to inspiratory airflow and volume. IRL provides 
resistance to inspiratory airflow that requires participants to produce a negative 
inspiratory pressure sufficient to overcome the resistance. The resistances can be 
provided by a variable sized aperture or foil mesh screens for flow-resistive loading, 
or by using a spring loaded or weighted plunger device for pressure-threshold 
loading. When used during high-intensity exercise PAV and IRL (5 cmH2O·L·s
-1
 
resistance) can reduce, or increase the WOB by ~40‒60%, respectively (Harms et al. 
1997; Harms et al. 1998). PAV and IRL can also reduce, or increase inspiratory 
muscle force output (integral of Pe multiplied by fB and labelled the total inspiratory 
muscle pressure-time product) by ~30‒80%, respectively (Babcock et al. 1995; 
Romer et al. 2006). However, using experimental approaches to manipulate the 
WOB has limitations. PAV or IRL possibly alters the recruitment of muscles 
involved with trunk stabilisation and locomotion (Calbet et al. 2007). Furthermore, 
unless a prescribed breathing pattern is imposed on participants during IRL, duty 
cycle (TI/TTOT; Clanton et al. 1985b), inspiratory flow rate (Clanton et al. 1985b; 
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McCool et al. 1986) and VT (Clanton et al. 1990) increase to accommodate the 
mechanical load. 
The WOB can be measured directly by mechanical work, or indirectly by 
measuring the O2 cost of breathing. The mechanical WOB is estimated by 
simultaneously measuring the changes in intrathoracic pressures and the volume of 
the lungs throughout a respiratory cycle. In practice this is usually measured by 
integrating the inspiratory limb area of a Pe‒VT loop. The oxygen uptake ( ̇O2) of 
the respiratory muscles can be measured by calculating the difference between 
whole-body  ̇O2 at rest, or during exercise, and the  ̇O2 during a volitional mimic at 
rest of the exercise hyperpnoea (volitional hyperpnoea). Isocapnia during volitional 
hyperpnoea is maintained at resting pressures by supplementing CO2 into the 
inspiratory circuit. However, it is important to note that to have a valid estimate of 
respiratory muscle  ̇O2 using volitional hyperpnoea the WOB must be rigorously 
controlled. When the WOB is not controlled, and the participant self-selects their 
own breathing and respiratory muscle recruitment patterns; respiratory muscle  ̇O2 
can increase by ~25% due to tachypnoea, the recruitment of less efficient respiratory 
muscles, and an increase in end-expiratory lung volume (Coast et al. 1993).   
 Using this rigorous experimental approach Aaron and colleagues (Aaron et al. 
1992a; Aaron et al. 1992b) instructed participants to mimic at rest the breathing 
pattern (fB) and WOB (end expiratory lung volume and Pe‒VT loop) associated with 
heavy exercise hyperpnoea. The difference between  ̇O2 during volitional 
hyperpnoea, and  ̇O2 at rest was used to calculate respiratory muscle  ̇O2. As minute 
ventilation ( ̇E) increased from 75 to 125 L·min
-1
 respiratory muscle  ̇O2 increased 
from 1.8 to 2.1 mL O2 per L·min
-1
 increase in  ̇E. As a fraction of whole-body  ̇O2 
respiratory muscle  ̇O2 in untrained adults was 3‒5% for moderate intensity (75% of 
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maximal oxygen uptake;  ̇O2max) exercise and 8‒10% at maximal exercise. 
Respiratory muscle  ̇O2 was higher (13‒16%) in trained participants that had a 
 ̇O2max of >60 mL·kg
-1
min
-1
. Regression analyses have shown that the WOB and 
respiratory muscle  ̇O2 both increase linearly during maximal incremental exercise 
until the limit of volitional tolerance (Figure 1.4). This increase in respiratory muscle 
 ̇O2 during exercise must be delivered with an appropriate increase in respiratory 
muscle blood flow.  
 
Figure 1.4 The estimated relationship between exercise ventilation and the work of 
breathing (solid line) and respiratory muscle oxygen uptake ( ̇O2) (dotted line). 
Work of breathing estimation based on regression equation from Aaron et al. (1992a) 
where the work of breathing = -80.041 + 1.459 (minute ventilation) + 0.011 (minute 
ventilation) 2. Respiratory muscle  ̇O2 based on a regression equation from Aaron et 
al. (1992b), where respiratory muscle  ̇O2 = 0.081 + 0.001 (exercise work of 
breathing - resting work of breathing). Adapted from Sheel and Romer (2012). 
 
 
1.3 RESPIRATORY MUSCLE BLOOD FLOW DURING EXERCISE 
The quantification of respiratory muscle blood flow in exercising humans is 
difficult because of the complex anatomical arrangement and large vascular network 
that the respiratory muscles have. Therefore, most information regarding respiratory 
muscle blood flow during exercise has been derived from animal investigations 
10 
 
(Manohar 1986a; Manohar 1986b; Manohar 1988; Manohar 1990; Manohar and 
Hassan 1991). For example, diaphragmatic blood flow in ponies (measured directly 
via microsphere distribution) increased from 11.5  2.8 mL·min-1·100g tissue at rest 
to 265  35.9 mL·min-1·100g tissue at maximal exercise which was greater than all 
other respiratory and non-respiratory skeletal muscles. The studies from exercising 
ponies indicate that at maximal exercise the respiratory muscles receive ~15% of the 
total cardiac output with 8‒9% and 5‒6% directed towards the inspiratory and 
expiratory muscles, respectively. These values reasonably agree with measurements 
of respiratory muscle blood flow in a variety of species (Laughlin et al. 1989; 
Manohar 1986a; Nattie 1983) and with available estimates of respiratory muscle 
blood flow in humans (Harms et al. 1997; Harms et al. 1998).  
Harms and colleagues (Harms et al. 1997; Harms et al. 1998) estimated 
respiratory muscle blood flow by simultaneously measuring cardiac output (Fick 
method) and leg blood flow (thermodilution) during several short duration (2.5 to 3.0 
min), high-intensity cycling exercise tests in which the WOB was either reduced with 
a PAV or increased with IRL. When the WOB was reduced or increased there was a 
corresponding increase or decrease in leg blood flow. Cardiac output and stroke 
volume were decreased with the reduced WOB and remained unchanged with the 
increased WOB. Based on these findings Harms et al. (1998) estimated the 
distribution of total cardiac output available during maximal cycling exercise to be 
~77% directed to the locomotor muscles, 14‒16% to the respiratory muscles and 7‒
9% to other metabolically active tissues (Figure 1.5). However, the use of the PAV to 
unload the inspiratory muscles can reduce the negativity of intrathoracic pressure at 
end-inspiration, so that changes in blood flow can be partly attributed to reductions 
in cardiac output and stroke volume (Harms et al. 1997; Harms et al. 1998). 
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Interestingly, using the same experimental design, but a lower intensity (50 and 75% 
 ̇O2max) and longer duration (15 to 20 min) exercise it was shown that there was no 
change in leg blood flow suggesting that there is a threshold above which this effect 
occurs (Wetter et al. 1999).  
 
 
Figure 1.5 Estimation of average changes during maximum cycling exercise in the 
total cardiac output available (total blood flow; A) and distribution of cardiac output 
(B) based on research where the work of breathing was either reduced via a 
proportional assist ventilator (low), normal, or increased via inspiratory flow-
resistive loading (high). Data from Harms et al. (1997 and 1998). Adapted from 
Dempsey (2012).      
  
Recent studies have shown that there is the potential to directly measure 
respiratory muscle blood flow in exercising humans. Respiratory muscle blood flow 
has been estimated using the light-absorbing tracer dye indocyanine green in 
combination with near-infrared spectroscopy of the intercostal muscles during 
exercise (Habazettl et al. 2010; Henderson et al. 2012; Vogiatzis et al. 2008; 
Vogiatzis et al. 2009) and volitional hyperpnoea at rest (Guenette et al. 2008; 
Guenette et al. 2011). Using this technique it has been shown that respiratory muscle 
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blood flow (estimated from the seventh intercostal space) progressively increases 
during elevations of  ̇E up to 120 L·min
-1
, and there were strong positive correlations 
between blood flow, cardiac output, the WOB and Pdi (Guenette et al. 2008). 
However the technique is currently limited as the optode positioned over the seventh 
intercostal space will measure all of the blood flow in view, and it is impossible to 
separate out the relative contributions from other muscles such as the diaphragm. It 
has been shown that the demands placed on the respiratory muscles during an 
increased WOB are substantial requiring, a considerable metabolic cost, and 
appropriate increase in respiratory muscle blood flow. This can occur due to the 
advantageous morphology of the respiratory muscles including efficient fibre types, 
high levels of enzyme activities, a large mitochondrial density, and a substantial 
vascular supply.   
 
1.4 RESPIRATORY MUSCLE MORPHOLOGY 
1.4.1 RESPIRATORY MUSCLE FIBRE TYPES 
Muscle fibre type distribution (performed histochemically using myofibrillar 
ATPase staining) has shown that male human cadavers (reported to be previously 
healthy) have ~60% type I muscle fibres in the internal and external intercostals and 
49% in the diaphragm (Figure 1.6; Mizuno and Secher 1989). Type II distribution 
was similar between the internal intercostals and the diaphragm (~30%), but only 
17% in the external intercostals. In contrast, type IIx fibre type was similar between 
the external intercostals and the diaphragm (~25%), and only 1% in the internal 
intercostals. This finding is in agreement with muscle fibre type distribution in 
diaphragm biopsies taken from healthy humans using myofibrillar ATPase staining 
(Sanchez et al. 1982; Sanchez et al. 1985) and expression of myosin heavy chain 
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isoforms (Levine et al. 1997; Nguyen et al. 2000). Interestingly, the distribution of 
fibre types in the diaphragm is remarkably similar to that of the vastus lateralis 
(Figure 1.6) suggesting that the superior oxidative capacity of the diaphragm is not 
explained by fibre type distribution, but rather its enzyme activities, mitochondrial 
density and vascular supply. These additional morphological adaptations are not 
present in the accessory inspiratory muscles.      
 
Figure 1.6 Relative distribution of slow twitch (type I), fast twitch a (type II), and 
fast twitch x (type IIx) muscle fibres in the external and internal intercostals, the 
costal diaphragm and the vastus lateralis taken from 8 male cadavers (previously 
healthy) who died aged 17 to 51 years (average 31 years). Adapted from Mizuno and 
Secher (1989).    
 
 
1.4.2 RESPIRATORY MUSCLE ENZYME ACTIVITY, MITOCHONDRIAL DENSITY AND 
VASCULAR SUPPLY 
 
 Although measurements of respiratory muscle enzyme activities have been 
made in human cadavers (Mizuno et al. 1985); these are often compromised by the 
varied and long time periods between death and tissue removal (Mizuno 1991; 
Powers et al. 1997). There are, however, several reports that have shown that the 
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activity of oxidative (i.e., Krebs cycle) enzymes in healthy sedentary rats are ~2 
times greater in the diaphragm compared with a locomotor muscle possessing similar 
fibre types (Powers et al. 1994a; Powers et al. 1994b; Sexton and Poole 1995). For 
example, Sexton and Poole (1995) have spectrophotometrically determined that 
resting citrate synthase (rate limiting enzyme in Krebs cycle) activity is higher in all 
parts of the diaphragm compared to the hind limb muscles of rats (Figure 1.7). 
Nevertheless, these large differences in oxidative capacity between the diaphragm 
and locomotor muscles could be explained by the activity of these muscles. The 
locomotor muscles of sedentary (caged) rats undergo minimal amounts of activity 
compared to the chronically active diaphragm. The reason for the greater oxidative 
activity could be due to the metabolically plastic nature of skeletal muscles (Powers 
et al. 1997).  
 
Figure 1.7 Citrate synthase activity of the hind limb muscles (soleus and plantaris) 
and regional parts of the diaphragm in rats at rest. Values are mean  SE from Sexton 
and Poole (1995). Adapted from Poole et al. (1997).  
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 The mitochondrial density of the respiratory muscles has only been examined 
in animals. In these, it has been observed using electron microscopy that the 
mitochondrial density in the diaphragm is ~2‒3 times greater than that found in the 
hind limbs of both active and large (Hoppeler et al. 1981), and sedentary and small 
(Gamboa and Andrade 2010) mammals.  
The vascular supply of the respiratory muscles is extensive and more closely 
reflects the vascular supply of the brain than other skeletal muscles (Comtois et al. 
1987). Unlike locomotor skeletal muscles which have a single arterial supply; the 
diaphragm has multiple including the superior and inferior phrenic arteries, 
intercostal artery and internal mammary artery (Comtois et al. 1987). This multiple 
arterial supply provides a protective arrangement from ischemia. The analysis of 
human cadavers by Mizuno and Secher (1989) that is described above has also 
shown that, although the fibre type distribution of the diaphragm and vastus lateralis 
are similar, the number of capillaries per muscle fibre is higher in the diaphragm. 
The area and circumference of diaphragm muscle fibres is also smaller than all other 
skeletal muscles which minimises diffusion distance. The capillary bed of the 
diaphragm is also ~2‒3 times greater than that found in other skeletal muscles 
(Hoppeler et al. 1981). In spite of these morphologically advantageous features, it is 
surprising that under certain conditions, the respiratory muscles (including the 
diaphragm) can still fatigue during exercise (exercise-induced diaphragm fatigue) 
and during strenuous contractions at rest through resistive loading or volitional 
hyperpnoea (breathing-induced diaphragm fatigue).  
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1.5 RESPIRATORY MUSCLE FATIGUE 
Respiratory muscle fatigue is defined as “a condition in which there is a loss 
in the capacity for developing force and/or velocity of a muscle, resulting from 
muscle activity under load and which is reversible by rest” (NHLBI 1990). 
Respiratory muscle fatigue is evident from a reduced force output relative to the 
baseline value (Romer and Polkey 2008).  
 
1.5.1 SITES OF RESPIRATORY MUSCLE FATIGUE 
 Central fatigue is a reduction in voluntary force output due to a decrease in 
the motor output from the brain to the motor neuron pool (Gandevia 2001). Central 
fatigue of the inspiratory muscles has been observed after IRL using the “twitch 
interpolation” technique where supramaximal stimulation is superimposed upon a 
maximal inspiratory effort (Müller Manoeuvre) (Bellemare and Bigland-Ritchie 
1987; Gandevia and McKenzie 1985; McKenzie et al. 1992). A different method is 
to deliver a motor-evoked potential by the use of transcranial electrical (Gandevia 
and Rothwell 1987) or magnetic (Similowski et al. 1996) stimulation of the motor 
cortex. A decrease in the amplitude of the motor evoked potential from transcranial 
stimulation indicates a reduced excitability of the motor cortex due to supraspinal 
mechanisms. Transcranial stimulation has been used to show central diaphragmatic 
fatigue after whole-body exercise (Dayer et al. 2007; Verin et al. 2004). However, 
the functional consequences of a decrease in the motor-evoked potential remain 
unknown.  
Peripheral fatigue is a reduction in force output due to processes distal to the 
neuromuscular junction (Fitts 1994). Peripheral fatigue can be categorised into high 
frequency and low frequency fatigue. High frequency fatigue results in depression of 
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the force output after high frequency stimulation (~50‒100 Hz). In contrast, low 
frequency fatigue results in depression of the force output after low frequency 
stimulation (e.g., 1‒30 Hz). It is believed that high frequency fatigue indicates 
interference in the propagation of the action potential along, or throughout, the t-
tubule system whereas low frequency fatigue indicates impairment of excitation-
contraction coupling (Jones 1996). Results from resistive loading and volitional 
hyperpnoea studies have reported that high frequency fatigue recovers quickly, after 
10‒20 min, whereas low frequency fatigue may require hours to fully recover 
(Aubier et al. 1981; Bai et al. 1984; Moxham et al. 1981). The following sections 
will focus only on peripheral fatigue.          
 
1.5.2 RESPIRATORY MUSCLE FATIGUE MEASUREMENT TECHNIQUES  
Peripheral respiratory muscle fatigue can be assessed with non-invasive and 
volitional measurements using maximal static inspiratory (MIP) or expiratory (MEP) 
pressures, maximal Pdi or Pe and maximal sniff or cough pressure. These 
measurements have demonstrated respiratory muscle fatigue after high-intensity 
(Bye et al. 1984; Coast et al. 1990; Coast et al. 1999; Griffiths and McConnell 2007; 
Lomax and McConnell 2003; Romer et al. 2002c; Volianitis et al. 2001) and 
strenuous and prolonged endurance exercise (Chevrolet et al. 1993; Cordain et al. 
1994; Hill et al. 1991; Loke et al. 1982; Ross et al. 2008) in a range of modalities. 
The major limitations of these techniques are that they are effort dependent and can 
be influenced by task learning or central drive (ATS/ERS 2002).  
 Respiratory muscle fatigue can also be assessed by analysing the frequency 
domain of electromyography (EMG) signals recorded using skin-surface electrodes 
positioned over the muscle of interest, or an electrode catheter passed intranasally 
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into the participant and positioned in the lower oesophagus for measurements of the 
crural diaphragm (ATS/ERS 2002; Luo et al. 2008). The rationale for frequency 
domain analysis is that fatigue can shift the power spectrum of the EMG to lower 
frequencies (Gross et al. 1979). Shifts in the EMG power spectrum have been 
reported after resistive loading (Bower et al. 1984; Fitting et al. 1988; Pardy and Bye 
1985) and heavy whole-body exercise (Aldrich et al. 1983). However, the validity of 
EMG power spectrum measurements remains controversial. Neural or sarcolemmal 
events may be responsible for power spectral shifts with fatigue rather than processes 
involving excitation-contraction coupling (Sieck and Fournier 1990). Therefore, 
there is a poor correlation between EMG spectral shifts and mechanical indices of 
fatigue (Moxham et al. 1982). Technical complications such as electrode position, 
signal-to-noise ratio and recruitment of muscles that potentially contribute to 
crosstalk can also complicate measurement of the EMG power spectrum (ATS/ERS 
2002; Luo et al. 2008). 
 With the methodological limitations of volitional measurements and EMG 
power spectrum described above; studies using these techniques to demonstrate 
respiratory muscle fatigue will not be discussed in this thesis. Arguably, the most 
valid method of assessing respiratory muscle fatigue is to estimate the force output of 
the muscle in question by measuring the intrathoracic pressure response to motor 
nerve stimulation.  
Motor nerve stimulation is an objective, non-volitional measurement and can 
therefore measure the particular muscle in isolation and independent of effort. 
Electrical or magnetic devices provide stimulation and the force output is measured 
with a balloon pressure catheter system (Figure 1.2). For the diaphragm the phrenic 
nerves are stimulated, and the Pdi response is measured (Figure 1.8). For the 
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abdominal muscles the abdominal wall or thoracic nerves are stimulated, and the Pg 
response is measured. The measurement of changes in the pressure-frequency 
response of the muscle can gain an insight into the underlying mechanisms of 
fatigue. The additional use of an EMG system allows the measurement of the 
compound muscle action potential evoked during stimulation (i.e., M-wave) to detect 
changes in neuromuscular transmission (Aldrich 1987).  
To gain a valid measure of respiratory muscle fatigue using nerve stimulation 
several potential sources of error must be controlled; including abdominal 
compliance (Koulouris et al. 1989; Man et al. 2002), postactivation potentiation 
(Mador et al. 1994; Wragg et al. 1994), isovolumic conditions (Hubmayr et al. 1989; 
Smith and Bellemare 1987) and supramaximal stimulation (Davies and White 1982; 
Taylor et al. 1996).  
 
Figure 1.8 Oesophageal (Pe), gastric (Pg) and transdiaphragmatic pressure (Pdi) 
response to single frequency supramaximal bilateral phrenic nerve stimulation from 
an anterolateral approach.  
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 Whilst supramaximal stimulation is easy to achieve with electrical 
stimulation it is painful for participants. Thus, magnetic stimulation techniques with 
coils are more commonly used. For peripheral fatigue of the abdominal muscles; 
magnetic stimulation is undertaken by placing a circular coil over the thoracic nerve 
roots (Kyroussis et al. 1996). This technique has demonstrated exercise-induced 
abdominal fatigue (Taylor et al. 2006; Taylor and Romer 2008; Verges et al. 2007). 
For peripheral fatigue of the diaphragm; one method of magnetic stimulation of the 
phrenic nerves can be undertaken by placing a circular coil posteriorly over the 
midline between the fifth and seventh cervical vertebrae (Laghi et al. 1996). 
However, it has proved difficult to consistently achieve supramaximal stimulation 
with this, or with a similar anterior method (Mador et al. 1996; Polkey et al. 2000). 
The other method is to stimulate the phrenic nerves bilaterally from an anterolateral 
approach (BAMPS; Figure 1.9) which has been shown to be a reliable and valid 
nerve stimulation technique (Mills et al. 1996).  
 
 
 
Figure 1.9 Bilateral anterolateral magnetic phrenic nerve stimulation (BAMPS) in 
conjunction with a balloon pressure catheter system.  
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1.5.3 EXERCISE-INDUCED DIAPHRAGM FATIGUE 
The use of supramaximal bilateral phrenic nerve stimulation has 
demonstrated exercise-induced diaphragm fatigue at low (Babcock et al. 1995; 
Babcock et al. 1995; Babcock et al. 1996; Babcock et al. 2002; Johnson et al. 1993; 
Mador et al. 1993) and high frequencies (Babcock et al. 1998). Reductions of 15‒
30% in Pdi have been observed within 10 min after short-duration exercise at 
intensities greater than 80‒85%  ̇O2max, and Pdi does not return to baseline values 
until 1‒2 h post exercise (Babcock et al. 1995; Babcock et al. 1995; Babcock et al. 
1996; Babcock et al. 1998; Babcock et al. 2002; Johnson et al. 1993; Mador et al. 
1993). For example, Johnson et al. (1993) reported diaphragm fatigue after trained 
( ̇O2max: 61  4 mL·kg
-1
min
-1
) participants undertook treadmill running or cycling 
exercise at 85 and 95%  ̇O2max for 31  8 and 14  3 min, respectively. There was a 
significant reduction in the Pdi response to supramaximal electrical bilateral phrenic 
nerve single twitch (1 Hz) and tetanic stimulation (10 and 20 Hz) undertaken at a 
range of lung volumes from total lung capacity to residual volume. Pdi partially 
recovered by 30 min and was still depressed at ~70 min (Figure 1.10).   
It has been demonstrated that short-duration maximal incremental exercise 
until the limit of volitional tolerance does not alter the Pdi response to supramaximal 
nerve stimulation (Romer et al. 2007) indicating that this type of exercise does not 
result in diaphragm fatigue. This can probably be explained by the short duration of 
exercise during which the cumulative work history of the diaphragm is not great 
enough to reach fatiguing levels (Romer et al. 2007). This observation suggests that 
both exercise intensity and duration play a part in exercise-induced diaphragm 
fatigue. To the author’s knowledge no studies have used nerve stimulation 
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techniques to examine whether the diaphragm fatigues after longer duration constant 
load exercise with an initial intensity lower than 80‒85%  ̇O2max.   
 
Figure 1.10 Transdiaphragmatic pressure (Pdi) response to supramaximal electrical 
bilateral phrenic nerve single frequency (1 Hz) and tetanic stimulation (10 and 20 
Hz) at functional residual capacity before and in recovery from running or cycling 
exercise at 95% maximal oxygen uptake shown as a percentage of baseline values 
(A) and absolute values (B). Significant difference (from baseline 
*
 P < 0.05). Values 
are mean  SE for bottom panel. Adapted from Johnson et al. (1993).  
 
Recently several reports have suggested that the diaphragm fatigues 
immediately after rather than during exercise (Kabitz et al. 2007; Kabitz et al. 2007; 
Kabitz et al. 2008a; Kabitz et al. 2008b; Kabitz et al. 2010). Using BAMPS it was 
shown that peak to peak amplitude of transdiaphragmatic (single frequency) twitch 
pressure (Pditw) progressively increases during cycling exercise (~85%  ̇O2max), but 
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fell immediately after the end of exercise. The authors’ suggested that the increase in 
Pditw during exercise was due to a rise in intracellular acidosis and respiratory drive 
which acts to increase diaphragm strength. However, these findings may be 
explained by methodological limitations. Most importantly, the studies did not 
correct for changes in lung volume during exercise. End-inspiratory and -expiratory 
lung volumes increase during exercise to facilitate an increase in VT and expiratory 
flow rates (Johnson et al. 1992). Isovolumic conditions to measure changes in Pdi are 
important as diaphragm length is a critical determinant of force output and, the Pditw 
response to nerve stimulation. An increase in lung volume lengthens the inspiratory 
muscles and reduces their force generation capabilities (Braun et al. 1982; 
Hamnegard et al. 1995; Hubmayr et al. 1989; Johnson et al. 1993). When the Pditw 
response to BAMPS was corrected for changes in lung volume Pditw decreased within 
the initial two thirds of heavy cycling exercise, and remained reduced through to task 
failure (Walker et al. 2011). In summary, the diaphragm can fatigue during exercise 
and certain factors may contribute to exercise-induced respiratory muscle fatigue.   
 
1.5.4 FACTORS CONTRIBUTING TO EXERCISE-INDUCED RESPIRATORY MUSCLE 
FATIGUE  
 
The amount of muscle mass involved with the exercise may be a factor that 
contributes to exercise-induced respiratory muscle fatigue. Diaphragm fatigue has 
not been observed in wheelchair athletes with cervical spinal cord injury after high-
intensity (>90%  ̇O2max) upper-body exercise; most likely due to the relatively low 
amount of body mass involved in producing the ventilatory response to exercise 
(Taylor et al. 2010). Furthermore, respiratory muscle work alone does not seem to be 
the main factor contributing to exercise-induced diaphragmatic fatigue. When 
Babcock et al. (1995) asked participants to mimic at rest the breathing pattern (VT 
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and fB) and respiratory muscle recruitment pattern (peak transdiaphragmatic pressure; 
Pdipeak) commensurate with that attained in the final third of a prior heavy exercise 
test (~93%  ̇O2max for 13.2  2.0 min) the Pditw response to electrical bilateral phrenic 
nerve stimulation decreased by only 8.2  3.9%. It was only when diaphragmatic 
force output was increased by ~1.5 to 2 times that the decrease in Pditw matched that 
achieved during exercise (~26%). This finding implies that the diaphragms fatigue 
threshold increases when respiratory muscle work is undertaken at rest, and the 
authors’ interpreted that this was due to blood flow requirements. At rest, there may 
be an adequate supply of blood flow available to the diaphragm whereas during 
heavy exercise there may be competition between the working diaphragm and 
locomotor muscles (Harms et al. 1997; Harms et al. 1998). This interpretation has 
been supported by a similar experimental design which reported that the increase in 
intercostal muscle blood flow that accompanies an increased ventilation and WOB 
was reduced during cycling, but not volitional hyperpnoea at rest (Vogiatzis et al. 
2009). This competition for blood flow may reduce O2 transport to the working 
respiratory muscles. Evidence from Vogiatzis et al. (2008) supports this: Trained 
cyclists ( ̇O2max: 63  4 mL·kg
-1
min
-1
) exercised for 5 min during hypoxia, normoxia 
and hyperoxia at a ̇ max (235, 290 and 325 W) designed to elicit the same VT, fB and 
WOB during each trial. The Pditw response to bilateral electrical phrenic nerve 
stimulation was decreased to the greatest extent in hypoxia. Moreover, limb and 
seventh intercostal blood flow (measured with light-absorbing tracer dye indocyanine 
green in combination with near-infrared spectroscopy) and cardiac output did not 
change during any condition. This finding suggests that during heavy exercise there 
is competition between the respiratory muscles and locomotor muscles for blood 
flow. With hypoxia there is no increase in intercostal muscle blood flow which 
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compromises O2 supply, and exacerbates diaphragmatic fatigue. However, it should 
be noted that with the limitations of the near-infrared spectroscopy technique it is 
still not known whether the diaphragm receives an increase in blood flow. It is likely 
that this increase in diaphragmatic fatigue would compromise exercise tolerance.     
 
1.5.5 EXERCISE-INDUCED RESPIRATORY MUSCLE FATIGUE AND EXERCISE 
TOLERANCE 
 
The question of whether exercise-induced respiratory muscle fatigue may 
negatively impact upon exercise tolerance has been examined by fatiguing the 
respiratory muscles with IRL or volitional hyperpnoea before commencement of 
exercise. IRL can be used to preferentially fatigue the inspiratory muscles whereas 
volitional hyperpnoea has been used to globally fatigue the respiratory muscles. 
These studies have shown that exercise capacity has decreased (Mador and Acevedo 
1991; Martin et al. 1982) or not changed (Dodd et al. 1989; Sliwinski et al. 1996; 
Spengler et al. 2000). However, these studies have either not assessed diaphragm 
fatigue (Dodd et al. 1989; Martin et al. 1982; Spengler et al. 2000) or not used 
objective nerve stimulation techniques (Mador and Acevedo 1991). Thus, it is 
possible that some of these studies may not have elicited inspiratory muscle fatigue 
before commencement of subsequent exercise, or induced fatigue that is not 
commensurate with exercise-induced inspiratory muscle fatigue (Romer and Polkey 
2008). Moreover, a significant change in breathing pattern during the subsequent 
exercise has been observed, specifically an increased fB with no change in VT (rapid, 
but not shallow breathing), and a heightened sensation of both leg and breathing 
discomfort (Mador and Acevedo 1991; Martin et al. 1982). The elevation in fB is 
caused by an increase in central motor output (Sheel et al. 2001; St Croix et al. 
2000). The conscious awareness of central motor output (via corollary discharge 
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from the motor cortex to the sensory cortex) increases perceptions of dyspnoea 
(Gandevia et al. 1981) which are both important determinants of exercise tolerance 
(Jones and Killian 2000; Presland et al. 2005). Therefore, it is unclear whether the 
reduction in exercise tolerance is due to an alteration in breathing pattern, a 
heightened sense of dyspnoea and/or, respiratory muscle fatigue.   
To avoid these confounding effects researchers have unloaded the inspiratory 
muscles with a PAV during exercise. Using this approach, Babcock et al. (2002) 
have shown that diaphragmatic fatigue was abolished after cycling exercise at ~85% 
 ̇O2max until volitional tolerance with a PAV where during the second half of 
exercise the WOB was reduced by ~50% and  ̇O2 by ~12‒13%. In contrast, when 
the exercise was performed without PAV for the same duration (9.6  0.6 min) the 
WOB and  ̇O2 were unchanged, and Pditw was reduced by 20.3  3.1% at the end of 
exercise and was still reduced 60 min into recovery.  
Harms et al. (2000) reported an improvement in exercise tolerance when a 
PAV was used with male trained cyclists ( ̇O2max: 61  4 mL·kg
-1
min
-1
). Participants 
cycled at ~90%  ̇O2max until volitional tolerance and compared to control conditions 
cycling capacity increased by 14% with a PAV, and decreased by 15% with IRL 
(Figure 1.11). However, earlier studies showed no benefit on exercise tolerance using 
a PAV (Gallagher and Younes 1989; Krishnan et al. 1996; Marciniuk et al. 1994). 
There may be several explanations for the differences in findings. Firstly, the earlier 
studies were undertaken at relatively lower exercise intensities (70‒80%  ̇O2max), 
which may not elicit diaphragmatic fatigue (see MECHANISMS BY WHICH 
RESPIRATORY MUSCLE FATIGUE MAY REDUCE EXERCISE TOLERANCE). Secondly, 
participants in those earlier studies had lower fitness levels compared with the 
participants used by Harms et al. (2000). As stated earlier, the O2 cost of breathing 
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during heavy exercise is ~5% higher in trained, compared to moderately fit, 
participants (Aaron et al. 1992a; Aaron et al. 1992b) suggesting that reducing the 
WOB would be most noticeable in the highly fit participants. Finally, Harms et al. 
(2000) utilised several familiarisation trials and multiple randomised exercise 
capacity tests in an attempt to reduce the effect of random variability on exercise 
tolerance. It must be noted, however, that a placebo group was not used by Harms et 
al. (2000) which weakens internal validity and risks participant bias. These findings 
do still suggest that diaphragm fatigue and the WOB may influence exercise 
capacity. There may be several mechanisms by which respiratory muscle fatigue 
limits exercise tolerance.  
 
 
Figure 1.11 Relationship between exercise capacity time to volitional tolerance with 
experimentally changing the work of breathing using a proportional assist ventilator 
(PAV) to unload, or inspiratory flow-resistive loading (IRL) to load, the respiratory 
muscles. Note that with PAV 16 of 21 trials were longer than control trials, whereas 
with IRL 15 of 18 trials were shorter than control trials. Adapted from Harms et al. 
(2000).    
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1.5.5.1 MECHANISMS BY WHICH RESPIRATORY MUSCLE FATIGUE MAY LIMIT 
EXERCISE TOLERANCE 
 
Exercise-induced respiratory muscle fatigue may limit exercise tolerance by 
decreasing the relative contribution of the diaphragm to total ventilation. As stated 
earlier (see RESPIRATORY MECHANICS AND KINEMATICS DURING EXERCISE), when 
exercise progresses there is a gradual increase in the recruitment of rib cage muscles 
to deliver the ventilatory response (Aliverti et al. 1997). This has also been 
demonstrated at higher intensity (80‒85%  ̇O2max) constant-load exercise until the 
limit of volitional tolerance (Babcock et al. 1995; Babcock et al. 1995; Babcock et al. 
1996; Babcock et al. 1998; Babcock et al. 2002; Johnson et al. 1993). The 
recruitment of less efficient respiratory muscles as exercise progresses may distort 
the chest wall (Goldman et al. 1976; Grimby et al. 1976), impair breathing 
mechanics (Dodd et al. 1988; Hart et al. 2002) and thus increase the metabolic and 
blood flow demands of these muscles. Accessory respiratory muscle recruitment may 
also increase the perception of dyspnoea by increasing sensory input to the central 
nervous system (Romer and Polkey 2008). Respiratory muscle fatigue may also 
increase the severity of dyspnoea (Gandevia et al. 1981; Supinski et al. 1987; Suzuki 
et al. 1992; Ward et al. 1988). However, this effect seems to be localised to the 
accessory inspiratory muscles as diaphragm fatigue does not increase neural drive 
(Luo et al. 2001), and specific resistive loading of the diaphragm does not increase 
the perception of inspiratory effort (Bradley et al. 1986; Ward et al. 1988)       
A more probable mechanism by which respiratory muscle fatigue may limit 
exercise tolerance are cardio-respiratory interactions during exercise. In 2002, 
Jerome Dempsey’s research group in Wisconsin, USA, proposed that fatiguing 
respiratory muscle contractions cause a fatigue-induced metaboreflex (Figure 1.12) 
(Dempsey et al. 2002). There is compelling evidence for the metaboreflex from 
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animal studies. After the diaphragm or abdominal muscles are stimulated electrically, 
pharmacologically or infused with a bolus of lactic acid there is an increase in 
efferent sympathetic activity and mean arterial pressure whereas limb vascular 
conductance decreases (Hussain et al. 1991; Offner et al. 1992; Rodman et al. 2003). 
For example, when lactic acid is infused into the phrenic and deep circumflex 
arteries (which supply the diaphragm and abdominal muscles) of dogs at rest and 
during sub-maximal exercise mean arterial pressure increased by 21% and cardiac 
output was reduced by 6% (Rodman et al. 2003). Furthermore, limb perfusion was 
reduced by 20% which was caused by an increased locomotor muscle sympathetic 
nerve activity. These vascular responses appear to be sympathetically mediated 
because the effects were not observed with pharmacological blockade of the 
adrenergic receptors.  
 
Figure 1.12 Respiratory muscle metaboreflex is started by respiratory muscle fatigue 
mediated supraspinally through group III/VI afferents and resulting in 
sympathetically mediated vasoconstriction of limb locomotor vasculature increasing 
peripheral locomotor muscle fatigue and (via feedback) increases the perception of 
dyspnoea and thus contributing to limit high-intensity exercise tolerance (Dempsey 
et al. 2002). Adapted from Romer and Polkey (2008).    
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There is evidence for the metaboreflex in humans. When participants 
undertake inspiratory and expiratory resistive loading at rest until task failure (or 
diaphragm fatigue) there is a time dependent increase in muscle sympathetic nerve 
activity in the resting leg; even with a compensatory increase in systemic blood 
pressure (St Croix et al. 2000). This is accompanied by a decrease in limb vascular 
conductance (femoral blood flow measured with Doppler ultrasound / mean arterial 
pressure) and a reduction in limb blood flow (Sheel et al. 2001; Sheel et al. 2002). In 
exercise the interpretation of the metaboreflex is complex as the increase in muscle 
blood flow depends upon the combination of vasodilators and vasoconstrictors 
(Romer and Polkey 2008). Harms et al. (1997) have shown an increase in vascular 
conductance and blood flow to the limbs when the WOB is reduced with a PAV 
during heavy exercise. Conversely, increasing the WOB with IRL causes the 
opposite effect, and there are decreases in limb vascular conductance and limb blood 
flow. It could be speculated that the change in limb vascular conductance was 
sympathetically mediated as these changes with the WOB were correlated with 
changes in noradrenaline spillover. However, direct recordings of sympathetic nerve 
activity are more accurate than noradrenaline (Folkow et al. 1983), and recently this 
has been undertaken during exercise (Katayama et al. 2012). Participants cycled at 
sub-maximal intensities (~40% peak oxygen uptake;  ̇O2peak) for 15 min with 
spontaneous breathing throughout or IRL (5 min at MIP = 30% and TI/TTOT = 0.5) in 
the middle third of exercise. Muscle sympathetic nerve activity (via 
microneurography of the right median nerve at the elbow) was increased to a greater 
extent with IRL than spontaneous breathing (83.4 vs. 19.2%) even with a 
compensatory increase in systemic blood pressure (Figure 1.13). In a prior exercise 
trial of the same intensity, and with IRL, global inspiratory muscle fatigue (via MIP) 
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decreased by ~10%. These results suggest that inspiratory muscle fatigue increases 
muscle sympathetic vasomotor outflow (metaboreflex), and these findings have been 
recently confirmed (Katayama et al. 2013). However, the assessment of inspiratory 
muscle fatigue was measured with MIP and exercise can reduce central drive 
globally contaminating the interpretation of MIP (ATS/ERS 2002). Furthermore, 
with this small amount of global inspiratory muscle fatigue it could be speculated 
that, during exercise (but not at rest; Sheel et al. (2001) and St Croix et al. (2000)), 
muscle sympathetic nerve activity increases without fatiguing respiratory 
contractions. What is still unknown regarding the metaboreflex is whether it occurs 
during dynamic heavy whole-body exercise.  
     
Figure 1.13 Recordings of flow, blood pressure (BP) and muscle sympathetic nerve 
activity (MSNA) during 15 min cycling exercise at ~40% peak oxygen uptake with 5 
min of inspiratory flow-resistive loading (IRL) during the middle third of exercise. 
Note the increase in BP and MSNA during IRL. Adapted from Katayama et al. 
(2012).     
 
The metaboreflex may also increase peripheral locomotor fatigue and the 
perceptions of leg effort during high-intensity (>90%  ̇O2peak) exercise (Romer et al. 
2006). After the respiratory muscles were unloaded with a PAV there was an 
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increase in cycling exercise capacity, a reduction in the amount of quadriceps fatigue 
(via twitch force from magnetic stimulation of femoral nerve), and a reduction in leg 
effort perceptions compared to control conditions of the same exercise duration (13.2 
 0.9 min). Conversely, when respiratory muscle force output was increased with 
IRL there was the opposite effect, and quadriceps fatigue was exacerbated, there was 
a decrease in exercise duration (7.0  0.6 min), and heightened leg effort perceptions. 
Recently, it has been shown that prior fatigue of the quadriceps can also mediate the 
opposite effect and increase respiratory effort sensations (Grippo et al. 2010). Whilst 
the metaboreflex is important during exercise; it does not play a role during 
respiratory muscle fatigue following resistive loading or volitional hyperpnoea 
(breathing-induced respiratory muscle fatigue).     
 
 
1.5.6 BREATHING-INDUCED RESPIRATORY MUSCLE FATIGUE 
Using nerve stimulation techniques, peripheral low frequency diaphragm 
fatigue has been observed after restive loading (Laghi et al. 1995; Laghi et al. 1996; 
Mador et al. 1996; Moxham et al. 1981; Sheel et al. 2001; Sheel et al. 2002; 
Travaline et al. 1997a; Travaline et al. 1997b) and volitional hyperpnoea (Babcock et 
al. 1995; Hamnegard et al. 1996; Mador et al. 1996; Mador et al. 2002; Rafferty et al. 
1999; Renggli et al. 2008; Verges et al. 2009; Verges et al. 2010) undertaken at rest.  
The limitations of IRL has been discussed previously (see WORK OF 
BREATHING DURING EXERCISE), and most studies have used this protocol to induce 
(and examine) the mechanisms of diaphragmatic fatigue. The difficulty with 
interpreting the findings from volitional hyperpnoea is that most, but not all 
(Babcock et al. 1995), have not mimicked the WOB and/or respiratory muscle 
recruitment patterns that are commensurate with whole-body exercise (see WORK OF 
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BREATHING DURING EXERCISE). When the WOB and/or respiratory muscle 
recruitment patterns are mimicked the degree of fatigue is reduced. For example, 
when Babcock et al. (1995) asked participants to mimic at rest the breathing pattern 
(VT = 2.7 L and fB = 43 breaths·min
-1
) and respiratory muscle recruitment pattern 
(Pdipeak) commensurate with heavy exercise for ~13 min the Pditw response to bilateral 
electrical phrenic nerve stimulation decreased by ~8%. In contrast, Renggli et al. 
(2008) reported that the Pditw response to cervical magnetic stimulation decreased by 
~20% following 8 min of volitional hyperpnoea where only VT (~2.9 L) and fB (~46 
breaths·min
-1
)
 
were controlled. The differences could be explained by stimulation 
techniques, but most likely (as breathing pattern was similar) by an increase in end-
expiratory lung volume and thus increased WOB by the participants in the Renggli et 
al. (2008) study. This has previously been observed when participants attempt to 
mimic the pressure-volume characteristics of exercise hyperpnoea (Klas and 
Dempsey 1989).   
  
1.5.6.1 MECHANISMS FOR BREATHING-INDUCED DIAPHRAGM FATIGUE 
The aetiology for breathing-induced diaphragm fatigue is considerably 
different from that observed after whole-body exercise. Metabolite accumulation 
(hydrogen ions, inorganic phosphates and potassium) within the respiratory muscles 
may explain part of diaphragmatic fatigue after high levels of work. Indeed, 
volitional hyperpnoea increases blood lactate concentration both at rest (Brown et al. 
2008; Renggli et al. 2008; Verges et al. 2009; Verges et al. 2010), and when 
superimposed upon exercise (Brown et al. 2012; Johnson et al. 2006) suggesting that 
the respiratory muscles are capable of net lactate release. It has also been reported 
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that oxidative stress may play a role in breathing-induced diaphragmatic fatigue (see 
BREATHING-INDUCED OXIDATIVE STRESS AND RESPIRATORY MUSCLE FATIGUE).  
During longer duration respiratory muscle work (with isocapnia) peripheral 
diaphragm fatigue may relate to a reduction in respiratory muscle glycogen content. 
Due to experimental limitations there is no data on the effect of increased respiratory 
muscle work on diaphragm glycogen content. There are, however, many well 
controlled animal studies showing a reduction in diaphragm glycogen content in rats 
after prolonged and strenuous exercise (Fregosi and Dempsey 1986; Green et al. 
1987; Green et al. 1988; Ianuzzo et al. 1987; Namiot et al. 1985; Namiot and Gorski 
1988). Green et al. (1987) reported a decrease (73‒80%) in glycogen (measured 
microphotometrically using the periodic acid-Schiff technique) in the diaphragms of 
rats after 30 min treadmill running (25 metre·min
-1
 and 8% grade) compared to 
control animals. In another group of rats that continued exercising until exhaustion 
(which represented an additional 94 min) no further reduction in diaphragm glycogen 
was evident, suggesting that at least in the early phase of exercise, the respiratory 
muscles are dependent upon glycogen as a substrate. Supporting this, there is also a 
decrease in diaphragm glycogen content (~30% measured microphotometrically 
using the periodic acid-Schiff technique) in sheep exposed to high resistive loads 
(>150 cmH2O·L
-1
·s) (Bazzy et al. 1988). Interestingly, respiratory muscle fatigue 
(assessed after task failure) occurred at a time when considerable glycogen was still 
present in type I fibres in the diaphragm suggesting that only a small reduction is 
required to initiate task failure. Although not demonstrated in humans it could be 
speculated that a decrease in respiratory muscle glycogen, in part, contributes to 
breathing-induced diaphragm fatigue. The previous sections have shown that the 
WOB is considerable during exercise and can result in diaphragm fatigue. This can 
35 
 
contribute to locomotor fatigue and subsequently reduce exercise tolerance. Many 
experiments have used a PAV to reduce the WOB. However, the use of a PAV 
during exercise competition or with patients that exhibit an increased WOB at rest is 
impractical. As a consequence, specific training of the respiratory muscles may 
provide a unique alternative to potentially improve exercise tolerance.  
 
1.6 RESPIRATORY MUSCLE TRAINING 
1.6.1 HISTORICAL PERSPECTIVES 
Respiratory muscle training (RMT) was first developed in clinical 
populations by Delhez et al. (1966) where 3 s Müller manoeuvres were repeated for 8 
weeks resulting in an increased MIP of 37%. It was concluded that the increase in 
inspiratory muscle strength (which was a surprising finding at the time) may reduce 
the potential for the respiratory muscles to limit ventilatory work. The now classic 
study by Leith and Bradley in 1976 was the first to investigate the effects of RMT on 
the strength and endurance of the respiratory muscles. They observed that 5 weeks of 
RMT using repeated static inspiratory manoeuvres over the vital capacity range 
(strength training) improved MIP by 55% whereas volitional hyperpnoea training at 
rest (endurance training) improved maximal sustainable ventilatory capacity by 18%. 
This was the first study to demonstrate that known training principles apply to the 
respiratory muscles. These training principles still apply to modern day RMT which 
can be performed using voluntary isocapnic hyperpnoea (VIH), flow-resistive 
loading and pressure-threshold loading.  
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1.6.2 RESPIRATORY MUSCLE TRAINING TECHNIQUES 
1.6.2.1 VOLUNTARY ISOCAPNIC HYPERPNOEA 
VIH requires the participant to increase  ̇E to a prescribed level for a given 
period of time. Typical training intensities are 50‒80% of the individual maximum 
voluntary ventilation (MVV) with fB fixed at 30‒45 breaths·min
-1
 and a VT of 50‒
60% of vital capacity (~2.5 to 3.0 L). VIH is performed for ~30 min daily and for up 
to 4 weeks (Boutellier and Piwko 1992; Boutellier et al. 1992; McMahon et al. 2002; 
Morgan et al. 1987; Spengler et al. 1999). The accurate monitoring of breathing 
pattern is fundamental to VIH in order to maintain the prescribed training intensity. 
VIH causes a rapid reduction in arterial partial pressure of carbon dioxide (PCO2). 
Additional CO2 is added to the inspiratory breathing circuit to maintain isocapnia 
using either laboratory based equipment to monitor end-tidal and/or PCO2 or by 
using a re-breathing bag. The re-breathing bag (typically fixed at 50% vital capacity) 
inflates during expiration and the remainder of the expirate is released into the 
atmosphere. In the subsequent inspiration the inspirate is comprised of both 
atmospheric and CO2 enriched air from the re-breathing bag. Early studies had 
participants undertake VIH within the laboratory. More recently, commercially 
available portable devices have been made available (Figure 1.14).  
VIH is used to improve respiratory muscle endurance rather than strength. It 
targets the velocity axis of the respiratory muscle force-velocity curve and both the 
inspiratory and expiratory muscles are trained. Considerable improvements in 
respiratory muscle endurance have been observed after VIH with Boutellier and 
Piwko (1992) an increase from 4.2 to 15.3 min after 4 weeks of VIH in untrained 
individuals. Larger increases have been reported from trained individuals after VIH 
with increases from 6.1 to 40 min in healthy trained individuals (Boutellier et al. 
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1992), 9.8 to 36.7 min in moderately trained males reporting (Verges et al. (2007) 
and 14.7 to 36.0 min in well-trained competitive runners (Leddy et al. 2007).  
VIH has very high external validity as it mimics the ventilatory response to 
exercise. However, training sessions are time consuming and often require 
supervision and/or specialised and expensive equipment. The high flow rates 
required with VIH may also cause chronic dying of the airways leading to 
bronchoconstriction (McConnell and Romer 2004).       
 
  
Figure 1.14 Example of commercially available portable voluntary isocapnic 
hyperpnoea respiratory muscle training device. CO2, carbon dioxide. Adapted from 
www.spirotiger.com.   
 
1.6.2.2 FLOW-RESISTIVE LOADING 
During flow-resistive loading participants inspire through a variable sized 
aperture which provides resistance. During inspiration the pressure generated by the 
inspiratory muscles (i.e., training resistance) is dependent upon inspiratory flow rate. 
Thus, monitoring the breathing pattern during training is important as a decrease in 
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inspiratory flow rate reduces the amount of resistance and therefore inspiratory load. 
A novel approach to flow-resistive loading has been to use the ‘TIRE’ system (Test 
of Incremental Respiratory Endurance) where an inspiratory pressure (based on a 
percentage of MIP) is attained for six repetitions with 60 s recovery between 
inspiratory efforts. Training sessions require participants to inspire repeatedly against 
a load of 80‒100% MIP until the target pressure can no longer be maintained and are 
typically for 3 days per week for 4 to 10 weeks (Enright et al. 2006; Gething et al. 
2004a; Gething et al. 2004b). To increase the training intensity the recovery time 
between breaths is reduced (Enright et al. 2006; Gething et al. 2004a; Gething et al. 
2004b).  
Flow-resistive loading specifically targets the inspiratory muscles. The 
specific effect of flow-resistive loading on the inspiratory muscle force-velocity 
curve is dependent upon inspiratory flow rate and the amount of resistance. 
Improvements in both strength and endurance of the inspiratory muscles have been 
observed using the TIRE system. Improvements in MIP of 18‒41% have been 
reported after 4 to 6 weeks (Enright et al. 2006; Gething et al. 2004a). Improvements 
in inspiratory muscle endurance have also been observed. For example, sustained 
inspiratory pressure (which requires participants to inspire maximally from residual 
volume to total lung capacity over 30 s) increases from 36 to 47% (Enright et al. 
2006; Gething et al. 2004a). Diaphragm thickness (via B mode ultrasonography) at 
functional residual capacity has been reported to increase by 12% (Enright et al. 
2006). Enright et al. (2006) also reported an increase in vital capacity and total lung 
capacity from 4.1 to 4.4 L and 5.7 to 6.1 L, respectively. It was suggested that these 
improvements were not due to increases in absolute lung volume but rather the 
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increased ability of the upper chest wall and neck inspiratory muscles to expand the 
thorax at greater lung volumes.  
However, flow-resistive loading has weak external validity as it bears no 
relation to the dynamic inspiratory muscle function observed during whole-body 
exercise. Furthermore, the TIRE system is costly and can only be utilised within the 
laboratory setting by most users. The training is also physically demanding with each 
session lasting ~30 min. 
  
1.6.2.3 PRESSURE-THRESHOLD LOADING    
Both flow-resistive loading and pressure-threshold loading are commonly 
referred to as inspiratory muscle training (IMT). Pressure-threshold IMT requires the 
participant to produce a negative pressure to overcome a threshold load and initiate 
inspiration. Pressure-threshold IMT allows variable loading to determine intensity. 
This type of loading has been achieved by using a weighted plunger (Clanton et al. 
1985a), a solenoid valve (Bardsley et al. 1993) and a constant negative pressure 
system (Chen et al. 1998). More recently, commercially available devices are also 
available with a spring-loaded poppet valve (Figure 1.15; Caine and McConnell 
2000). From here on, unless otherwise stated, it will be assumed that studies have 
utilised this type of device. With pressure-threshold IMT, each inspiratory 
manoeuvre is initiated from residual volume and VT is maximised. A rapid full 
inspiration minimises changes in PCO2 and negates the use of supplemental CO2 or a 
re-breathing bag. Pressure-threshold IMT is also near flow-independent (Caine and 
McConnell 2000). Thus, there is little requirement to monitor breathing pattern 
during training. Recently, another device has been made available with both an 
inspiratory and expiratory threshold load (IMT/EMT).   
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Figure 1.15 Example of commercially available pressure-threshold inspiratory 
muscle training device. Adapted from www.powerbreathe.co.uk.   
  
Pressure-threshold IMT targets the inspiratory muscles. The specific effect of 
pressure-threshold IMT on the inspiratory muscle force-velocity (pressure-flow) 
curve is dependent upon the load. Romer and McConnell (2003) have demonstrated 
the specificity of this. Participants were assigned to different 3 groups and undertook 
pressure-threshold IMT (30 breaths, twice per day, 6 times per week for 9 weeks at 
~50% MIP) with the following loads; high resistance-low flow (A), low resistance-
high flow (B), intermediate resistance and flow (C) or no pressure-threshold IMT 
(D). Group A exhibited the largest increase in inspiratory pressure, group B a large 
increase in inspiratory flow rate, group C uniform increases in inspiratory pressure 
and flow rate and group D no changes in inspiratory pressure or flow rate (Figure 
1.16). The most common training intensity used is intermediate resistance and flow 
(Brown et al. 2008; Brown et al. 2010; Brown et al. 2012; Johnson et al. 2007; 
McConnell and Sharpe 2005; Romer et al. 2002a). Training durations greater than 6 
weeks, do not provide any further benefit (Figure 1.16). Throughout pressure-
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threshold IMT the tension spring is periodically tightened to increase the training 
load and to accommodate the rapid improvement in MIP. This gives a very precise 
training load.   
 
Figure 1.16 Relative changes in maximum inspiratory flow rate (A) and maximum 
inspiratory pressure (B) after 3, 6 and 9 weeks of pressure-threshold inspiratory 
muscle training (IMT) with high resistance-low flow (Group A), low resistance-high 
flow (Group B), intermediate resistance and flow (Group C) or no pressure-threshold 
IMT (Group D). Significant difference (from pre-intervention 
*
 P < 0.05; from 
preceding measurement point 
^
 P < 0.05). Values are mean  SE. Adapted from 
Romer and McConnell (2003).  
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Increases in MIP of 17‒55% have been reported after 6 weeks of pressure-
threshold IMT (Brown et al. 2008; Brown et al. 2010; Brown et al. 2012; Johnson et 
al. 2007; McConnell and Sharpe 2005; Romer et al. 2002a). Additionally, pressure-
threshold-IMT improves the pressure-flow characteristics of the inspiratory muscles. 
IMT increases optimal inspiratory pressure (25%), optimal inspiratory flow rate 
(17%) and the maximum rate of pressure development (18%) (Romer et al. 2002a). 
The product of inspiratory pressure and flow (inspiratory muscle power) also 
increases by 49% (Romer et al. 2002a). Additional reports have shown an increase in 
diaphragm thickness (via B mode ultrasonography) of 8‒12% after IMT (Downey et 
al. 2007).  
Pressure-threshold IMT however has weak external validity as it bears no 
relation to the dynamic inspiratory muscle function observed during whole-body 
exercise. It is, however, very cost effective, easy to use, and is less time consuming 
than other modes of RMT with each session usually lasting ~5 min.    
 
1.6.3 RESPIRATORY MUSCLE TRAINING AND EXERCISE PERFORMANCE  
Many studies have investigated the effects of RMT on whole-body exercise 
performance. Interpretation of the findings is confounded by the many different tests 
used to measure changes in exercise performance. Furthermore, researchers have 
used a variety of RMT modes, durations and intensities, and many have used an 
inappropriate sample size and/or lack of appropriate controls. Recently, two 
systematic review articles with meta-analyses have been published regarding the 
effects of RMT on exercise performance (Hajghanbari et al. 2012; Illi et al. 2012). 
Illi et al. (2012) reviewed studies that have utilised RMT to assess changes in 
endurance exercise performance by maximal tests (constant load, time trial, repeated 
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sprint and maximal incremental) in rowing, running, swimming and cycling exercise 
modalities.  
Multiple linear regressions were undertaken on 46 original studies accepted 
and the model used accounted for the influence of confounders such as modality, 
type of RMT and test duration. The findings are summarised as follows: The overall 
mean difference in the effect of RMT on exercise performance between intervention 
and sham-training or no-training control groups was 11%, while subgroup 
differences were 21% for constant load tests, 13% for repeated sprint tests, and 2% 
for time trials and maximal incremental tests. Furthermore, repeated sprint tests 
(+19%) and constant load tests (+16%) detect changes in performance better than 
maximal incremental tests with no difference between time trials and maximal 
incremental tests.  
The meta-analysis was undertaken on 8 controlled studies that were selected 
on the basis that they included a sham-training or no-training control group and that 
they reported the relative change and standard deviation in exercise performance. 
This allowed the overall difference in exercise performance between RMT and the 
sham/no-training control group to be calculated. Mean relative differences in 
exercise performance were standardised based on their standard deviations as relative 
improvements in time trials are generally much smaller compared with those in 
constant load trials. Standardised mean difference (SMD) was 1.11. A subgroup 
analysis of the studies revealed that performance was improved to the greatest extent 
when assessed by a repeated sprint test (SMD: 2.96), a time trial (SMD: 1.85), and a 
constant load test (SMD: 0.66). No significant improvement in performance was 
detected by a maximal incremental test (SMD: 0.30).  
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Further multiple linear regressions were also undertaken on the 46 original 
studies. Participants with the lowest baseline whole-body fitness levels had the 
largest performance improvements after RMT (6% per 10 mL·kg
-1
·min
-1
 decrease in 
 ̇O2max). There were no differences in performance improvements between IMT and 
VIH, but combined IMT/EMT had greater performance improvements (+13% 
compared with IMT). With increasing test duration improvements in performance are 
greater (+0.4% per minute test duration), and the modality of exercise does not 
influence the magnitude of improvements.  
It must be noted, however, that this publication has several limitations: 
Firstly, out of the 49 studies (only 46 accepted) that were initially selected only 28 
(57%) were randomised controlled trials, 6 (12%) were controlled trials and 15 
(31%) were non-controlled trials. Secondly, the median quality score of research was 
2 out of 7, suggesting that the quality of work was low. A final consideration is that a 
funnel plot revealed potential publication bias suggesting an absence of negative 
smaller studies.  
 In summary, although the systemic review with meta-analyses from Illi et al. 
(2012) has limitations, it suggests the following: 1) RMT improves performance; 2) 
improvements in performance are best detected (in order) by repeated sprint tests, 
constant load tests and time trials; 3) improvements cannot be detected by maximal 
incremental tests; 4) the greatest improvements are in participants with the lowest 
baseline whole-body fitness levels; 5) the two most common RMT methods (VIH 
and IMT) do not differ significantly in their effect, while IMT/EMT might be 
superior; 6) performance is greater with longer test durations; and 7) the type of 
exercise modality does not influence the magnitude of improvements.  
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1.6.4 POSSIBLE MECHANISMS FOR IMPROVEMENT IN EXERCISE PERFORMANCE  
There may be many possible mechanisms to explain the finding that RMT 
improves performance (Table 1.1). Research indicates that improvements in 
performance are not due to cardiovascular adaptations, most likely because of the 
moderate cardiovascular demand placed on the whole-body during RMT (Markov et 
al. 2001; Romer et al. 2002a; Stuessi et al. 2001). 
Genuine physiological adaptations have been observed after RMT. There is 
an increase in the proportion of type I (38%) and size of type II (21%) fibres in the 
external intercostals (taken via biopsy) of chronic obstructive pulmonary disease 
(COPD) patients after 5 weeks of pressure-threshold IMT (Ramirez-Sarmiento et al. 
2002). Potentially, this increase in respiratory muscle oxidative capacity may 
decrease the WOB during exercise. Indeed, using the difference between whole-body 
 ̇O2 during exercise and the  ̇O2 during volitional hyperpnoea at rest Turner et al. 
(2012) observed that respiratory muscle  ̇O2 decreased by 1.5% at 75%  ̇O2max and 
3.4% at 100%  ̇O2max after 6 weeks of pressure-threshold IMT. These results suggest 
that IMT may decrease the O2 cost of breathing. However, the WOB was not 
mimicked during volitional hyperpnoea (see WORK OF BREATHING DURING 
EXERCISE), and it could be speculated that the decrease in the O2 cost of breathing 
after IMT was related to a change respiratory muscle recruitment patterns during 
volitional hyperpnoea. An improvement in O2 transport has also been reported after 
IMT. After 4 weeks of pressure-threshold IMT the  ̇O2 slow component was reduced 
during high-intensity (0.60 to 0.53 L·min
-1
) and maximal cycling exercise (0.28 to 
0.18 L·min
-1
) until the limit of volitional tolerance (Bailey et al. 2010). IMT also 
reduced the severity of global inspiratory muscle fatigue (via MIP). An attenuation of 
respiratory muscle fatigue using nerve stimulation techniques has been observed. 
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Verges et al. (2007) reported that 4‒5 weeks of VIH attenuated the reduction in Pditw 
response to cervical magnetic stimulation following high-intensity cycling exercise 
(~85% ̇ max), but only in participants who demonstrated a reduction in Pditw greater 
than 10%.  
The RMT adaptations in O2 utilisation within the respiratory muscles, 
improvements in O2 delivery and reduction respiratory muscle fatigue may be 
involved in attenuating the respiratory muscle metaboreflex. This would improve 
limb blood flow (and O2 delivery) and potentially reduce locomotor fatigue; although 
this is not yet investigated. Witt et al. (2007) reported that the sympathetic response 
to fatiguing diaphragmatic work during resistive loading (MIP = 60%, fB = 15 
breaths·min
-1
 and TI/TTOT = 0.7) is attenuated after 5 weeks of pressure-threshold 
IMT. Before IMT, cardiac frequency (fC) and mean arterial pressure were 83  4 
beats·min
-1
 and 99  3 mmHg at task failure (~9 min). When resistive breathing was 
undertaken for the same duration and intensity after IMT, fC and mean arterial 
pressure were reduced to 74  42 beats·min-1 and 89 mmHg, respectively.  
McConnell and Lomax (2006) reported that prior fatigue of the inspiratory 
muscles using a similar resistive breathing task reduced subsequent isolated plantar 
flexion performance relative to a control trial. The reduction in performance in the 
control trial was similar to when a pressure cuff was fastened around the leg which 
reduced leg blood flow from 7.75  1.70 to 6.86    1.24 mL·min·mmHg-1. After 4 
weeks of pressure-threshold IMT (and with a similar volume of inspiratory muscle 
work prior to plantar flexion exercise) the time to the limit of tolerance was 
significantly improved. The improvement in plantar flexion exercise tolerance was 
attributed to an IMT-mediated improvement in leg blood flow following fatiguing 
inspiratory muscle work. This finding has also been demonstrated in chronic heart 
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failure patients where calf blood flow during fatiguing inspiratory muscle work was 
increased as was forearm blood flow during intense handgrip exercise after 4 weeks 
of pressure-threshold IMT (Chiappa et al. 2008).     
These indirect measures suggest a possible role for RMT in attenuating the 
respiratory muscle metaboreflex during intense exercise with fatiguing 
diaphragmatic work. However, many studies have shown that RMT improves 
performance during exercise below the threshold for diaphragm fatigue and the 
respiratory muscle metaboreflex. For example, pressure-threshold IMT improves 20 
and 40 km time trial performance where the average power output is ~75%  ̇max 
(Romer et al. 2002a). Thus, other possible mechanisms are likely to underpin the 
improvements in performance observed at sub-maximal exercise intensities. These 
mechanisms may be decreased systemic blood lactate concentrations ([La
-
]B) and/or 
a reduction in the perception of locomotor or respiratory effort perceptions. 
 
Table 1.1 Possible mechanisms for the improvement in performance after respiratory 
muscle training. 
Reference Possible mechanism 
Bailey et al. (2010) Improved oxygen uptake kinetics 
Griffiths and McConnell (2007); 
Romer et al. (2002c) 
Decreased respiratory and limb effort 
perceptions 
McConnell and Lomax (2006); 
Witt et al. (2007) 
Attenuated respiratory muscle metaboreflex 
McConnell and Sharpe (2005); 
Spengler et al. (1999) 
Decreased systemic blood lactate concentration 
Ramirez-Sarmiento et al. (2002) Increase in proportion of type I and size of type 
II fibres in the external intercostals (COPD 
patients) 
Turner et al. (2012) Decreased oxygen cost of breathing 
Verges et al. (2007) Attenuated respiratory muscle fatigue 
  
COPD, chronic obstructive pulmonary disease.  
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A common observation after RMT is a reduction in systemic [La
-
]B which has 
been reported during maximal incremental cycling (Spengler et al. 1999), 6 min 
maximal rowing (Griffiths and McConnell 2007; Volianitis et al. 2001), constant 
power exercise until the limit of tolerance (Bailey et al. 2010; Boutellier and Piwko 
1992; Leddy et al. 2007; Spengler et al. 1999), exercise at maximal lactate steady-
state (MLSS; McConnell and Sharpe 2005) and during repeated sprint exercise 
(Romer et al. 2002b; Tong et al. 2008). The reductions (>2 mmol·L
-1
) are often 
similar to those observed after whole-body exercise training. Recently, several 
reports have also observed a reduction in [La
-
]B during volitional hyperpnoea at rest 
following RMT (Brown et al. 2008; Verges et al. 2009). Reductions in [La
-
]B after 
RMT may occur when trained respiratory muscles either increase their lactate uptake 
and metabolism or decrease efflux, or a combination of both (Spengler et al. 1999). 
During intense exercise a reduction in circulating metabolites may attenuate the 
discharge of chemosensitive afferent fibres located within the diaphragm which is 
known to trigger the respiratory muscle metaboreflex (Rodman et al. 2003).  
During sub-maximal exercise the lower [La
-
]B may be more important in 
attenuating the perceptions of limb discomfort. Romer et al. (2002b) observed a 
significant correlation between the change in systemic [La
-
]B and total recovery time 
taken between repeated sprints, as well as the reduction in the rating of perceived 
exertion (RPE). Thus, favourable changes in acid-base balance may be associated 
with the reduction in the intensity of peripheral effort sensations.  
Many studies have reported a decrease in respiratory effort perceptions after 
RMT (Bailey et al. 2010; Romer et al. 2002a; Romer et al. 2002b; Verges et al. 2007; 
Volianitis et al. 2001). Along with the previous mechanisms discussed, there may be 
several possibilities that reduce respiratory effort perceptions during exercise. The 
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enhancement in respiratory drive that initiates ventilation and which is detected by 
the sensory brain centres intensifies the perception of dyspnoea (el-Manshawi et al. 
1986). However, after pressure-threshold IMT the pressure generated during first 0.1 
s of inspiration (providing a measure of respiratory muscle motor drive) decreases by 
22% (Huang et al. 2003). Kellerman et al. (2000) also reported a reduction in motor 
output to the respiratory muscles and the magnitude estimation of the inspiratory 
load to varying amounts of resistive loads after 4 weeks of pressure-threshold IMT. 
Kellerman et al. (2000) attributed the findings to an attenuated discharge of 
respiratory muscle mechanoreceptors. Throughout repeated bouts of RMT sensory 
afferents within the respiratory muscles may become desensitised. Repeated 
exposures to high metabolite concentrations which may occur during RMT would 
reduce the afferent-mediated efferent response to a given change in metabolite 
concentration during subsequent exercise (Sinoway et al. 1992; Sinoway et al. 1993). 
Improvements in inspiratory muscle strength may also reduce the absolute force 
generated (Kellerman et al. 2000) and detected (Redline et al. 1991) for a given 
ventilation.  
The improvement in performance after RMT may be related to one, or many, 
of the mechanisms discussed. It is most probable that they are all linked. McConnell 
and Romer (2004) have suggested that the improvement in performance after RMT 
may relate to a reduction in the discomfort associated with high levels of respiratory 
muscle work and/or fatigue. They hypothesise that the increase in respiratory muscle 
strength and/or fatigue resistance after RMT may decrease inhibitory feedback from 
respiratory muscles during exercise. This may delay the recruitment of less efficient 
accessory muscles, reduce operating lung volumes, and/or reduce the fraction of 
maximum tension generated with each breath. Potentially, this may reduce 
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respiratory muscle metabolite accumulation, and/or minimise the effects of the 
respiratory muscle metaboreflex, while leading to reductions in both limb fatigue and 
peripheral effort sensations and therefore improving performance. Whilst this is an 
interesting hypothesis it is yet to be proven. Since there is not one specific 
mechanism that can be attributed to the improvement in performance after RMT, and 
since performance is not always improved, it has resolved in controversy 
surrounding the area.   
 
 
1.6.5 RESPIRATORY MUSCLE TRAINING AND CONTROVERSY 
Controversy has surrounded the benefits of RMT on improving inspiratory 
muscle strength (Caine and Sharpe 2002; Hart et al. 2001; McConnell et al. 2002; 
Polkey and Moxham 2004) and exercise tolerance (McConnell and Romer 2004; 
McConnell 2012; Patel et al. 2012). It is commonly understood that changes in 
inspiratory muscle strength measured via MIP do not correlate with improvements in 
performance. Therefore, this debate will not be discussed. The debate regarding the 
ergogenic benefit of RMT on exercise tolerance has two opposing views; those who 
feel there is no benefit of RMT and those who feel the marginal gains are worthwhile 
for the small effort involved. This debate most likely stems from two issues: Firstly, 
there is not one single attributable mechanism to the improvement in performance 
unlike whole-body exercise training (e.g., increased  ̇O2max); and secondly, unlike 
whole-body exercise training performance is not always improved, and if it is the 
gains are marginal. The issue may relate to study design. An improvement in 
performance will be only shown if the exercise outcome is sensitive to RMT and the 
sample size is large enough to demonstrate an effect (Illi et al. 2012). Furthermore, 
the study should be designed with the appropriate controls. For studies using clinical 
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populations that are unaccustomed to exercise this may require many participants. In 
contrast, in studies with reliable, trained individuals a smaller amount may be 
required. Alternatively, like most interventions (e.g., supplements), RMT seems to 
have responders and non-responders (Guenette et al. 2006) and, therefore, an effect 
may not be observed in all participants. For clinicians using RMT to improve a 
patient’s tolerance to exercise this may not be acceptable as a “treatment” should 
either work or not and if it does the mechanisms should be evident. Until a study 
either demonstrates a conclusive mechanism, or an effect on performance with a 
large sample size, this debate may continue. One area of RMT that has received little 
attention is the ageing population. This is surprising since the ageing respiratory 
system undergoes significant changes which RMT may improve.    
 
 
1.7 THE RESPIRATORY SYSTEM IN HEALTHY AGEING 
Three physiological events can account for most of the changes in the 
respiratory system during healthy ageing: 1) a progressive increase in lung 
compliance; 2) a progressive decrease in chest wall compliance; and 3) a progressive 
decrease in the strength of the respiratory muscles.  
Lung static elastic recoil pressure measured in 20 to 60 year olds was 
reported to progressively decease at an average rate of 0.1 to 0.2 cmH2O per year 
(Turner et al. 1968). The factors that contribute to this may be changes in the spatial 
arrangement and/or cross linking of the elastic fibre network (Fukuchi 2009). This 
becomes more pronounced after 50 years of age and may lead to a homogenous 
enlargement of air spaces causing a reduction in alveolar surface area (Fukuchi 
2009). These changes functionally resemble emphysema, but histologically they are 
not associated with evidence of a destruction of alveolar walls (Verbeken et al. 
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1992). The decrease in parenchymal elasticity increases lung compliance and the 
static pressure-volume curve is shifted to the left and a steeper slope (Turner et al. 
1968).  
Chest wall compliance was reported to decrease (~31%) with age in 50 
participants from 24 to 75 years (Estenne et al. 1985). Chest wall stiffening may be 
related to calcifications of the costal cartilages and chrondosternal junctions, or 
degenerative joint disease of the dorsal spine as these are often observed in chest 
radiographs (Edge et al. 1964). Chest wall mechanics are also changed by alterations 
in the shape of the thorax. Osteoporosis can result in partial (wedge) or complete 
(crush) vertebral fractures leading to increased dorsal kyphosis and 
anteroposteriordiamater (barrel chest) (Cummings and Melton 2002; Gunby and 
Morley 1994).  
The reduction in chest wall compliance is somewhat greater than the increase 
in lung compliance. Therefore, total respiratory system compliance decreases and is 
~20% less in an individual of 60 years compared to an individual of 20 years of age 
(Turner et al. 1968).  This adaptation does not change total lung capacity. However, 
at relaxed end-expiration the rate of the decrease in lung recoil with ageing exceeds 
that of the chest wall so that functional residual capacity increases by 1 to 3% per 
decade (Zaugg and Lucchinetti 2000). Since total lung capacity remains unchanged, 
there is an increase in residual volume of 5 to 10% per decade which results in air 
trapping and a decrease in vital capacity of 20 to 30 mL per year (Zaugg and 
Lucchinetti 2000). The increase in residual volume is due to the loss of elastic recoil, 
and to a lesser extent a change in respiratory muscle function. 
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1.7.1 RESPIRATORY MUSCLE FUNCTION IN HEALTHY AGEING 
Respiratory muscle function is impaired by the concomitant changes in 
geometric modifications to the rib cage, decreased chest wall compliance and 
increase in functional residual capacity. The remodelling of the chest wall with 
ageing flattens the curvature of the diaphragm shifting its length-tension relationship 
to a shorter length, placing the diaphragm at a mechanical disadvantage and 
decreasing its force generating capabilities (Edge et al. 1964; Polkey et al. 1997; 
Polkey et al. 1998).  
Indeed, inspiratory muscle strength has been shown to decrease with age 
whether measured volitionally, or objectively using non-volitional nerve stimulation 
techniques. A study of 668 ambulatory participants aged 20 to 90 years of age 
showed that MIP for males and females decreased from 117.6 and 79.5 cmH2O 
below the age of 40 years to 66.0 and 45.5 cmH2O above the age of 75 years (Harik-
Khan et al. 1998). Tolep et al. (1995) also reported that Pdipeak during a maximum 
Müller manoeuvre was 25% lower in older (~68 years) compared to younger (~24 
years) adults. Lastly, Polkey et al. (1997) measured the paired Pdi response to cervical 
magnetic stimulation and the sniff Pdipeak during a Müller manoeuvre in 15 older (~73 
years) and 15 younger (~29 years) adults. Both Pdi (-23%) and sniff Pdi (-13%) were 
lower in older adults.  
In addition to the reduction in inspiratory muscle strength there is also a 
decrease in inspiratory muscle endurance and an increase in the O2 cost of breathing 
The maximum sustained inspiratory pressure at task failure after incremental 
pressure-threshold loading (5 cmH2O increases every 2 min with breathing pattern 
controlled) was significantly correlated with age in 60 participants aged 20 to 80 
years, demonstrating that time to task failure was lower in older adults (Johnson et al. 
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1997). However, it could be speculated that changes in central drive during ageing 
made these participants susceptible to task failure earlier. Respiratory muscle  ̇O2 at 
rest was also significantly correlated with age (r = 0.77, P < 0.01) in 37 males aged 
23 to 77 years of age, indicating that the O2 cost of breathing increases with age 
(Takishima et al. 1990).  
Apart from the remodelling of the chest wall the factors that contribute to the 
age-related changes in respiratory muscle function are poorly understood. In humans 
there is very limited data, but it has been suggested that the decrease in inspiratory 
muscle strength is related to nutritional status which is often deficient in ageing. A 
study of 4443 ambulatory participants showed that there are significant correlations 
between MIP and lean body mass (measured with bioelectrical impedance) or total 
body mass (Enright et al. 1994). Alternatively, it could be speculated that age-related 
changes in respiratory muscle function are due to morphological changes. However, 
Caskey et al. (1989) evaluated diaphragm muscle thickness using computed 
tomography in 120 participants from the ages of 30 to 80 years and reported that it 
did not change significantly with increasing age. In contrast, Marzani et al. (2005) 
reported that Type I fibres (performed histochemically using myofibrillar ATPase 
staining) in the rectus abdominis increased from 44% in adults aged 18 to 48 to 59% 
in older adults aged 66 to 99 years.  
The data regarding morphological changes in the diaphragms of ageing rats 
compared to younger controls is inconsistent. There are inconsistencies regarding 
fibre types (Table 1.2). Furthermore, muscle fibre cross sectional area does not 
change (Kavazis et al. 2012; van Lunteren et al. 1995) and diaphragm weight either 
increases (Powers et al. 1996; Smith et al. 2002), or does not change with ageing 
(Criswell et al. 1997; Criswell et al. 2003; Powers et al. 1991). Interestingly, it has 
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been demonstrated with in vitro isolated diaphragm muscle strips that there is an 
increase in the maximum shortening of older compared to younger rats (Powers et al. 
1996). The decrease in inspiratory muscle strength could be explained, in part, by an 
age-related increase in the water content of the diaphragm and a decrease in 
myofibrillar protein concentration. Criswell et al. (1997) reported that maximal 
tetanic force (normalised to the cross-sectional area) of in vitro diaphragm strips was 
16.4% lower in the diaphragms of older rats. There was, however, no difference in 
total diaphragm mass between younger and older rats, but an age-related increase in 
the water content of the diaphragm and a decrease in myofibrillar protein 
concentration. Recently, using three-dimensional confocal microscopy and 
histochemical staining it has been reported that in the diaphragms of ageing rats there 
is a decreased motor endplate, especially on type IIb/x fibres (Suzuki et al. 2009). 
These morphological changes may contribute to the decreased force production and 
selective denervation of type IIb/x muscle fibres with aging. The decrease in 
inspiratory muscle endurance with ageing is also difficult to explain as the activity of 
oxidative enzymes in the diaphragms of ageing rats is either higher (Powers et al. 
1992a; Powers et al. 1992b) or lower (Smith et al. 2002) than younger controls. The 
inconsistent findings with ageing rats may be related to differences in rat breed, age 
at sampling, or methodological techniques. Furthermore, the findings in the 
respiratory muscles are inconsistent with the locomotor muscles of humans where 
there is a decrease in the number, and cross sectional area, of type II fibres in the 
vastus lateralis (Lexell 1995). This may be due to the load bearing work undertaken 
by the locomotor muscles.   
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Table 1.2 Fibre type changes performed histochemically using myofibrillar ATPase 
staining or myosin heavy chain isoforms in the diaphragms of aging rats compared 
with younger controls.   
Reference 
Fibre type change with ageing  
Type I Type II Type IIa Type IIb/x 
Eddinger et al. (1985) ↑ N/A ↓ ↔ 
Gosselin et al. (1992b) ↔ ↔ N/A N/A 
van Lunteren et al. (1995) ↓ ↑ N/A N/A 
 
    
 
Myosin heavy chain isoform change with ageing 
Type I Type II Type IIa Type IIb/x 
Gosselin et al. (1992a) ↑ ↓ N/A N/A 
Gosselin et al. (1994) ↔ N/A ↑ ↑ 
Powers et al. (1996) ↔ N/A ↓ ↑ 
Smith et al. (2002) ↔ N/A ↓ ↑ 
 
N/A, not applicable 
 
1.7.2 RESPIRATORY MUSCLE TRAINING IN AGEING 
To date, four published studies have examined the effects of RMT in older 
adults (Table 1.3). After IMT or IMT/EMT there was an increase in MIP of 21‒39% 
(Aznar-Lain et al. 2007; Huang et al. 2011; Watsford and Murphy 2008). Belman 
and Gaesser (1988) and Watsford and Murphy (2008) both observed changes in 
pulmonary function after RMT. Belman and Gaesser (1988) an increase in vital 
capacity after VIH, and Watsford and Murphy (2008) forced expiratory volume in 1 
s (FEV1) and peak expiratory flow (PEF) after IMT/EMT. In younger adults the 
changes following VIH or IMT/EMT in these pulmonary function measures are 
equivocal (Griffiths and McConnell 2007; Leddy et al. 2007; Verges et al. 2007; 
Wells et al. 2005). In contrast, FVC is rarely, and PEF never, changed after IMT in 
younger adults (Brown et al. 2008; Brown et al. 2010; Brown et al. 2012; Johnson et 
al. 2007). Improvements in respiratory muscle endurance have also been observed. 
Belman and Gaesser (1988) observed an increase in maximum sustainable 
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ventilatory capacity and MVV. Watsford and Murphy (2008) also observed an 
increase in MVV and incremental pressure-threshold loading. Exercise capacity was 
shown to be unchanged following maximal incremental exercise (Aznar-Lain et al. 
2007; Belman and Gaesser 1988) which is consistent with younger adults (Illi et al. 
2012). Exercise capacity did increase during constant load exercise (Aznar-Lain et al. 
2007) and during a time trial (six minute walking test; 6MWT) (Huang et al. 2011). 
Perception of effort during exercise was equivocal with one study observing a 
decrease (Watsford and Murphy 2008), or no change (Belman and Gaesser 1988) 
after RMT. Other findings include an increase in physical activity levels (PAL) and 
quality of life (QoL) measures. Using accelerometers to record quantitative PAL, 
Aznar-Lain et al. (2007) reported an increase in moderate to vigorous physical 
activity (MVPA). Aznar-Lain et al. (2007)  suggested this was due to an increase in 
the intensity of exercise performed as no other accelerometry measure changed after 
IMT. Huang et al. (2011) also observed an increase in the physical subcategory of 
the Short Form-36 (SF-36) QoL questionnaire.  
 
 
 
58 
 
Table 1.3 Respiratory muscle training studies using older adults. 
 
6MWT, six minute walk test; EMT, expiratory muscle training; IMT, inspiratory muscle training; ITL, incremental pressure-threshold loading; MEP, maximal expiratory 
pressure; MIP, maximal inspiratory pressure; MSVC, maximum sustainable ventilatory capacity; MVPA, moderate to vigorous physical activity; MVV, maximum voluntary 
ventilation; PEF, peak expiratory flow; QoL, quality of life; RPE, rating of perceived exertion; VC, vital capacity; VIH, voluntary isocapnic hyperpnoea
Reference 
Participants 
(Male/Female) 
Age 
(years) 
RMT 
Intervention 
duration 
RMT 
frequency 
RMT 
duration 
RMT 
Intensity 
Exercise tests Outcomes 
          Aznar-
Lain et al. 
(2007) 
2/7 68.5  
6.3 
IMT 8 wk 3–5 x wk 8–10 sets 
/ 5–6 
reps 
50% MIP 1. Maximal 
incremental 
treadmill 
2. Exercise 
capacity at first 
ventilatory 
threshold 
↑ MIP  
↔ exercise capacity to 1 
↑exercise capacity to 2 
↑MVPA 
 
Belman 
and 
Gaesser 
(1988)  
7/5 69.7  
0.8 
VIH 8 wk 4 x wk 2 x 15 
min∙d-1  
70% 
MVV 
1. Maximal 
incremental 
treadmill 
2. 12 min at 
70%  ̇O2max 
treadmill 
↑ respiratory endurance (MSVC and MVV) 
↑ VC 
↑ ventilatory reserve 
↔ exercise capacity to 1 
↔ in cardiorespiratory responses to 1 and 2 
↔ in RPE leg and dyspnoea 
Huang et 
al. (2011) 
22/2 70.6  
4.8 
IMT 6 wk 5 x wk 4 sets / 6 
reps 
75% MIP 1. 6MWT ↑ MIP  
↑ 6MWT distance 
↓ RPE dyspnoea 
↑ QoL 
Watsford 
and 
Murphy 
(2008) 
0/13 64.8  
2.5 
IMT/
EMT 
8 wk 12 x wk Mixed 
sets / 
reps 
30% MIP 1. 6 min 
incremental 
treadmill 
↑ FVC, PEF, MIP and MEP 
↑ respiratory endurance (ITL) 
↓ RPE dyspnoea 
↑ ventilatory reserve 
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Taken together, these studies suggest that RMT is effective in older adults 
and there are increases in inspiratory muscle strength and endurance, pulmonary 
function, exercise capacity (in outcome tests that are sensitive to RMT), PAL, QoL 
and a decrease in effort perceptions during exercise. Nevertheless, these studies have 
risked participant bias by failing to employ a placebo group (Belman and Gaesser 
1988; Huang et al. 2011; Watsford and Murphy 2008), or are limited by a small 
sample size which may incur a type 2 error (Aznar-Lain et al. 2007). 
A novel area in exercise and respiratory physiology has been the study of the 
inflammatory response to exercise. Recent data also indicates that during increased 
levels of work the respiratory muscles also produce and release inflammatory 
markers. Whether RMT can change this response is unknown. The thesis will now 
turn its focus on to this area.  
 
1.8 INFLAMMATION 
The immune system is a network of cells, proteins, tissues, and organs that 
cooperate to defend the body against attacks from elements that are foreign. The 
primary function of the immune system is to maintain homeostasis. This is achieved 
through the recognition and elimination of noxious stimuli (e.g., invading 
pathogens), and the repair and removal of damaged or abnormal tissue. This can 
occur during sepsis, trauma or disease. When the cellular elements of the immune 
system are challenged by noxious stimuli there is a local response known as 
inflammation. At the site of inflammation there is the initiation the acute-phase 
response.  
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1.9 THE ACUTE-PHASE RESPONSE AND ACUTE-PHASE PROTEINS    
The acute-phase response is characterised by fever, altered vascular 
permeability and metabolic and pathological changes, and typically lasts between 24 
to 72 h (Baumann and Gaulde 1994). The cascade of the acute-phase response is 
initiated and coordinated by a range of cells and inflammatory mediators. At the 
local site of the sepsis, trauma or disease by macrophages, and systemically in the 
blood by monocytes (Baumann and Gaulde 1994). These cells produce cytokines 
which stimulate adjacent cells in the surrounding tissue to release additional 
cytokines and chemokines, and initiate inflammation and infiltration. Cytokines 
released in the systemic circulation also stimulate the production of hepatic acute-
phase proteins. 
Acute-phase proteins can be classed as positive or negative depending on if 
their plasma concentration increases (positive) or decreases (negative) by at least 
25% during the acute-phase (approximately the first 7 days) of inflammatory 
conditions (Gabay and Kushner 1999; Morely and Kushner 1982; Sheet and 
Whitehead 1994). The physiological significance of a decrease of certain plasma 
proteins during the acute-phase response is not fully understood, but it has been 
suggested that negative acute-phase proteins may be non-essential for the protection 
of the host during inflammatory conditions (Gabay and Kushner 1999). Positive 
acute-phase proteins have a variety of physiological functions such as destroying or 
inhibiting the growth of microbes, restricting the inflammatory response, providing 
coagulations factors and contributing to the innate immune system by increasing 
vascular permeability and chemoattracting phagocytic cells (Gabay and Kushner 
1999). Negative acute phase proteins may allow amino acids to focus on producing 
positive acute-phase proteins more efficiently (Gabay and Kushner 1999). 
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1.10 THE CYTOKINE  
The word ‘cytokine’ originates from the Greek word ‘cyto’ meaning cell and 
‘kine’ meaning movement. Cytokines are simple peptides, proteins or glycoproteins 
with a molecular weight ranging from 6000 to 60,000 kDa (Akira et al. 1993). They 
are produced by, and communicate with, immune and non-immune cells, organs and 
organ systems throughout the body. The cytokine family also includes chemokines 
which are small cytokines or proteins (8‒10 kDa) (Luster 1998). The name 
chemokines is based on their ability to chemoattract leukocytes.  
When cytokines are produced they influence target cells. The type of target 
cell chosen by a particular cytokine is determined by the type of specific receptor on 
its surface. The receptor may be present on the surface of the same cell that produces 
the cytokine. This is termed autocrine regulation - regulating the activity of a cell by 
its own product (Figure 1.17A). Alternatively, the target receptor may be present 
only on the surface of another cell and not on the producer cell. If the target cell 
resides close to the producer cell this is termed paracrine regulation - regulating the 
activity of a different cell by its product (Figure 1.17B). Also, a producer cell can 
exert its actions on target cells that reside in distant parts of the body or in other 
tissues or organs. This is similar to the action of polypeptide hormones and is termed 
endocrine regulation (Figure 1.17C).  
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Figure 1.17 Regulation of cytokines. A) autocrine regulation; B) paracrine 
regulation; C) endocrine regulation.  
 
1.10.1 MEASUREMENT OF CYTOKINES  
Although the gene expression of cytokines were not measured in the 
experimental chapters of this thesis these techniques have been important in 
determining the cellular sources of cytokines that will be described in more detail 
later. Thus, a short overview will be given: Messenger ribonucleic acid (mRNA) can 
be measured with reverse transcription polymerase chain reaction (RT-PCR), 
Northern blotting or microarrays. The protein expression of cytokines can be 
63 
 
measured with several techniques including Western blot, histochemical staining or 
by enzyme linked immunosorbant assay (ELISA). 
The ELISA has become the ‘gold standard’ in measuring systemic (blood-
borne) cytokine concentrations. ELISA is a biochemical technique used to detect the 
presence of an antigen (cytokine) in a sample (Figure 1.18). ELISA is simple and 
reliable, and the development of commercially available kits has been the stimulus 
for a plethora of research into the cytokine response to exercise. From here on unless 
otherwise stated, it will be assumed that systemic cytokine concentrations have been 
measured using ELISA. 
 
 
Figure 1.18 A) Sandwich enzyme linked immunosorbant assay (ELISA). 1) A 
surface is prepared to which a known quantity of capture antibody (specific for the 
cytokine) is bound; 2) the antigen-containing sample (e.g., plasma) is added to the 
plate; 3) a specific antibody is added, and binds to the antigen (sandwich); 4) 
enzyme-linked secondary antibodies are applied; and 5) a chemical is added to be 
converted by the enzyme into a colour or fluorescent signal and the absorbency 
signal of the plate wells is measured to determine the presence and quantity of the 
cytokine (B). Note the left hand side wells increase in colour concentration and thus 
cytokine concentration.  
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1.10.2 SYSTEMIC CYTOKINE RESPONSE TO EXERCISE 
Using ELISA the systemic response of various plasma cytokines to prolonged 
and strenuous exercise has been observed (Figure 1.19). During exercise such as a 
marathon there is a substantial (100-fold) increase in the plasma concentration of 
interleukin-6 (IL-6) which is followed by cytokine inhibitors interleukin-1 receptor 
antagonist (IL-1ra), soluble tumour necrosis factor-α receptor (sTNF-αr) and the anti-
inflammatory cytokine interleukin-10 (IL-10) (Ostrowski et al. 1999). Significant 
increases also occur in the concentrations of chemokines interleukin-8 (IL-8), 
macrophage inflammatory protein-α (MIP-α) and macrophage inflammatory protein-
1β (MIP-1β) (Ostrowski et al. 2001). Only very prolonged exercise with an eccentric 
component results in a small increase in the plasma concentrations of classical pro-
inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) 
(Ostrowski et al. 1999). This is markedly different to the cytokine response to 
infections where there is a dramatic increase in TNF-α (Pedersen and Febbraio 
2008). The primary cytokine investigated in response to exercise has been IL-6. This 
is due to the large increase IL-6 during and in recovery from prolonged and 
strenuous exercise 
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Figure 1.19 Plasma cytokine response during and in recovery from prolonged and 
strenuous exercise such as a marathon. IL-1, interleukin-1; IL-1ra, interleukin-1 
receptor antagonist; IL-6, interleukin-6; IL-8, interleukin-8; MIP-1β, macrophage 
inflammatory protein-1β; sTNF-αr, soluble tumour necrosis factor-α receptor; TNF-
α, tumour necrosis factor-α. Adapted from Pedersen and Toft (2000).   
 
 
1.11 INTERLEUKIN-6 
IL-6 is part of a family of cytokines which includes interleukin-11, oncostatin 
M, leukemia inhibitory factor, ciliary neurotrophic factor, cardiotrophin-1 and 
cardiotrophin-like cytokine (Heinrich et al. 2003). IL-6 is a glycoprotein with a 
molecular mass of 22‒27 kDa, but this can be dependent upon the cellular source of 
IL-6 and the amount of post-translation modification (Pedersen et al. 2001). 
During muscular contraction IL-6 signals by binding to type 1 plasma 
membrane receptor complexes containing the transducing receptor chain 
glycoprotein 130 homodimer and ligand binding chain (gp130rα/IL-rβ) (Pedersen 
and Febbraio 2008). It has been recently shown that c-Jun N-terminal 
kinase/activator protein-1 (JNK/AP-1) signalling controls IL-6 transcription in 
contracting skeletal muscle rather than the classical view of inflammatory 
IKKβ/NFκβ signalling (Whitham et al. 2012). 
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1.11.1 EFFECTS OF DURATION, INTENSITY AND MODALITY  
Overall, the combination of duration, intensity, and modality of the exercise 
determines the magnitude of the exercise-induced IL-6 increase. Fischer (2006) has 
shown that the single most important factor in determining the plasma IL-6 response 
to exercise is duration (Figure 1.20). The author reviewed 74 exercise trials using 4 
different modalities and ~800 participants. Linear regression of the data 
demonstrated that 51% of the variation in the plasma IL-6 increase can be explained 
by the duration of exercise. This review has also been recently supported 
experimentally by the finding that plasma IL-6 concentration is higher following a 
full- compared to a half-distance marathon (Reihmane et al. 2012).  
Scott et al. (2011) have recently reported that the plasma IL-6 response to 
exercise is also dependent upon intensity. Plasma IL-6 concentration immediately 
after 1 h of treadmill running was higher at an intensity of 75%  ̇O2max compared to 
intensities of 65 or 55%  ̇O2max. Furthermore, although not statistically significant, 
the plasma IL-6 concentration was higher at 65% compared to 55%  ̇O2max.  
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Figure 1.20 The overall log10-log10 linear relation between exercise duration and fold 
change in plasma interleukin-6 (IL-6). Based on data from 74 exercise trials using 4 
different modalities and ~800 participants.  Adapted from Fischer (2006). 
 
It was initially hypothesised that IL-6 release was related to muscle damage, 
and that a greater IL-6 response may occur after an eccentric rather than a concentric 
modality (Bruunsgaard et al. 1997). This hypothesis was based on two observations: 
Firstly, when the duration and intensity of exercise was identical systemic IL-6 
concentrations were higher following primarily eccentric exercise, and lower 
following primarily concentric exercise; and secondly, eccentric (but not concentric) 
exercise was significantly correlated to markers of muscle damage such as creatine 
kinase (Bruunsgaard et al. 1997). However, research using primarily eccentric 
exercise modalities (Croisier et al. 1999; Ostrowski et al. 1999; Starkie et al. 2001a), 
and a modified cycle ergometer to perform purely eccentric exercise (Toft et al. 
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2002), has now conclusively shown that eccentric exercise is not associated with a 
higher plasma IL-6 concentration than exercise involving non-damaging muscle 
contractions (Figures 1.20 and 1.21). Rather, the amount of muscle mass involved 
with the modality is important, as when larger muscle groups are utilised as in 
running or swimming, there is a greater systemic IL-6 response (Gomez-Merino et 
al. 2006; Nieman et al. 1998). This is primarily due to the source of IL-6 during 
exercise.       
 
Figure 1.21 Different modes of exercise and the corresponding increase in plasma 
interleukin-6 (IL-6). Based on data from 74 exercise trials using 4 different 
modalities and ~800 participants. Values are mean log10-log10  SD. Adapted from 
Fischer (2006).  
 
1.11.2 SOURCE OF INTERLEUKIN-6 DURING MUSCULAR CONTRACTIONS 
A variety of cells can be activated to express IL-6 in vivo. The primary 
sources include activated monocytes and macrophages, fibroblasts and endothelial 
cells; with other cellular sources being T and B cells, neutrophils, eosinophils, 
osteoblasts and keratinocytes (Akira et al. 1993). Monocytes and macrophages are 
classed as peripheral blood mononuclear cells (PBMC) and are the major sources of 
IL-6 during sepsis, trauma or disease (Akira et al. 1993). However, it has been 
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consistently demonstrated that PBMC (Ullum et al. 1994), and in particular 
monocytes (Starkie et al. 2000; Starkie et al. 2001b), do not produce IL-6 during 
exercise.  
Research primarily from the muscle research group in Copenhagen, Denmark 
has now fully established that contracting skeletal muscle is the primary source of 
IL-6 during exercise. Ostrowski et al. (1998) were the first to provide evidence that 
IL-6 is released from contracting skeletal muscle and utilised comparative 
polymerase chain reaction (PCR) to quantify if the vastus lateralis and/or PBMC 
produced IL-6 mRNA before and after a marathon. At rest, IL-6 mRNA in muscle 
was undetectable, but at the end of the marathon it was detectable in 4 PCR product 
bands (the amount of DNA was not quantified). IL-6 mRNA was not expressed in 
PBMC. However, in addition to myocytes, muscle biopsies can contain many other 
types of cells that are known to produce IL-6 including smooth muscle cells, 
fibroblasts, endothelial cells and macrophages (Cicco et al. 1990; De Rossi et al. 
2000; Jirik et al. 1989; Klouche et al. 1999). Therefore, the increase in IL-6 mRNA 
detected following exercise could be from various other cells other than myocytes.   
Steensberg et al. (2000) supported the finding from Ostrowski et al. (1998) 
and provided strong evidence that contracting skeletal muscle can account for nearly 
all the production and release of IL-6. Seven males performed one-legged dynamic 
knee extensor exercise (a purely concentric model) for 5 h at ~40%  ̇max and IL-6 
release from exercising and resting legs was measured using the arterial–venous 
difference technique. This technique involves inserting one indwelling catheter into 
the femoral artery (same blood supply for both legs) and two other catheters into the 
femoral veins (one for each leg). The arterial–femoral venous (a–fv) differences for 
exercising and resting legs were determined as arterial plasma IL-6 concentration -
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venous plasma IL-6 concentration. Net release of IL-6 from exercising and resting 
leg was calculated using Ficks principle: Blood flow (via Doppler ultrasonography) ∙ 
a–fv difference. The results of this study are presented in Figure 1.22 and 
demonstrate that net IL-6 release from the exercising leg almost entirely accounts for 
the increase in the systemic plasma IL-6 concentration. Importantly, even though the 
femoral arteries to both the resting and exercising legs had the same supply of 
assorted hormones, metabolites, and other potential IL-6 mediators no net release of 
IL-6 was detected in the resting leg indicating that the release of IL-6 from the 
muscle is dependent upon the muscle contracting, and not upon secreted factors such 
as adrenaline. This study, however, does not conclusively demonstrate that skeletal 
muscle is the source of IL-6 during exercise. The a–fv difference technique can only 
measure the net uptake or release of a specific molecule (e.g., IL-6) over a specific 
area of tissue (e.g., the upper leg).  
 
 
Figure 1.22 Net release of interleukin-6 (IL-6) from exercising and resting legs 
during 5 h one-legged dynamic knee extensor exercise at ~40% of maximal power 
output. Significant difference (from rest 
*
 P < 0.05; between exercising and resting 
leg 
^ 
P < 0.05). Values are mean  SD.  Adapted from Steensberg et al. (2000). 
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As discussed above, the detection of IL-6 mRNA from muscle biopsies and 
IL-6 production/release using the a–fv difference technique is limited. To 
conclusively find the cellular source of IL-6 within contracting skeletal muscle 
Hiscock et al. (2004) determined IL-6 in muscle protein and mRNA in myofibres 
before and after 2 h of semi-recumbent cycling exercise (~55%  ̇O2peak) using 
immunohistochemistry and in situ hybridisation. This is a valid, reliable, and 
sensitive method of localising and detecting specific mRNA sequences in 
morphologically preserved tissue sections. After exercise, there was an increase in 
IL-6 protein content in the periphery of individual myofibres (Figure 1.23) and an 
increase in IL-6 mRNA. This finding and others (Malm et al. 2000) provide 
convincing evidence that contracting skeletal myocytes are the primary source of IL-
6 during and following exercise. Since this finding IL-6 has been termed a myokine.  
 
 
Figure 1.23 Interleukin-6 protein content in the periphery of individual human 
myofibres (stained green) before (A) and after (B) 2 h semi-recumbent cycling 
exercise at ~55% peak oxygen uptake. Adapted from Hiscock et al. (2004)  
 
Along with myocytes, an increase in IL-6 has been detected in other sources 
after exercise. These include the brain (Nybo et al. 2002), adipose (Lyngso et al. 
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2002) and peri-tendon (Langberg et al. 2002) tissue. The mutual contribution of these 
sources (compared with skeletal muscle) to systemic IL-6 is unclear, but it is 
suggested that it they contribute very little (Pedersen and Febbraio 2008). Since 
almost any cell type may produce IL-6 with adequate stimulation (Akira et al. 1993), 
future research may reveal further sites that contribute to systemic IL-6 in response 
to exercise. 
 
1.11.3 STIMULI FOR INTERLEUKIN-6 DURING MUSCULAR CONTRACTIONS 
Skeletal myocytes can produce IL-6 in response to various stimuli ex vivo, 
including incubation with lipopolysaccharide (Bergmann et al. 1999), calcium-
sensitive phosphatase calcineurin (Banzet et al. 2007), reactive oxygen species 
(ROS; Kosmidou et al. 2002), nitric oxide (NO; Makris et al. 2010), and 
inflammatory cytokines (Febbraio and Pedersen 2002). However, the unique 
characteristic of human skeletal muscle is that it can produce IL-6 during contraction 
in the absence of inflammatory markers (Febbraio and Pedersen 2002), and 
independent of TNF-α (Keller et al. 2006), linking IL-6 to metabolism rather than 
inflammation.  
The most potent stimuli for the production of IL-6 in human skeletal muscle 
during exercise may be low muscle glycogen content. It is commonly understood that 
during prolonged and strenuous exercise the glycogen content in contracting skeletal 
muscle decreases and the contracting muscles become reliant upon blood glucose for 
an energy substrate. Based on this understanding, and the findings of Steensberg et 
al. (2000), it led researchers to hypothesise that IL-6 may be produced and released 
from the contracting muscles, signalling to the liver to increase its glucose output, 
maintaining substrate homeostasis (Gleeson 2000). This should prevent an extreme 
73 
 
fall in the blood glucose concentration. Thus, IL-6 is produced and released due to an 
‘energy crisis’ within the contracting muscle. This hypothesis expanded on previous 
findings that found carbohydrate ingestion attenuates increases in plasma IL-6 
concentration during prolonged and strenuous exercise (Nehlsen-Cannarella et al. 
1997; Nieman et al. 1998). 
To test the ‘energy crisis’ hypothesis Steensberg et al. (2001) employed a 
similar experimental design to the study undertaken previously (Steensberg et al. 
2000), but with pre-exercise muscle glycogen stores altered. The day before the main 
experimental trial, muscle glycogen content in the quadriceps of one leg was 
depleted by participants undertaking 1 h of one-legged cycling exercise followed by 
1 h of two-armed cranking. On the day of the main experimental trial, participants 
then performed 4‒5 h (point of volitional tolerance) of two-legged knee extensor 
exercise at ~40%  ̇max. Once again, the a–fv difference technique was utilised. 
Figure 1.24 clearly shows that during the first 3 h of exercise the net release of IL-6 
was higher in the glycogen depleted leg than the control leg, but they were similar 
post exercise. These results are supported by others (Keller et al. 2001) and provide 
strong evidence that the glycogen availability in contracting skeletal muscle is 
associated with changes to the rate of IL-6 production and release in those muscles 
during exercise - supporting the ‘energy crisis’ hypothesis.  
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Figure 1.24 Net release of interleukin-6 (IL-6) from glycogen depleted and control 
legs during and in recovery from 4‒5 h one-legged dynamic knee extensor exercise 
at ~40% of maximal power output. Significant difference (from rest 
*
P < 0.05; 
between glycogen depleted and control leg 
^
 P < 0.05). Values are mean  SD. 
Adapted from Steensberg et al. (2001).  
 
1.11.4 POSSIBLE BIOLOGICAL ROLES OF INTERLEUKIN-6 DURING MUSCULAR 
CONTRACTIONS 
 
The pleiotropic nature of IL-6 means that it has a variety of biological roles 
during muscular contractions, and when it is released peripherally it acts in an 
endocrine like manner (Table 1.4 and Figure 1.25). Febbraio et al. (2004) have 
elegantly shown that IL-6 released from contracting skeletal muscle during exercise 
may signal to the liver to stimulate hepatic glucose production. Participants 
performed 2 h of cycling exercise on separate days at 70%  ̇O2peak, 40%   ̇O2peak or 
40% ̇ O2peak plus constant infusion of recombinant human (rh) IL-6 at a rate intended 
to match the elevated plasma IL-6 concentration observed during the 70%  ̇O2peak 
trial (~9 pg·mL-1). Hepatic glucose production was estimated from endogenous 
glucose production by infusing participants with a glucose stable isotope during all 
trials. Endogenous glucose production was significantly higher during the 40% 
 ̇O2peak plus rhIL-6 trial compared to the 40%  ̇O2peak trial, and was very similar to 
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the endogenous production seen during the 70%  ̇O2peak trial. Interestingly, there 
were no differences in the systemic concentrations of cortisol, insulin, glucagon or 
catecholamines (adrenaline or noradrenaline) between 40%  ̇O2peak plus rhIL-6 trial 
compared to the 40%  ̇O2peak trial suggesting that IL-6 was responsible for 
stimulating hepatic glucose production and not these markers that are also known to 
stimulate glucose production.  
 
Table 1.4 Possible biological roles of interleukin-6 during muscular contraction.  
Reference Possible biological role  
Carey et al. (2006) Stimulate glucose uptake in myocytes 
Febbraio et al. (2004) Stimulate hepatic glucose production 
Steensberg et al. (2003) Stimulate C-reactive protein, cortisol, IL-1ra and IL-10 
production 
Starkie et al. (2003) Inhibit TNF-α production  
Wolsk et al. (2010) Stimulate whole-body lipolysis and fat oxidation 
Wolsk et al. (2010) Stimulate skeletal muscle lipolysis  
Nemet et al. (2006) Stimulate growth hormone and inhibit IGF-1 production 
  
IL-1ra, interleukin-1 receptor antagonist; IL-10, interleukin-10; TNF-α, tumor 
necrosis factor-α; IGF-1, insulin-like growth factor-1.   
 
Carey et al. (2006) have reported an increase in glucose uptake in L6 
myotubes incubated with IL-6 via an increase in translocation of glucose transporter 
type 4 (GLUT4) from intracellular pools to the plasma membrane. This occurred 
through the phosphatidylinositol 3-kinase (PI3-K) pathway (Figure 1.25). This 
finding suggests that within skeletal muscle IL-6 may stimulate glucose uptake in 
myocytes, but whether this effect occurs in vivo in exercising humans remains 
unknown.   
It has been demonstrated that IL-6 has a peripheral biological role in 
stimulating lipolysis and fat oxidation using human rhIL-6 infusion for whole-body 
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(Petersen et al. 2005; van Hall et al. 2003) or subcutaneous adipose tissue (Lyngso et 
al. 2002) measurements. Recently, Wolsk et al. (2010) have provided simultaneous 
recordings of whole-body, subcutaneous adipose tissue and skeletal muscle 
measurements of lipolysis and fat oxidation in healthy humans. Lipolysis was 
estimated by infusing participants with a fatty acid stable isotope, and fat oxidation 
by measuring expired gases to calculate the respiratory exchange ratio. Catheters 
were placed into skeletal muscle and adipose tissue to record blood measurements. 
Infusing rhIL-6 for 4 h at a rate that ended in a plasma concentration of 42.19  2.70 
pg·mL
-1
 (similar to a marathon) resulted in an increase in whole-body lipolysis and 
fat oxidation, skeletal muscle lipolysis, but no effect on adipose tissue lipolysis. 
There were also no differences in systemic concentrations of insulin, glucagon, or 
adrenaline (substances that are known to stimulate lipolysis). There was a slight 
increase in cortisol, but its actions on stimulating lipolysis are still unclear 
(Macfarlane et al. 2008). Interestingly, using this in vivo model with humans, Wolsk 
et al. (2010) did not confirm that lipolysis and fatty acid oxidation occurs via an 
increase in the phosphorylation of AMP-activated protein kinase (AMPK) and signal 
transducer and activator of transcription 3 (STAT3) within skeletal muscle. This has 
been previously reported in rat skeletal muscle (Kelly et al. 2009a), L6 myotubes 
(Petersen et al. 2005) and human myocytes (Al-Khalili et al. 2006). Wolsk et al. 
(2010) found that STAT3 was only involved. The difference may be explained by the 
dose of IL-6 used for in vitro experiments where concentrations are typically 1000-
fold higher than those seen physiologically in humans. Figure 1.25 has, therefore, 
been adapted with this new information from the figure originally presented by 
Pedersen and Febbraio (2008). 
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Figure 1.25 Possible biological roles of interleukin-6 (IL-6) during muscular 
contractions. Type I and type II muscle fibres produce IL-6 which subsequently 
exerts its effects both locally within the muscle, and when released into the 
circulation peripherally in several organs in an endocrine like manner. In skeletal 
muscle IL-6 acts in an autocrine or paracrine manner to signal through a glycoprotein 
130 homodimer and ligand binding chain (gp130rα/IL-rβ) to result in activation of 
phosphatidylinositol 3-kinase (PI3-K) or signal transducer and activator of 
transcription 3 (STAT3) to increase glucose uptake or fat oxidation. Adapted from 
Pedersen and Febbraio (2008). 
  
IL-6 possesses both pro- and anti-inflammatory properties, but the current 
view is that it is primarily an anti-inflammatory cytokine (Petersen and Pedersen 
2006). When IL-6 is infused into humans it results in shock, but unlike classic 
cytokines TNF-α and IL-1, it does not cause fever and capillary leakage syndrome 
(Tilg et al. 1997). Therefore, IL-6 seems to have a role in inducing hepatocyte 
derived acute phase proteins (e.g., C-reactive protein) of which many have anti-
inflammatory properties (Steensberg et al. 2003). The anti-inflammatory properties 
of IL-6 also include the direct inhibition of the pro-inflammatory cytokine TNF-α 
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(Starkie et al. 2003) and the upregulation of cortisol and anti-inflammatory cytokines 
IL-1ra and IL-10 (Steensberg et al. 2003). It has been suggested that IL-6 mediates 
cortisols effects on neutrophil binding (Steensberg et al. 2003). IL-1ra prevents 
signal transduction of IL-1 by blocking IL-1 receptors (Dinarello 2000) and IL-10 is 
a potent inhibitor of Th1- monocyte- and macrophage- derived cytokines and 
attenuates the surface expression of TNF-α receptors amongst other roles 
(Dickensheets et al. 1997; Joyce et al. 1994). 
It has been reported that when very high concentrations of rhIL-6 are infused 
(peak concentration of 106.2  9.6 pg·mL-1) for 3 h into healthy humans there are 
increases in growth hormone and decreases in insulin-like growth factor-1 (Nemet et 
al. 2006). However, when lower concentrations of rhIL-6 are infused this effect is 
not seen (Febbraio et al. 2004) suggesting that there may be an optimum 
concentration required to achieve this effect.    
 
 
1.12 OTHER CYTOKINES IN EXERCISE 
Although other cytokines are observed in the systemic circulation following 
prolonged and strenuous exercise (Figure 1.19) very little is known about their 
cellular sources and/or biological roles. Table 1.5 reports the findings of Chan et al. 
(2004) who have shown that the mRNA expression of a number of cytokines and 
chemokines are detectable in skeletal muscle at rest, but after cycling exercise (1 h at 
70%  ̇O2peak) with and without prior glycogen depletion there was only an increase 
in the mRNA expression of IL-6 and IL-8. The results of this study are 
complimented by Nieman et al. (2003) who also reported the same findings before 
and after treadmill running (3 h at 70%  ̇O2peak) with and without carbohydrate 
feeding. Both studies suggest that IL-8 may have a biological role similar to IL-6. 
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Nieman et al. (2003), however, also reported that IL-1β and TNF-α were detectable 
after exercise without carbohydrate feeding. It is probable that this response was due 
to an inflammatory response from muscle damage and/or injury occurring during 
running exercise. During cycling, a concentric exercise, this may not occur. The 
possible biological role for these cytokines during muscle damage and/or injury will 
be explained later (see BIOLOGICAL ROLES OF BREATHING-INDUCED CYTOKINES).  
 
Table 1.5 Detection of cytokine mRNA expression at rest and after 1 h cycling 
exercise at 70% peak oxygen uptake with and without prior glycogen depletion. 
Adapted from Chan et al. (2004).   
 Cytokine 
Expression Influenced by 
glycogen content Rest Exercise 
IL-1α No No No 
IL-1β Yes No No 
IL-2 No No No 
IL-4 No No No 
IL-5 No No No 
IL-6 Yes Yes Yes 
IL-8 Yes Yes Yes 
IL-10 No No No 
IL-12p35 No No No 
IL-12p40 No No No 
IL-15 Yes No No 
IFN-γ No No No 
TNF-α Yes No No 
 
IL-1α, interleukin-1α; IL-1β, interleukin-1β; IL-2, interleukin-2; IL-4, interleukin-4; 
IL-5, interleukin-5; IL-6, interleukin-6; IL-8, interleukin-8; IL-10, interleukin-10; IL-
12p35, interleukin-12p35; IL-12p40, interleukin-12p40; IL-15, interleukin-15; IFN-
γ, interferon-γ; TNF-α, tumor necrosis factor-α.  
 
Large increases in the plasma concentrations of IL-1ra and IL-10 are 
observed following prolonged and strenuous exercise (Figure 1.19). Nieman and 
colleagues (Nieman et al. 2006; Nieman et al. 2007) reported that after 2 h cycling 
exercise at ~ 64% ̇ max IL-1ra and IL-10 mRNA expression in blood leukocytes are 
increased. Furthermore, there was also an increase in IL-8, but not IL-6 mRNA 
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expression in leucocytes suggesting that IL-8 may have dual cellular sources, and 
supports the evidence that  IL-6 is primarily released from skeletal muscle.  
 
1.13 BREATHING-INDUCED CYTOKINES 
1.13.1 BREATHING-INDUCED SYSTEMIC CYTOKINE RESPONSE 
A series of excellent studies by Vassilakopoulos and colleagues have 
provided compelling evidence that the respiratory muscles can produce and release 
cytokines (Sigala et al. 2011; Sigala et al. 2012; Vassilakopoulos et al. 1999; 
Vassilakopoulos et al. 2002; Vassilakopoulos et al. 2004). Vassilakopoulos et al. 
(1999) reported increases in the plasma concentrations of IL-6 and IL-1β of up to 
130% after IRL at ~75% MIP until task failure which occurred after 54  10 min. 
There was no significant increase in the plasma concentrations of these cytokines 
after IRL at ~35% MIP for the same duration suggesting that this was not an effect of 
experimental conditions. A later study (Vassilakopoulos et al. 2002) confirmed these 
observations using the same IRL protocol for 45 min and also reported an increase in 
plasma TNF-α concentration (Figure 1.26). Using intracellular flow cytometry, 
Vassilakopoulos et al. (2002) also excluded monocytes as the cellular source of the 
cytokines. Thus, the increase in plasma cytokine concentration was attributed to 
increased rates of release from the inspiratory muscles. 
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Figure 1.26 Plasma concentration of interleukin-1β (IL-1β), interleukin-6 (IL-6) and 
tumor necrosis factor-α (TNF-α) at rest and in recovery from 45 min inspiratory 
flow-resistive loading at ~75% maximal inspiratory pressure. Significant difference 
(from rest 
*
 P < 0.05). Values are mean  SD. Adapted from Vassilakopoulos et al. 
(2002).  
 
1.13.2 SOURCE OF BREATHING-INDUCED SYSTEMIC CYTOKINE RESPONSE 
Sigala et al. (2011) supported this suggestion and reported that when 
anaesthetised rats were exposed to IRL (~48% peak tracheal pressure) for either 1, 3 
or 6 h, or quietly breathed (control) for 6 h there was a significant time-dependent 
increase in the diaphragm protein expression of IL-6, and to a lesser extent IL-1β, 
TNF-α and IL-10 (Figure 1.27). These findings confirmed earlier reports of a 
significant increase in cytokine mRNA expression in the diaphragms of rats after a 
similar IRL protocol (Vassilakopoulos et al. 2004).   
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Figure 1.27 Protein expression of cytokines interleukin-1β (IL-1β), interleukin-6 
(IL-6), interleukin-10 (IL-10) and tumor necrosis factor-α (TNF-α) in the diaphragm 
of rats after 6 h of tidal breathing (control) or 1, 3 and 6 h of inspiratory flow-
resistive loading at ~48% peak tracheal pressure. Significant difference
 
(from control 
*
 P < 0.05). Values are mean  SE. Adapted from Sigala et al. (2011).      
 
More evidence for the upregulation of cytokines within the respiratory 
muscles due to increased respiratory muscle work has come from patients with stable 
COPD. The inspiratory muscles of COPD patients experience increased workloads 
due to airflow limitation, hyperinflation, and a reduction in inspiratory muscle 
contractile properties (Casaburi 2001; Levine et al. 2003). Casadevall et al. (2007) 
reported that the external intercostals (taken via biopsy) of COPD patients had higher 
mRNA and protein expression of TNF-α, IL-1β and IL-6 (although IL-6 mRNA was 
not significant) compared to aged-matched healthy controls. There were no 
differences for IL-10. MIP in COPD patients was 65  22% of predicted values and 
they also had lower inspiratory muscle endurance compared to healthy controls. 
Whether the upregulation of respiratory muscle cytokines in COPD patients spills out 
into the systemic circulation and contributes to the systemic inflammation observed 
(Garcia-Rio et al. 2010) is unknown. It could be speculated, however, that they do as 
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the plasma response of TNF-α from COPD patients during moderate intensity 
exercise is greater than the response observed in healthy controls (Rabinovich et al. 
2003). The source of this increase could not be determined as TNF-α mRNA in the 
vastus lateralis was unchanged in both groups after exercise.   
There may be other sources of the systemic cytokines observed after IRL in 
healthy humans (Vassilakopoulos et al. 1999; Vassilakopoulos et al. 2002). 
Cytokines can be upregulated within the lungs of murines exposed to negative or 
positive pressure induced hyperventilation (von Bethmann et al. 1998) or IRL 
(Toumpanakis et al. 2010) and it could be speculated these could enter the systemic 
circulation from permeation of epithelial and endothelial barriers with increased 
transmural pressures (Uhlig 2002). However, these results were obtained by 
profound overdistention of the lung, which is unlikely during IRL in humans, since 
they can self-regulate end-inspiratory and/or end-expiratory lung volumes.  
 
1.13.3 BIOLOGICAL ROLES OF BREATHING-INDUCED CYTOKINES 
 The biological roles of breathing-induced cytokines during strenuous 
respiratory muscle contractions in humans are unknown. It is probable that IL-6 has 
the same roles in metabolism observed in whole-body exercise (Figure 1.28). This 
notion would be supported by the reductions in diaphragm glycogen content of 
murines exposed to IRL (Ciufo et al. 2001) and whole-body exercise (Green et al. 
1987; Green et al. 1988; Ianuzzo et al. 1987; Namiot et al. 1985; Namiot and Gorski 
1988). IL-1β and TNF-α may have a role in mediating muscle damage and/or injury 
and evidence also suggests they may compromise diaphragmatic contractility (Figure 
1.28). 
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Figure 1.28 Possible biological roles of breathing-induced cytokines interleukin-1β 
(IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) during strenuous 
respiratory muscle contractions. Strenuous respiratory muscle contractions may 
augment reactive oxygen species (ROS) which are mediated by nitric oxide (NO) 
and subsequently upregulate IL-6, IL-1β and TNF-α. When IL-6 is released into the 
peripheral circulation it exerts its effects on several organs in an endocrine like 
manner. Within the muscle, IL-1β and TNF-α may both reduce muscle contractility 
and mediate muscle injury. TNF-α may also mediate muscle regeneration. Adapted 
from Vassilakopoulos and Hussain (2007). 
 
1.13.3.1 MUSCLE DAMAGE 
Significant diaphragm injury has been observed in animals after exposure to 
severe resistive loads (Jiang et al. 1998; Jiang et al. 2001; Palacio et al. 2002; Reid 
and Belcastro 2000; Simpson et al. 2004; Wang et al. 2005; Zhu et al. 1997), after 
IRL in humans (Foster et al. 2012; Orozco-Levi et al. 2001; Palacio et al. 2002) and 
in COPD patients at rest (Casadevall et al. 2007; Casadevall et al. 2009). Many 
factors may be involved in this process including increased activity of the proteolytic 
enzyme caplain or augmented ROS production (Jiang et al. 2001; Sigala et al. 2011).  
IL-1β may also contribute to the development of muscle injury through the 
upregulation of adhesion molecule expression on the surface of endothelial cells, 
leading to augmentation of transendothelial migration of blood-borne inflammatory 
markers (Cannon et al. 1989). This response results in the initial recruitment of 
85 
 
neutrophils, and later macrophages, into muscle interstitial sites. When rabbits were 
exposed to 1.5 h of IRL there was significant fibre injury detected in the diaphragms 
72 h later (Wang et al. 2005). This was associated with significant upregulation of 
intracellular adhesion molecule-1 expression in blood vessels that traversed the 
diaphragm and a large infiltration of macrophages and neutrophils in the interstitium 
of the diaphragm. A similar response of muscle injury followed by increased 
intramuscular IL-1β expression has been observed following whole-body eccentric 
exercise in humans (Fielding et al. 1993).  
Although experimental data for the role of TNF-α in muscle injury is lacking 
it might also contribute by augmenting oxidative stress (see OXIDATIVE STRESS) in a 
paracrine fashion (Li and Reid 2001). Increased oxidative stress has been observed in 
the diaphragm up to 3 days after severe resistive loading in rabbits, and the change 
could not be attributed to an acute increase in cytokine production (Jiang et al. 2001).  
It must be noted that the increase in pro-inflammatory cytokines involved in 
muscle damage is limited by the compensatory upregulation of anti-inflammatory 
cytokines IL-4 and IL-10 (Sigala et al. 2011; Sigala et al. 2012; Vassilakopoulos et 
al. 2004) which minimise the harmful biological effects of pro-inflammatory 
cytokines.  
 
1.13.3.2 MUSCLE REGENERATION   
Although several reports have implicated pro-inflammatory cytokines in the 
development of muscle injury there is evidence that they may also be involved in 
muscle regeneration. For example, TNF-α and IL-1β are upregulated in skeletal 
muscle several days after the development of muscle injury from whole-body 
exercise and they may act to enhance proteolytic removal of damaged proteins and 
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cells through the recruitment and activation of phagocytes (Paulsen et al. 2012). In 
vitro experiments using double knockout mice have demonstrated that when TNF-α 
synthesis is blocked the repair of damaged muscle is prevented (Chen et al. 2005; 
Chen et al. 2007). In COPD patients expression of TNF-α in the external intercostals 
was directly related to both general muscle damage, and a direct relationship was 
observed between markers of muscle damage and markers of regeneration 
(Casadevall et al. 2009). Taken together, these reports suggest that once the muscle is 
damaged TNF-α acts to help repair and regenerate the muscle.  
 
1.13.3.3 MUSCLE CONTRACTILITY 
In addition to the effect of pro-inflammatory cytokines on muscle injury and 
regeneration, TNF-α may also be involved in inspiratory muscle contractility.  
Wilcox et al. (1994) reported that when anaesthetised, mechanically ventilated dogs 
were infused with TNF-α for up to 6 h, there was a significant decrease in the Pdi 
response to bilateral electrical phrenic nerve stimulation at a range of frequencies; 
demonstrating significant diaphragm fatigue (Figure 1.29). There was no effect on 
Pdi in control dogs receiving saline infusion. Several other reports support a role for 
TNF-α in reducing respiratory muscle contractility. In vitro experiments on isolated 
diaphragm strips have shown reduced diaphragm contractility after incubation with 
TNF-α (Hardin et al. 2008; Reid et al. 2002; Wilcox et al. 1996). An increased 
expression of TNF-α in the external intercostals of COPD patients is correlated with 
reduced MIP and inspiratory muscle endurance. However, it must be noted that the 
supraphysiological dose of TNF-α infused into dogs (Wilcox et al. 1994), or 
incubated with isolated diaphragm strips (Hardin et al. 2008; Reid et al. 2002; 
Wilcox et al. 1996) would not be seen in humans undertaking IRL or whole-body 
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exercise. Significant increases in the protein expression of TNF-α only occur after 6 
h of IRL in rats suggesting significant muscle damage is required to elicit a response 
(Figure 1.27; Sigala et al. 2011). Furthermore, the increased expression of TNF-α in 
the external intercostals of COPD patients (Casadevall et al. 2007; Casadevall et al. 
2009) are due to several years of muscle dysfunction.  
 
Figure 1.29 Transdiaphragmatic pressure (Pdi) response to supramaximal bilateral 
electrical phrenic nerve stimulation at a range of frequencies after 0, 3 and 6 h of 
tumor necrosis factor-α (TNF-α) infusion in dogs. Significant difference (from 0 h * 
P < 0.05, 
**
 P < 0.01). Values are mean  SE. Adapted from Wilcox et al. (1994).      
 
 
1.14 OXIDATIVE STRESS 
It has been recently demonstrated that breathing-induced cytokines are 
upregulated by oxidative stress. At rest there is a continuous production of free 
radicals (atoms, molecules, ions with unpaired electrons or an open shell). The 
antioxidant defence mechanisms remove most free radicals before they can damage 
biomolecules such as lipids, proteins and nucleic acids. In resting healthy humans 
these processes are in balance so that a steady-state exists; there is always a certain 
amount of free radicals with a corresponding level of oxidative damage. Oxidative 
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stress refers to a state where there is either an excessive production of free radicals, 
or deficient antioxidant defences (Sies 1985). 
 
1.14.1 FREE RADICAL FORMATION  
It is generally considered that free radicals and, in particular, ROS are formed 
during oxygen metabolism in the mitochondria (Di Meo 2001). The process of ATP 
production through oxidative phosphorylation involves the transport of hydrogen 
ions across the inner mitochondrial membrane through the electron transport chain. 
Within the electron transport chain, electrons are passed along a series of proteins via 
oxidation-reduction reactions. Each acceptor protein along the chain has a greater 
reduction potential than the previous and an oxygen molecule is the final destination 
for an electron along the chain. The oxygen is normally reduced to water, but in 
about 0.1‒2% of electrons passing along the chain, the oxygen is incompletely 
reduced to produce a superoxide radical (Di Meo 2001).   
 
1.14.2 ANTIOXIDANT DEFENCE MECHANISMS 
A well organised system of both enzymatic and nonenzymatic antioxidants 
within muscle fibres protects against oxidative stress. These antioxidants are located 
throughout the cytoplasm and in various organelles (e.g., mitochondria). Both 
enzymatic and nonenzymatic antioxidants are also located within the extracellular 
and vascular space. The primary enzymatic antioxidants include catalase, glutathione 
peroxidise and superoxide dismutase and are accompanied by peroxiredoxin, 
glutaredoxin and thioredoxin (Powers and Jackson 2008). These enzymatic 
antioxidants are complimented by numerous nonenzymatic antioxidants including 
bilirubin, glutathione and uric acid and by dietary antioxidants including vitamin C, 
vitamin E and carotenoids (Powers and Jackson 2008).  
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1.14.3 MEASUREMENT OF OXIDATIVE STRESS 
 The measurement of oxidative stress in vivo is difficult as ROS and reactive 
nitrogen species are highly reactive and/or have a very short half-life (< 1 s for some) 
(Palmieri and Sblendorio 2007). The measurement can be estimated from 1) free 
radicals; 2) radical mediated damages to lipids, proteins and nucleic acids; and 3) 
antioxidant enzyme activity or concentration (Palmieri and Sblendorio 2007). A 
complete review of the topic is beyond the scope of this thesis. Therefore, only a 
brief overview will be given.  
Free radical production can be measured using direct methods. Electron spin 
resonance is a direct spectroscopic technique that allows direct measurement of ROS 
from their paramagnetic properties (Palmieri and Sblendorio 2007). However, the in 
vivo technique cannot be used in humans because of the toxicity of the measurement 
(Palmieri and Sblendorio 2007).  
A basic measurement of oxidative damage is the analysis of the rate of 
peroxidation of membrane lipids or fatty acids. Lipid peroxidation results in the 
breakdown of lipids to an array of primary oxidation products such as conjugated 
dienes or lipid hydroperoxides and secondary oxidation products such as 
malondialdehyde, F2-isoprostane or expired pentane, ethane or hexane (Palmieri and 
Sblendorio 2007). Malondialdehyde is produced during fatty acid auto-oxidation and 
is most commonly measured by its reaction with thiobarbituric acid which generates 
thiobarbituric acid reactive substances (TBARS). Although TBARS is accepted as a 
general marker of lipid peroxidation, it is not specific to malondialdehyde and can 
overestimate malondialdehyde (Palmieri and Sblendorio 2007). F2-isoprostanes are 
produced by free radical catalysed peroxidation of arachidonic acid (Roberts 2000). 
Many recent studies have shown that F2-isoprostanes are a reliable method for 
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endogenous lipid peroxidation (Roberts 2000). Another lipid peroxidation technique 
is the measurement of volatile hydrocarbon end products in expired air such as 
pentane, hexane and ethane. This method has the strength of being non-invasive, but 
as these gases can be formed by other ways than free radical oxidation it is limited by 
a lack of precision (Rimbach et al. 1999).  
Free radical modification of proteins causes formation of carbonyl groups 
into amino acid side chains (Stadtman and Levine 2000). The most common analysis 
of free radical damage to proteins is the measurement of carbonyl formation 
(Stadtman and Levine 2000). Total proteins are often also measured to give the 
carbonyl/protein ratio which increases the precision of protein oxidation (Chen et al. 
2001). This method is of interest because the half-life of the carbonyl is long and a 
high level of carbonyl can show the cumulative effects of oxidative stress (Chen et 
al. 2001).  
Free radicals can induce several types of damage to nucleic acids including 
DNA strand and protein cross link breaks and base modifications. There are various 
methods to assess free radical damage to nucleic acids (Dizdaroglu et al. 2002). One 
method is the modified comet assay which can measure oxidative damage with the 
use of bacterial repair endonucleases with appropriate specificities. The comet assay 
is a rapid, sensitive and reliable measurement of systemic oxidative stress in cells 
such as PBMC (Collins 2009; Singh et al. 1988). Comparison of findings is 
confounded, however, by the variety of protocols utilised by different laboratories.  
Antioxidant activity can be measured in enzymatic enzymes (catalase, 
glutathione peroxidise and superoxide dismutase), nonenzymatic antioxidants 
(bilirubin, glutathione and uric acid) and by numerous dietary antioxidants (vitamin 
C, vitamin E and carotenoids acid) (Palmieri and Sblendorio 2007). Antioxidants are 
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typically measured in blood or urine and the measurement techniques are simple and 
reliable. However, changes in antioxidant status during acute and chronic exercise 
may represent a redistribution of antioxidants between tissue and plasma (Ji 1995).      
In summary, all the methods discussed have limitations and because of the 
complexity of oxidative stress no single measurement will summarise all the effects. 
If the laboratory is not limited by expense or time a battery of markers would be the 
most beneficial (Palmieri and Sblendorio 2007). If, however, only one method can be 
utilised it should asses the effects of oxidative stress on eithier a specific site of 
interest, or be reliable at measureing stystemic oxidative stress (Palmieri and 
Sblendorio 2007).  
 
1.14.4 BREATHING-INDUCED CYTOKINES AND OXIDATIVE STRESS 
When rats were exposed to 6 h of IRL and pre-treated with ROS inhibitors 
there was a decrease in diaphragmatic cytokines via P38 mitogen activated protein 
kinase (P38 MAPK) and nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) pathways (Sigala et al. 2011). NO regulates NF-κB and MAPK 
activity and, therefore, when rats were pre-treated with NO inhibitors and exposed to 
6 h of IRL there was an increase in diaphragmatic cytokines (Sigala et al. 2012). 
Taken together this research suggests that ROS regulates cytokine production within 
the diaphragm and NO mediates this production (Figure 1.28). However, it must be 
noted that although hypoxemia was prevented in rats exposed to IRL by 
supplementing the inspiratory line with 100% O2, they still experienced significant 
respiratory acidosis. Arterial pH in rats exposed to IRL significantly decreased from 
7.4  0.01 at rest to 7.0  0.02 after 6 h (Sigala et al. 2011). Since oxidative stress 
can be upregulated by respiratory acidosis (Arbogast and Reid 2004) it is difficult to 
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determine whether the increase in oxidative stress within the diaphragm was due to 
strenuous contractions, or respiratory acidosis.  
 The observation that oxidative stress upregulates breathing-induced cytokines 
in rats has also been supported in humans. When participants were supplemented 
with a combination of antioxidants (to scavenge ROS) and undertook IRL (45 min at 
~75% MIP) the plasma concentration of IL-1β was undetectable, there was no 
increase in the plasma concentration of TNF-α, and the increase in IL-6 was 
significantly reduced (Vassilakopoulos et al. 2002). Furthermore, supplementation of 
antioxidants (vitamin C and E to reduce ROS), or infusion with nitro-L-arginine 
methyl (to increase NO) both reduce IL-6 production from skeletal muscle during leg 
extension exercise (Fischer et al. 2004a; Steensberg et al. 2007).  
 
1.14.5 BREATHING-INDUCED OXIDATIVE STRESS 
Many reports have conclusively shown that oxidative stress is increased in 
the respiratory muscles of animals following exposure to severe resistive loads 
(Anzueto et al. 1992; Barreiro et al. 2006; Borzone et al. 1994; Ciufo et al. 1995; 
Goodyear-Bruch et al. 2008; Jiang et al. 2001; Sigala et al. 2011; Sigala et al. 2012; 
Vassilakopoulos et al. 2007), endurance exercise (Itoh et al. 2004; Lawler et al. 1994; 
Oh-ishi et al. 1997; Powers et al. 1994b; Vincent et al. 1999; Vincent et al. 2000) and 
in vitro fatiguing stimulation of isolated diaphragm fibres (Diaz et al. 1993; Kolbeck 
et al. 1997; Reid et al. 1992; Reid et al. 2002).  
Furthermore, compared to healthy human controls, levels of oxidative stress 
are higher in the respiratory muscles of COPD patients (Barreiro et al. 2005; Marin-
Corral et al. 2009; Wijnhoven et al. 2006). Recently, using immunoblotting and 
histochemical staining techniques, Marin-Corral et al. (2009) reported increased 
93 
 
oxidation of proteins involved in energy production and contractile performance 
(creatine kinase, carbonic anhydrase III, actin and myosin) and increased superoxide 
anion in the diaphragm (taken with a biopsy) of severe COPD patients. This increase 
in oxidative stress is a likely contributor to the respiratory muscle dysfunction 
(decreased strength and endurance) observed in these patients.   
 
 
1.14.6 BREATHING-INDUCED OXIDATIVE STRESS AND RESPIRATORY MUSCLE 
FATIGUE 
 
Reports have demonstrated that respiratory muscle contractile properties are 
altered by oxidative stress. A decrease in muscle contractility has been observed in 
vitro by incubating isolated muscle fibres with ROS (Lawler et al. 1997) and NO 
(Lawler and Hu 2000). Conversely, contractile performance is improved by 
administrating antioxidants before or during fatiguing contractions in vitro (Diaz et 
al. 1994; Khawli and Reid 1994; Shindoh et al. 1992) and in vivo (Kelly et al. 2009b; 
Supinski et al. 1995; Supinski et al. 1997; Travaline et al. 1997b). For example, time 
to volitional tolerance during IRL (~80 Pdipeak) was increased from 14 to 23 min 
following intravenous infusion of the antioxidant N-acetylcysteine compared to 
placebo infusion and moreover, the Pditw response to bilateral electrical phrenic nerve 
stimulation was significantly reduced up to 24 h after task failure (Figure 1.30; 
Travaline et al. 1997b). This study indicates that by increasing the diaphragms 
antioxidant defence mechanisms against oxidative stress inspiratory muscle 
endurance can be increased, and diaphragm fatigue reduced. 
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Figure 1.30 Transdiaphragmatic twitch pressure (Pditw) response to supramaximal 
bilateral electrical phrenic nerve stimulation before and in recovery from inspiratory 
resistive loading at ~80% peak transdiaphragmatic pressure with N-acetylcysteine or 
placebo infusion in healthy humans. Values are mean  SD. Adapted from Travaline 
et al. (1997b).      
 
 
1.15 EFFECTS OF TRAINING ON CYTOKINES AND OXIDATIVE STRESS 
1.15.1 TRAINING AND CYTOKINES 
Compared to healthy counterparts, chronic heart failure patients have reduced 
inspiratory muscle strength and endurance (Ribeiro et al. 2009) and higher systemic 
cytokine concentrations at rest (Orus et al. 2000). It could, therefore, be speculated 
that these higher contractile demands result in an upregulation of respiratory muscle 
cytokines that spill out into the systemic circulation, and that RMT would attenuate 
this. Nonetheless, serum concentrations of IL-6 and TNF-α do not change after 10 
weeks of flow-resistive loading (3 times a week at ~60% MIP) (Laoutaris et al. 
2007). It cannot be determined from this study whether the local expression of 
cytokines within the respiratory muscles changed after training.  
At the end of 90 min treadmill running exercise IL-1 was lower in the 
diaphragms of rats that undertook prior long-term endurance exercise training (up to 
90 min·d
-1
 for 9 weeks) than untrained controls (Oh-ishi et al. 1997). This suggests 
95 
 
that IL-1 may be reduced in the respiratory muscles after exercise training. However, 
IL-1 was measured with the thymocyte proliferation assay which was developed 
before the availability of recombinant IL-1 proteins, and the assay can detect both 
IL-1 and IL-6 (Bagby et al. 1996). Therefore, it may be that it was IL-6, and not IL-
1, that was reduced after exercise training. This would be supported by the reduction 
in IL-6 within lower limb muscle of humans following endurance exercise training 
(Fischer et al. 2004b; Yfanti et al. 2012).  
Fischer et al. (2004b) were the first to report the effect of exercise training on 
IL-6 mRNA expression in the vastus lateralis of healthy humans. Before and after 
dynamic one legged knee extension training (5 d∙wk-1 at ~75%  ̇max for 10 weeks) 
participants performed a 3 h acute bout of the same exercise at 50% of their pre-
training  ̇max (the same relative power). The absolute power was 44% higher after 
training. The increase in IL-6 mRNA expression after the acute exercise was 76-fold 
before training, but only 8-fold after training. Furthermore, resting skeletal muscle 
glycogen content had increased by ~74% after training and the resting muscle 
glycogen levels correlated negatively (r = -0.34, P < 0.05) with the IL-6 mRNA 
expression immediately after the acute exercise. Therefore, the higher muscle 
glycogen content was associated with lower IL-6 mRNA expression after exercise 
(Figure 1.31). In addition, the exercise-induced increase of plasma IL-6 was similar 
before and after training.  
Interestingly, while the plasma IL-6 response to exercise seems to be reduced 
by training the muscular expression of the IL-6 receptor appears to be upregulated. 
After exercise training the basal IL-6 receptor α (IL-6rα) mRNA content in trained 
skeletal muscle is increased by ~100% (Akerstrom et al. 2009; Keller et al. 2005). It 
may, therefore, be possible that the downregulation of IL-6 is partially counteracted 
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by an increased expression of IL-6rα, and the sensitivity of IL-6 is increased (Figure 
1.31).  
 
Figure 1.31 Schematic representation of how interleukin-6 (IL-6) may be regulated 
after exercise training. Exercise training results in an increase in glycogen synthase 
and the trained muscle will consequently store more muscle glycogen. During acute 
exercise the untrained muscle is highly dependent on glycogen as a substrate whereas 
training leads to increased β-oxidating enzymes and an enhanced capability to 
oxidise fat and, hence, to use fat as a substrate during exercise. The trained muscle, 
therefore, uses less glycogen during muscular contractions. The activation of muscle 
IL-6 is glycogen dependent. During prolonged and strenuous exercise there is a 
decrease in skeletal muscle glycogen content and IL-6 is upregulated at a faster rate.  
More IL-6 is produced at the same relative work compared with conditions with high 
muscle glycogen. During acute exercise this results in a lower plasma IL-6 
concentration for trained compared to untrained muscles. The trained muscle may 
also be more sensitive to IL-6. Adapted from Pedersen and Febbraio (2008). 
 
1.15.2 TRAINING AND OXIDATIVE STRESS  
Several reports have now clearly shown that long term (weeks to months) 
endurance exercise training elevates key antioxidant enzymes in the diaphragms of 
rats compared to untrained controls (Figure 1.32; Powers et al. 1994b; Vincent et al. 
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1999; Vincent et al. 2000). These training-induced increases in diaphragmatic 
antioxidant capacity improve its ability to scavenge ROS and, thus, protect against 
exercise-induced oxidative stress (Powers and Shanely 2002). Interestingly, short-
term endurance exercise (1 h∙d-1 at ~70%  ̇O2max for 5 days) results in ~20% 
increases in manganese-superoxide dismutase activity which is similar in magnitude 
to that observed after 8 to 10 weeks of training (Vincent et al. 2000). In contrast, 
there are no significant increases in diaphragmatic antioxidant enzymes in dogs 
exposed to IRL (2 h∙d-1 at 31‒45% MIP for 2 weeks) compared to untrained controls 
(Barreiro et al. 2005). It could be postulated that this training load may not be a great 
enough stimulus for an adaptation. In support of this, those dogs that received the 
highest training loads also had the greatest amounts of oxidative stress evident.   
 
Figure 1.32 Costal diaphragm antioxidant enzyme capacity after endurance exercise 
training in rats. MnSOD, manganese superoxide dismutase; GPX, glutathione 
peroxidise; GSH, glutathione. Significant difference (from untrained control 
* 
P < 
0.05). Values are mean from Powers et al. (1994b); Vincent et al. (1999); and 
Vincent et al. (2000). Adapted from Powers and Shanely (2002).      
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1.16 SYSTEMIC CYTOKINES AND OXIDATIVE STRESS IN AGEING 
1.16.1 SYSTEMIC CYTOKINES IN AGEING 
Aging is associated with an elevated systemic concentration of cytokines at 
rest. This has been termed systemic low-level inflammation and can be defined as a 
2‒4 fold increase in the resting concentration of inflammatory mediators 
(Bruunsgaard 2006). There is mounting evidence that suggests systemic low-level 
inflammation contributes significantly to the ageing process and age related diseases 
including, amongst others, atherosclerosis, cancer, dementia, metabolic syndrome, 
osteoporosis and sarcopenia (Chung et al. 2009). The mechanisms that underpin the 
role of systemic low-level inflammations in the development of age-related diseases 
are best understood by examining the metabolic effects of inflammation during acute 
illness. During acute illness, antigen-presenting cells recognise foreign elements and 
secrete pro-inflammatory cytokines IL-1β and TNF-α which assist the recruitment of 
T cells and the development of an antigen-specific response (Baumann and Gaulde 
1994). In addition, these acute phase products can have a substantial effect on 
metabolism resulting in hyperglycaemia, insulin resistance and increased 
gluconeogenesis (Baumann and Gaulde 1994). An increase in these markers elevates 
bone reabsorbtion (Aris et al. 1998), dyslipidemia (Marik 2006), and proteolysis 
(Mitch and Goldberg 1996) whilst also increasing other parts of the inflammatory 
cascade that can have downstream biological effects. Whilst the changes during 
acute illness are much greater than those observed in ageing, it is suggested that 
long-term exposure to inflammation can contribute to the ageing process and age 
related diseases (Beavers et al. 2009).      
Several studies have reported that compared to younger counterparts, older 
adults (65+ years) and the elderly (80+ years) have a higher resting systemic 
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concentration of cytokines such as TNF-α (Paolisso et al. 1998), IL-1β (Paganelli et 
al. 2002) and IL-6 (Bruunsgaard et al. 1999; Cohen et al. 1997; Ershler et al. 1993; 
Giuliani et al. 2001; Hager et al. 1994; Straub et al. 1998; Wei et al. 1992; Zietz et al. 
2001). The resting plasma concentrations of TNF-α and IL-6 increase with age in 
randomly selected healthy humans (Figure 1.33; Bruunsgaard et al. 1999). However, 
some studies have failed to demonstrate age-related increases in TNF-α (Fagiolo et 
al. 1993; Peterson et al. 1994) and IL-6 (Beharka et al. 2001; Peterson et al. 1994). 
The differences in findings may relate to variations in the sensitivity of assays used, a 
lack of statistical power, differences in the age of study populations or differences in 
the health status of study participants (Bruunsgaard 2006). Indeed, the plasma IL-6 
concentrations from randomly selected elderly participants are higher than very 
healthy elderly individuals selected in accordance with the SENIEUR (healthy 
ageing) protocol (10.3  0.7 vs. 1.8  0.3 pg·mL-1), demonstrating a strong influence 
of health status on resting systemic IL-6 concentrations (Baggio et al. 1998).  
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Figure 1.33 Plasma concentration of interleukin-6 (IL-6) and tumor necrosis factor-α 
(TNF-α) at rest in healthy humans of increasing age. Significant difference ((P < 
0.05) of 18‒30 years from older age groups * 55‒65 years; ^ 80 years; and † 100+ 
years). Values are mean. Adapted from Bruunsgaard et al. (1999).  
 
 
1.16.2 BREATHING-INDUCED CYTOKINES IN AGEING 
No studies have examined whether the respiratory muscles contribute to the 
systemic inflammation observed with ageing. In peripheral skeletal muscle, findings 
are equivocal to whether mRNA expression of IL-1β and TNF-α at rest increases 
with age (Hamada et al. 2005; Leger et al. 2008; Przybyla et al. 2006; Raue et al. 
2007). Furthermore, IL-6 mRNA expression at rest is similar between younger and 
older males (Hamada et al. 2005; Pedersen et al. 2004; Przybyla et al. 2006; Trenerry 
et al. 2008). These findings suggest that in skeletal muscle IL-1β and TNF-α may, 
but IL-6 probably does not, contribute to the systemic inflammation observed with 
ageing.  
Yende et al. (2006) have shown in 2005 healthy older adults (73 years) 
without obstructive lung disease that plasma IL-6 concentrations are not correlated 
with MIP. They were, however, inversely correlated with the percent of predicted 
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values of FEV1. This finding suggests that plasma IL-6 concentrations are associated 
with age-related changes in lung function (but not inspiratory muscle strength) in 
healthy older adults.  
 
1.16.3 OXIDATIVE STRESS IN AGEING 
The mitochondrial theory of ageing hypothesises that ageing is related to an 
accumulation of ROS mediated oxidative damage and to a functional decline in the 
mitochondria (Wallace 2005). It is generally accepted that ROS increase with age 
and they play significant role in the ageing process (Fulle et al. 2004). This is 
especially true in skeletal muscle where there is a pronounced generation of free 
radicals due to the high amount of O2 consumption compared to other tissues, and 
which results in higher levels of ROS (Fulle et al. 2004). 
 
1.16.4 BREATHING-INDUCED OXIDATIVE STRESS IN AGEING 
Indeed, levels of ROS (reactive carbonyls and malondialdehyde-protein 
adducts) and reactive nitrogen species (3-nitrotyrosine), and the activity of 
antioxidant enzymes (manganese-superoxide dismutase and catalase) are 
significantly higher in the external intercostals (taken with a biopsy) of older than 
younger adults (68 vs. 25 years) (Barreiro et al. 2006). Marzani et al. (2005) have 
supported some, but not all, of these findings. The activity of antioxidant enzyme 
manganese-superoxide dismutase was higher and the ratio of reduced to oxidised 
glutathione was lower in the rectus abdominis of older compared to younger (66‒90 
vs. 18‒48 years) adults. However, there were no other differences in all other 
antioxidant enzymes including catalase. The differences between the studies may be 
explained by several reasons, including the type and work undertaken by the muscle 
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analysed (inspiratory vs. expiratory), the fibre type makeup of the muscle, or that 
Marzani et al. (2005) reported that both older and younger participants had rectus 
abdominis biopsy before surgery and the condition that required them to have 
surgery may have increased and/or changed levels of oxidative stress. These findings 
do provide evidence that the respiratory muscles contribute to increased levels of 
oxidative stress that is observed in the ageing process.  
 
1.17 GENERAL SUMMARY 
Increased respiratory muscle work is encountered during strenuous whole-body 
exercise, and at rest in older adults and those with pulmonary limitations such as 
chronic obstructive pulmonary disease. When sufficiently strenuous it can result in 
diaphragmatic fatigue, increased blood lactate concentrations, and an alteration in 
respiratory muscle recruitment patterns. Increased respiratory muscle work also 
elevates cytokines IL-6 and IL-1β within the respiratory muscles and systemically. 
There is mounting evidence that inflammation contributes significantly to the ageing 
process and age related diseases. Enhanced oxidative stress, glycogen depletion and 
diaphragmatic fatigue are all potential stimuli for this production. Whole-body 
exercise training can attenuate systemic inflammation and oxidative stress in younger 
adults during exercise and in older adults who experience this at rest. An attenuation 
of muscle glycogen or increases in antioxidant enzymes may explain such 
reductions. Inspiratory muscle training (IMT) may also elicit similar adaptations in 
the inspiratory muscles, and thus also attenuate these markers.  
 
1.18 RESEARCH AIMS 
In younger adults the research aims were to evaluate whether: 
103 
 
(I) The respiratory muscles contribute to exercise-induced increases in 
systemic cytokines and oxidative stress. 
(II) An increase in systemic cytokines and oxidative stress is related to 
diaphragmatic fatigue.  
(III) IMT attenuates systemic cytokines and/or oxidative stress during 
whole-body exercise or a volitional mimic at rest of exercise 
hyperpnoea. 
(IV) IMT alters an estimation of the maximum lactate steady-state and 
respiratory muscle recruitment patterns during the lactate minimum 
test.  
In older adults the research aims were to evaluate whether: 
(V) IMT attenuates systemic cytokines and/or oxidative stress at rest.  
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CHAPTER 2 ‒ GENERAL METHODS
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2.0 YOUNGER PARTICIPANT PREPARATION  
 Younger participants provided written, informed consent to participate in the 
research which was approved by the Nottingham Trent University ethics committee. 
A self-reporting medical questionnaire confirmed that participants were non-
smokers, free from illness and injury and were not taking any medication (including 
supplements or antioxidants) during the study (Appendix 1). Each participant 
completed a 24 h estimated diet record prior to their first trial which was then 
replicated prior to all subsequent trials. Throughout each study, participants were 
instructed to adhere to their habitual training regimen and not to engage in any 
strenuous exercise the day preceding and the day of a trial. Participants arrived at the 
laboratory 4 h postprandially having abstained from alcohol and caffeine in the 24 h 
before testing.  
 
2.1 ANTHROPOMETRIC MEASUREMENTS 
Body mass was measured to the nearest 0.1 kg using a calibrated electronic 
scale (Tanita Body Composition Analyser/Scale; Tanita UK Ltd, Yiewsley, UK) 
whilst participants were in lightweight clothing and barefoot (Eston 2008). Height 
was measured with a portable stadiometer (Seca Stadiometer; Seca Ltd, Birmingham, 
UK) while participants were looking straight ahead, standing barefoot, heels 
together, and with arms hanging naturally by their sides (Eston 2008). 
 
2.2 LODE EXCALIBUR SPORT CYCLE ERGOMETER 
 During volitional hyperpnoea trials participants were seated on, or during 
exercise trials participants cycled on, an electromagnetically braked cycle ergometer 
(Excalibur Sport; Lode, Groningen, The Netherlands; Figure 2.1). The cycle 
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ergometer was externally calibrated (Lode). The ergometer was set in hyperbolic 
mode in which power output was constant and independent of pedal cadence. The 
handlebars and saddle height, and their respective horizontal displacements were 
adjusted for each individual and these configurations were recorded to the nearest 
mm and replicated for subsequent trials. The handlebars of the ergometer were 
modified with time trial bars (Aeroforce EA70 Clip on bar; Easton, CA, USA). The 
pedals on the cycle ergometer had toe clips and slots for cleated shoes. Participants 
could use either option, but once they had selected one were instructed to adhere to 
this option for the duration of the study. Pedal cadence was displayed at all times on 
a digital screen mounted on the handlebars. The power output of the cycle ergometer 
was controlled on an external personal computer running specific software on which 
exercise protocols were programmed to the nearest 1 W and 1 s (Lode ergometery 
manager, Version 5.18.20; Lode).  
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Figure 2.1 Experimental setup using cycling exercise or volitional hyperpnoea 
(Chapters, 3, 4 and 6), including electromagnetically braked cycle ergometer, breath 
by breath analyser (right hand computer), balloon pressure catheter system (left hand 
computer) and venous cannula (right hand).  
  
 
2.3 PULMONARY FUNCTION: DYNAMIC SPIROMETRY 
Pulmonary function was assessed according to published guidelines (Miller et 
al. 2005) using a pneumotachograph (Pneumotrac; Vitalograph, Buckingham, UK) 
calibrated with a 3 L syringe. Participants performed manoeuvres wearing a noseclip 
and standing upright. A minimum of 3 and a maximum of 8 flow-volume loops were 
performed to determine forced vital capacity (FVC), FEV1, PEF and peak inspiratory 
flow (PIF) rates until within and between-manoeuvre criteria were satisfied, i.e., two 
largest recordings of FVC and FEV1 within 100 mL of each other (Miller et al. 
2005). A 10 s maximal voluntary ventilation (MVV10) procedure was performed to 
determine the maximal breathing capacity. A minimum of 2 MVV10 procedures were 
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performed and continued until repeat measurements were within 20% of each other 
(Miller et al. 2005). The highest value recorded for the flow-volume loop and MVV10 
were used for subsequent analysis (Miller et al. 2005). Spirometry data was 
compared to normal values provided by referenced equations. For younger 
participants, FVC, FEV1, FEV1/FVC and PEF were compared to Quanjer et al. 
(1993). For older participants, FVC, FEV1 and FEV1/FVC were compared to 
Falaschetti et al. (2004) and PIF and PEF to Garcia-Rio et al. (2004).  
 
2.4 VOLITIONAL INSPIRATORY AND EXPIRATORY MUSCLE STRENGTH 
A hand-held mouth pressure meter (MicroRPM; CareFusion, Hampshire, 
UK) measured MIP and MEP as an index of global inspiratory and expiratory muscle 
strength, respectively. The mouthpiece assembly incorporated a 1 mm orifice to 
prevent glottic closure during inspiratory efforts and minimise the contribution of the 
buccal muscles to inspiratory pressure development (Black and Hyatt 1969). 
Participants wore a noseclip and manoeuvres were performed whilst standing, 
sustained for at least 1 s and initiated from residual volume (MIP) or total lung 
capacity (MEP), respectively. Repeat efforts separated by 30 s were performed until 
three serial measures differed by no more than 10% or 10 cmH2O, whichever was 
smallest (Brown et al. 2010; Johnson et al. 2012). The highest value recorded was 
used for subsequent analysis. Mouth pressure data was compared to normal values 
provided by referenced equations from Wilson et al. (1984) and Enright et al. (1995) 
for younger and older participants, respectively.  
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2.4.1 ACCURACY AND PRECISION OF THE MOUTH PRESSURE METER 
The accuracy and precision of the mouth pressure meter was tested with a 
capacitive sensor with a pressure capacity of ≥ 1360 cmH2O (1000 torr, Pirani strain 
gauge; MKS Barathon, MKS Instruments, MS, USA) and which was maintained at a 
constant temperature (55ºC) by a digital signal conditioner (Type 270B; MKS 
Instruments). A two-point calibration was performed on the strain gauge before 
commencement of each study. Firstly, the strain gauge pressure was set to zero, and 
secondly, to the atmospheric pressure provided by a laboratory based wall-based 
mercury manometer. The mouth pressure meter was connected via flexible tubing to 
the strain gauge and an electric syringe pump fitted with a 60 mL syringe (KDS 
210C; KD Scientific, MA, USA) using a three way stopcock. The pump opened the 
syringe at a constant rate of 70.57 mL·min
-1
. Displacement of the syringe to multiple 
limits was repeated 10 times generating a range of pressures from 6 to 294 cmH2O.   
The relationship between the pressure measurements from the mouth pressure 
meter (PMOUTH) and the calibrated strain gauge (PSTRAIN) is shown in Figure 2.1A. 
The correlation coefficient between PMOUTH and PSTRAIN was excellent. The 
difference between PMOUTH and PSTRAIN is plotted using a Bland and Altman plot 
(Bland and Altman 1986) in Figure 2.1B. Also shown in Figure 2.1B are the mean 
limits and the 95% confidence interval. This data demonstrates that the mouth 
pressure meter provides an accurate and precise measure of pressure given the 
narrow limits of agreement.    
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Figure 2.2 A) Strain gauge pressure (PSTRAIN) against mouth pressure meter pressure 
(PMOUTH); B) difference in pressure between PSTRAIN and PMOUTH against the mean of 
PSTRAIN and PMOUTH.  ̅, mean.  
 
 
2.5 ZAN 600 USB CPX BREATH BY BREATH ANALYSER 
Pulmonary gas exchange and ventilatory responses were measured at the 
mouth using an online breath by breath gas analysis system operated by an integrated 
personal computer (ZAN 600USB; Nspire Health, Oberthulba, Germany; Figure 
2.1). Pulmonary gases were continuously sampled and analysed using fast response 
selective analysers at a flow rate of 0.66 L·s
-1
 (O2: amperometric solid state 
electrolyte sensor and CO2: infrared spectroscopy). The expired gases were time 
aligned with expired airflow using specific data acquisition software (GPI version 
3.0; Nspire Health) to provide breath by breath pulmonary gas exchange 
measurements expressed as standard temperature, pressure, dry (STPD). Expired 
volumes of air were measured using a pneumotachograph (Type II flow sensor; 
Nspire Health) with a low dead space (<40 mL) and expressed as body temperature, 
pressure, saturated (BTPS). According to the manufacturers guidelines the additional 
resistance provided by the flow pneumotachograph was 1.0, 1.7, 2.4 and 2.9 cmH2O 
for flow rates of 6.2, 8.4, 10.0 and 11.2 L·s
-1
, respectively. The flow 
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pneumotachograph and gas analysers were calibrated before all trials using a 3 L 
syringe and gases of known concentrations (BOC Gases, Guildford, UK), 
respectively. The pneumotachograph was attached to a facemask (Vmask
TM
 model 
7400; Hans Rudolph, KS, USA) with a low dead space (97 mL) and secured to the 
participants face with an elastic quick release mesh cap.  
 
2.5.1 AGREEMENT BETWEEN ZAN 600 USB CPX AND A ‘GOLD STANDARD’ 
 The accuracy and precision of the online breath by breath expired gas 
analysis system was assessed against the closed circuit Douglas bag technique during 
exercise. The Douglas bag technique is the ‘gold standard’ for expired volumes and 
gas analysis (Bassett et al. 2001). Exercise was performed on an electromagnetically 
braked cycle ergometer (Excalibur Sport; Lode) with five constant power outputs 
(100, 130, 160, 190 and 220 W) each lasting 5 min. Expired air was collected in the 
final min of each power output. The breath by breath flow pneumotachograph was 
connected in series with a two-way non re-breathing valve (model 2730; Hans 
Rudolph) with the Douglas bag (non-permeable with a 200 L capacity) connected via 
corrugated tubing to the expiratory port. This permitted simultaneous measurement 
of expired air samples using both methods.  
Douglas bag expired air samples were analysed for concentrations of O2 and 
CO2 using paramagnetic and infrared analysers, respectively (Series 1400; 
Servomex, Crowborough, UK), and calibrated immediately before analysis with 
gases of known concentrations (BOC Gases). Expired gas volumes were determined 
using a dry gas meter calibrated with a known volume of air (Harvard Apparatus, 
Kent, UK).  ̇E,  ̇O2 and carbon dioxide production ( ̇CO2) were corrected to BTPS 
and STPD. The relationship between the pulmonary measurements from the ZAN 
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600 USB CPX and Douglas bag technique is shown in Figure 2.2. The correlation 
coefficient between the ZAN 600 USB CPX and Douglas bag technique was 
excellent for all the pulmonary measurements. The difference between ZAN 600 
USB CPX and Douglas bag technique for pulmonary measurements is plotted using 
a Bland and Altman plot (Bland and Altman 1986) in Figure 2.3. Also shown in 
Figure 2.3 are the mean limits and the 95% confidence interval. This data 
demonstrates that the ZAN 600 USB CPX provides an accurate and precise measure 
of expired volumes and gas analysis given the narrow limits of agreement.    
 
Figure 2.3 Relationship between ZAN 600 USB CPX and Douglas bag technique. 
A) Minute ventilation,  ̇E; B) oxygen uptake,  ̇O2; C) carbon dioxide production, 
 ̇CO2.  
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Figure 2.4 Difference in minute ventilation ( ̇E; A), oxygen uptake ( ̇O2; B) and 
carbon dioxide production ( ̇CO2; C) against mean of ZAN 600 USB CPX and 
Douglas bag technique.  ̅, mean. 
 
2.6 BALLOON PRESSURE CATHETER SYSTEM 
Pe and Pg were measured using two thin walled (~0.6 mm) latex balloons 
sealed over a single polyethylene catheter (Nspire Health), which was attached to a 
differential pressure transducer ( 400 cmH2O) (TSD104A; BIOPAC Systems, 
California, USA) and differential bridge amplifier (DA100C; BIOPAC Systems) 
(Figure 2.1). Pressure transducers were calibrated across the physiological range and 
were sampled at 200 Hz using an analogue-digital converter and recorded using 
specific data acquisition software (Acqknowledge version 3.7.3; BIOPAC systems). 
The balloon catheter was initially positioned in the stomach following local 
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anaesthesia of the nasal mucosa and posterior pharynx using 2% lidocaine 
(Instillagel
®
; Farco-Pharma GmbH, Cologne, Germany). The air within the 
oesophageal and gastric balloons was initially evacuated with a glass syringe and 
following a Valsalva manoeuvre, and were subsequently filled with 1 and 2 mL of 
air, respectively. The catheter was then withdrawn until, during repeated sniffs, Pe 
became negative. Subsequently, the catheter was withdrawn a further 10 cm. During 
the first experimental trial of the study the distance from the tip of the nares to the 
most distal point of the catheter was recorded and replicated in subsequent trials. Pdi 
was calculated by subtracting Pe from Pg.  
 
2.7 BILATERAL ANTERIOR MAGNETIC PHRENIC NERVE STIMULATION 
 BAMPS was applied using two double 25 mm coils connected to two 
Magstim 200
2
 stimulators (Magstim Co, Dyfed, UK) that were triggered 
simultaneously. Participants initially rested for 20 min to minimise post-activation 
potentiation (Mador et al. 1994; Wragg et al. 1994). The location of each phrenic 
nerve was then identified by stimulating the area at the posterior border of the 
sternomastoid muscle at the level of the cricoid cartilage and determining the area 
associated with the largest Pditw. This location was marked with indelible ink and 
used for subsequent stimulations. During stimulations, participants were seated 
upright with no abdominal binding (Koulouris et al. 1989; Man et al. 2002), wore a 
noseclip, and prior to stimulation were instructed to hold at functional residual 
capacity (Hubmayr et al. 1989; Smith and Bellemare 1987), which was inferred from 
visual feedback of Pe.  
Skin surface EMG of the right costal diaphragm was recorded using bi-polar 
surface electrodes (self-adhesive, silver-silver chloride, 10 mm recording surface 
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diameter; Unilect, Worcestershire, UK) placed on the sixth and eighth intercostal 
spaces in the anterior axillary line (Glerant et al. 2006). Electrodes were positioned to 
optimise peak to peak amplitude of M-wave responses. EMG signals were passed 
through a differential amplifier (1902 Mk IV; Cambridge Electronic Design, 
Cambridge, UK), sampled at 2000 Hz using an analogue-digital converter (Micro 
1401; Cambridge Electronic Design) and recorded using specific data acquisition 
software (Spike 2 version 5.12; Cambridge Electronic Design).  
To determine supramaximal phrenic nerve stimulation, 3 single twitches were 
obtained every 30 s at intensities of 50, 60, 70, 80, 85, 90, 95 and 100% of maximal 
stimulator output. A plateau in M-wave and Pditw responses with increasing 
stimulation intensities indicated maximum depolarisation of the phrenic nerves. The 
technical considerations regarding supramaximal stimulation have been described 
previously (Davies and White 1982; Taylor et al. 1996). Pditw was assessed every 30 s 
using eight single stimulations at 100% of maximal stimulator output. To assess the 
potentiated Pditw response, participants subsequently performed a 3 s maximal 
Müeller manoeuvre and ~5 s later a twitch was delivered. This procedure was 
repeated six times, with each measure separated by 30 s. A potentiated Pditw has 
greater sensitivity to fatigue especially when the degree of fatigue is small (Laghi et 
al. 1995; Laghi et al. 1998). The average of the median three individual Pditw 
responses was used for analysis. Diaphragm fatigue was defined as a >15% reduction 
in Pditw compared to the baseline value (Kufel et al. 2002). 
 
2.7.1 REPRODUCIBILITY OF BILATERAL ANTERIOR MAGNETIC PHRENIC NERVE 
STIMULATION 
 
Four healthy males with normal respiratory function visited the laboratory on 
two separate visits and BAMPS was applied. Their age, body mass and height (mean 
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 SD) were 24  3 years, 75  7 kg and 179  10 cm, respectively. Reproducibility 
was assessed using the coefficient of variation (CV). Planned pairwise comparisons 
were made with repeated measures t-tests with Bonferroni adjustment. 
A plateau (i.e., no significant increase in amplitude with increasing 
stimulation intensity) in M-wave and Pditw amplitude (Figure 2.4) in response to 
supramaximal BAMPS was observed for both visits indicating maximal 
depolarisation of the phrenic nerves. The plateau occurred at 85 to 90% of maximum 
stimulator output. The between-occasion reproducibility of the neuromuscular 
function measurements is shown in Table 2.1. There was excellent reproducibility for 
Pditw, and to a lesser extent M-wave measurements. End-expiratory Pe and M-wave 
(potentiated) responses were less reproducible. End-expiratory Pe represents the 
pressure at an estimated functional residual capacity. Since this volume is estimated 
by sense alone, and without a target, there is variability in the measurement. A 
variability of 0.2‒0.5 cmH2O has been previously reported (Taylor and Romer 
2009). The variability in potentiated M-wave responses is due to the Müeller 
manoeuvre which is effort dependent. To the author’s knowledge there is no previous 
reproducibility measurements published on the M-wave responses after potentiated 
stimuli. The within-occasion between twitch CV for Pditw and M-wave responses 
(mean of both visits) was 4.1% and 12.4% for non-potentiated and 4.4% and 12.2% 
for potentiated stimuli, respectively.  
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Table 2.1 Between-occasion reproducibility of neuromuscular function 
measurements. 
 
 
Visit 1 Visit 2 CV (%) 
Non-potentiated 
 
End-expiratory Pe (cmH2O) -5.4  2.3 -4.8  2.5 21.9 
End-expiratory Pg (cmH2O) 7.5  1.5 8.9  1.7 12.7 
Pditw (cmH2O) 15.7  6.0 17.1  5.4 5.67 
M-wave (mV) 1.3  0.9 1.5  1.5 10.4 
    
Potentiated 
   
End-expiratory Pe (cmH2O) -6.0  1.6 -6.3  2.4 17.2 
End-expiratory Pg (cmH2O) 7.0  2.1 8.3  1.7 12.7 
Pditw (cmH2O) 25.0  11.7 25.6  9.6 5.21 
M-wave (mV) 1.4  0.7 1.8  2.0 24.9 
Pdipeak during Müller manoeuvre (cmH2O) 118  20 120  22 2.80 
 
CV, coefficient of variation; Pe, oesophageal pressure; Pg, gastric pressure; Pditw, 
transdiaphragmatic twitch pressure; Pdipeak, peak transdiaphragmatic pressure.  
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Figure 2.5 M-wave (A) and transdiaphragmatic twitch pressure (Pditw; B) responses 
to supramaximal BAMPS. Significant difference (from values at 100% of stimulators 
power output (P < 0.05) for 
a 
visit 1 and 
b
 visit 2). Values are mean. 
 
2.8 VOLITIONAL HYPERPNOEA 
During volitional hyperpnoea participants mimicked breathing ( ̇E, fB, and 
TI/TTOT) and respiratory muscle recruitment (Pdipeak) patterns obtained during 
achieved during cycling exercise at the participants lactate minimum power (Chapter 
3) and commensurate with heavy whole-body exercise (Chapter 4). An audio 
metronome paced fR and TI/TTOT, and real-time visual feedback of  ̇E and Pdipeak was 
provided throughout. During volitional hyperpnoea trials, a two-way non-rebreathing 
valve (model 2730; Hans Rudolph) was attached distally to the pneumotachograph 
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and a 1.5 m length of wide-bore tubing was connected to the inspiratory port to allow 
CO2 to be added into this tubing to increase the fraction of inspired carbon dioxide 
(FICO2) and retain end-tidal and, consequently, PCO2 at levels commensurate with 
rest (Brown et al. 2008; Johnson et al. 2006).  
 
2.9 BLOOD SAMPLING FOR YOUNGER PARTICIPANTS 
Arterialised venous blood was sampled from a dorsal hand vein via an 
indwelling 21-G teflon venous cannula (Surflo-W; Terumo, Leuven, Belgium; Figure 
2.1). The cannula was fitted with a 3-way stopcock valve (Becton Dickenson UK 
Ltd, Oxford UK) and secured to the hand using adhesive medical tape. This method 
of arterialised venous blood sampling has been shown to provide excellent agreement 
with arterial blood for measures of [La
-
]B, PCO2 and pH during both steady-state 
exercise and maximal incremental exercise until volitional tolerance (Forster et al. 
1972; McLoughlin et al. 1992). Prior to cannulation, arterialisation was ensured by 
immersing the hand in water at a temperature of ~40°C for 10 min and during trials 
by warming the hand using a stand mounted infrared lamp (Infraphil HP3614; 
Phillps, Amsterdam, The Netherlands). Following cannulation, a 5 mL intravenous 
infusion of 0.9% sodium chloride (Mini-Plasco Saline; Braun, Melsungen, Germany) 
was performed to maintain patency. Immediately before all blood sampling, residual 
fluids were withdrawn from the cannula and stopcock using a 1 mL syringe. On 
completion of a trial, the cannula was removed and medical gauze (Topper 8; 
Johnson & Johnson Ltd, Skipton, UK) was applied under firm pressure to the 
puncture site for a minimum of 10 min to avoid superficial haematoma.  
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2.10 BLOOD LACTATE CONCENTRATION  
1 mL arterialised venous blood samples were drawn into a syringe and were 
immediately transferred into sodium-heparinised 20 μL end-to-end capillary tubes 
(Biosen; EKF Diagnostics, Barleben, Germany). Capillary tubes were subsequently 
placed into a 1 mL micro test tube filled with lactate haemolysing solution (Biosen; 
EKF Diagnostics) and shaken vigorously for ~10 s. [La
-
]B was determined using an 
automated analyser (Biosen C_line Sport; EKF Diagnostics). The lactate contained in 
the sample is converted enzymatically by the immobilised lactate oxidase on the chip 
sensor of the analyser. The bicarbonate generated by the reaction is detected at the 
electrode. The amperometric signal (sensor current) is proportional to the lactate 
concentration in the sample. The analyser was calibrated before use with a standard 
solution of a known concentration of lactate (12 mmol·L-1). The within sample CV 
for [La
-
]B was 1.9% (n = 10 samples).   
 
2.11 BLOOD GASES  
1.5 mL arterialised venous blood samples were drawn into a syringe that 
contained sodium-heparin (PICO 50; Radiometer, Copenhagen, Denmark) and the 
syringe was inverted 8 times. The blood sample was subsequently aspirated into the 
injection port of an automated blood gas analyser (ABL 520; Radiometer) for the 
determination of PCO2 and pH. The analyser aspirates the blood into a measuring 
chamber which has ion selective electrodes. The pH electrode compares a potential 
developed at the electrode tip with a reference potential and the resulting voltage is 
proportional to the concentration of hydrogen ions. The PCO2 electrode is a pH 
electrode with a silicone rubber CO2 semi-permeable membrane covering the tip. 
CO2 combines with water in the space between the membrane and the electrode tip to 
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produce free hydrogen ions in proportion to the PCO2. The blood gas analyser 
performed automated calibrations at 2 h intervals. Additionally, four levels of quality 
control solutions (QUALICHECK 3+; Radiometer) were introduced monthly into the 
analyser to ensure accuracy and precision. The within sample CV was 2.2 and 3.4% 
for PCO2 and pH, respectively (n = 10 samples).    
 
2.12 ENZYME LINKED IMMUNOSORBANT ASSAY 
5 mL blood samples were drawn into a syringe and immediately transferred 
into pre-cooled tubes containing 1.6 mg·mL
-1
 of K3E ethylenediaminetetraacetic acid 
(EDTA) (SARSTEDT, Leicester, UK). Tubes were gently inverted several times and 
then centrifuged for 15 min at 1000 x g and 5ºC. The plasma supernatant was 
subsequently removed and stored at -80ºC until further analysis. Plasma cytokines in 
Chapters 3 and 4 were analysed using a commercial solid phase sandwich ELISA 
(Figure 1.18) (Quantikine; R&D Systems, Abingdon, UK). Plasma cytokine 
concentrations were read in duplicate using an automated absorbance microplate 
reader (ELx800; BioTek, Vermont, USA).  
 
2.13 MEASUREMENT OF SYSTEMIC OXIDATIVE STRESS: COMET ASSAY 
The measurement of systemic oxidative stress was undertaken using the 
comet assay which can determine levels of DNA damage at the level of the 
individual eukaryotic cell. In its basic form, the comet assay measures DNA strand 
breaks and alkali-labile sites, i.e. apurinic/apyrimidinic sites, or baseless sugars. 
These cannot be specifically related to oxidation, since they result from various 
forms of damage, and might also represent intermediates in the repair process.  
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The comet assay has been extensively utilised at Nottingham Trent 
University (see Marthandan et al. 2011 and 2013 for most recent publications) and 
when the same investigator undertakes scoring of slides the inter-assay CV is <10% 
(Moller 2006). Previous reports have shown that prolonged and strenuous whole-
body exercise can cause oxidative DNA damage in PBMC which can be measured 
with the comet assay (Collins et al. 1993; Wagner et al. 2011). Therefore, the 
technique would be suitable to detect changes in respiratory muscle ROS production. 
The technique does, however, exhibit large inter-individual differences in the amount 
of DNA damage due to, amongst others, endogenous factors such as diet, PBMC 
composition, or exposure to exogenous and endogenous genotoxins, and to a lesser 
extent variations in the handling and scoring of PBMC which cannot be excluded 
from the technique (Moller 2006).  
  
2.13.1 ISOLATION OF PERIPHERAL BLOOD MONONUCLEAR CELLS 
PBMC were used for the comet assay and were isolated using density gradient 
centrifugation. 5 mL of heparinised venous blood and 5 mL of phosphate buffered 
saline were layered onto a lymphocyte separation medium (Ficoll-Paque Plus; 
Griener Bio-One, Stonehouse, UK) inside a Leucosep tube (Griener Bio-One, 
Stonehouse, UK) and centrifuged for 15 min at 800 x g and room temperature. The 
opaque mononuclear cell layer was aspirated and washed 3 times in phosphate 
buffered saline and centrifuged for 10 min at 200 x g and room temperature. The 
cells were cryopreserved in liquid nitrogen for subsequent analysis in a medium 
consisting of 10% Dimethyl sulfoxide (Sigma-Aldrich, Gillingham, UK), 20% foetal 
bovine serum (Invitrogen, Paisley, UK) and 70% X-Vivo 10 media (Lonza, 
Wokingham, UK). 
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2.13.2 COMET ASSAY 
Levels of DNA damage (DNA single strand breaks and alkali labile lesions) 
in PBMC were determined using the alkaline comet assay (Singh et al. 1988) and the 
modified alkaline comet assay (Collins et al. 1993). In the modified comet assay, 
PBMC embedded on slides were treated with either 
formamidopyrimidineglycosylase (FPG) which recognises oxidatively modified 
purines (Boiteux et al. 1992), or with endonuclease III (ENDO III) which recognises 
oxidatively modified pyrimidines (Asahara et al. 1989). These enzymes nick DNA at 
the sites of oxidatively damaged nucleotides, creating single-strand breaks which can 
be detected with the alkaline comet assay. PBMC treated with 150 μM hydrogen 
peroxide for 5 min at 4ºC (to induce oxidative damage) were used as internal positive 
controls in the modified alkaline comet assay.  
The comet assays were performed at 4ºC to minimise the repair of existing 
basal levels of DNA damage present in PBMC. PBMC (2 x 10
4
 cells·gel
-1
) were 
embedded in a 1% agarose gel on frosted microscope slides, and lysed for 1 h in a 
high salt alkaline buffer (2.5 M sodium chloride, 0.1 M EDTA, 0.01 M Tris, 1% 
(v/v), Triton X-100, pH 10). For the modified comet assays, slides were equilibrated 
in enzyme buffer (0.04 M HEPES, 0.1 M potassium chloride, 0.5mM EDTA, 0.2 
mg·mL
-1
 bovine serum albumin, pH 8.0) prior to the application of FPG or ENDO 
III. Slides treated with the lesion specific enzymes were incubated at 37ºC in a humid 
dark chamber for 45 min. Following enzyme treatment (or immediately after alkaline 
lysis for the alkaline comet assay) the slides were placed in electrophoresis buffer 
(0.3 M sodium hydroxide, 1 mM EDTA, pH 13) for 20 min to allow alkaline 
unwinding of the DNA, and then electrophoresed at 25 V and 300 mA for 30 min. 
Subsequently, slides were neutralised (0.4 M Tris, pH 7.5) and stained (50 μg·mL-1 
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ethidium bromide) to visualise DNA. Stained slides were digitally analysed using 
ultraviolet microscopy (Carl Zeiss Ltd, Welwyn Garden City, UK) and scored (50 
PBMC per slide) using analysis software (Komet 5.5; Andor Bio Imaging, 
Nottingham, UK) (Figure 2.5).  
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Figure 2.6 Comet analysis. The damaged DNA inside the peripheral blood 
mononuclear cell (PBMC) nucleus is pulled from anode to cathode during 
electrophoresis. The slides are subsequently stained to visualise the DNA and they 
are viewed using ultraviolet microscopy. The top panel shows the analysis software 
where a live image is visualised and two separate PBMC have been randomly chosen 
and scored. Three separate boxes are placed around the PBMC to measure the 
intensity of light emitted from the background (green), the comet head - intact DNA 
(blue), and the comet tail - damaged DNA (yellow). The software calculates the light 
emitted from the head and tail as a percentage and subtracts the light emitted from 
the background. The bottom panel shows A) 90% DNA of the the head of the comet 
and 10% in the tail - 10% DNA damage; and B) 74% DNA of the the head of the 
comet and 26% in the tail - 26% DNA damage.  
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2.14 RATING OF PERCEIVED EXERTION 
RPE for leg discomfort and dyspnoea was measured using Borg’s modified 
CR10 scale (Borg 1982). For trials involving younger participants, both scales were 
mounted onto a magnetic board that faced the participant throughout the trial and 
measurements were taken via the participant moving a magnetic counter to the 
desired integer. For trials involving older participants, a single scale was used and 
participants pointed to the correct integer. Both sets of participants were familiarised 
with scales and were encouraged to provide a differential response relative to leg 
discomfort and dyspnoea.     
 
2.15 INSPIRATORY MUSCLE TRAINING 
IMT participants performed 30 consecutive dynamic inspiratory efforts twice 
daily for 6 weeks (younger) or 8 weeks (older) using an inspiratory pressure-
threshold device (POWERbreathe
®
 Classic series 1st generation; Gaiam, UK). The 
initial training load was 50% MIP. Thereafter, participants periodically increased the 
load so that 30 manoeuvres could only just be completed. Each inspiratory effort was 
initiated from residual volume and participants strove to maximise VT. This regimen 
is known to be effective in eliciting an adaptive response (Brown et al. 2008; Brown 
et al. 2010; Brown et al. 2012; Romer and McConnell 2003).  
 
2.16 LACTATE MINIMUM TEST 
The lactate minimum test was performed following the procedures of 
Johnson et al. (2009) who reported excellent agreement between lactate minimum 
and MLSS powers (mean bias  95% limits of agreement: 2  22 W). The test 
comprised three consecutive phases: (i) lactate elevation phase comprising maximal 
127 
 
incremental exercise; (ii) 8 min recovery phase at 60 W; and (iii) incremental phase 
comprising five consecutive 4 min stages at intensities of 45, 50, 55, 60, and 65% of 
the  ̇max achieved during the lactate elevation phase. During the lactate elevation 
phase power output was increased by 10 W every 15 s so that exercise intolerance 
occurred in approximately 10 min. The highest oxygen uptake recorded in any 30 s 
period defined V̇O2peak. During the incremental phase, arterialised venous blood 
samples were taken in the final seconds of each stage, and the lactate minimum 
power (i.e. estimated MLSS power) was calculated as the nadir of a 2
nd
 order 
polynomial fitting the [La
-
]B against power data.  
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CHAPTER 3 ‒ INSPIRATORY MUSCLE TRAINING REDUCES PLASMA 
INTERLEUKIN-6 CONCENTRATION DURING CYCLING EXERCISE BUT 
NOT A VOLITIONAL MIMIC OF THE EXERCISE HYPERPNOEA 
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3.0 INTRODUCTION 
The plasma concentration of several cytokines increases following prolonged 
and strenuous whole-body exercise, with the myokine IL-6 demonstrating the largest 
increase (Pedersen and Febbraio 2008). Contracting skeletal muscle accounts for 
most (but not all) of the exercise-induced increase in plasma IL-6 (Steensberg et al. 
2000), which acts to stimulate lipolysis (Wolsk et al. 2010), hepatic glucose output 
(Febbraio et al. 2004), and glucose uptake in the contracting myocytes (Carey et al. 
2006).  
Given their relatively small mass (~960 g; Freedman et al. 1983) it may seem 
unlikely that the respiratory muscles contribute to exercise-induced increases in 
plasma IL-6. However, Vassilakopoulos et al. (1999) reported a 120% increase in 
plasma IL-6 concentration in young and healthy humans following IRL at 75% MIP. 
The increase in plasma IL-6 concentration was attributed to increased rates of IL-6 
release from the inspiratory muscles, which is supported by the observation of 
increased IL-6 mRNA and protein expression in the diaphragm of rats exposed to 
IRL (Sigala et al. 2011; Sigala et al. 2012; Vassilakopoulos et al. 2004). Although 
these findings have clinical relevance to those with asthma and obstructive lung 
disease, they cannot be generalised to healthy humans performing whole-body 
exercise as, compared to IRL, spontaneous exercise hyperpnoea elicits different 
breathing and respiratory muscle recruitment patterns (Clanton et al. 1985b; Clanton 
et al. 1990; Eastwood et al. 1994).    
Vassilakopoulos et al. (1999 and 2002) also suggested that the increase in 
plasma IL-6 concentration (and other cytokines) may be due to inspiratory / 
diaphragm muscle fibre injury / fatigue since IRL was performed until task failure, 
which occurred after 54  10 min. However, inspiratory muscle fatigue was assessed 
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using a volitional measure of MIP, which may decline following IRL until task 
failure due to a decrease in central drive globally rather than diaphragm fatigue 
(ATS/ERS 2002; McKenzie et al. 1997). The question of whether respiratory 
muscles release IL-6 during exercise, and if this is related to diaphragm fatigue, may 
be better addressed using volitional hyperpnoea at rest. In this model validity is 
improved by mimicking the breathing and respiratory muscle recruitment patterns 
experienced during whole-body exercise (Babcock et al. 1995; Klas and Dempsey 
1989) and the presence of diaphragm fatigue can be measured more objectively by 
using bilateral phrenic nerve stimulation (ATS/ERS 2002).  
Recent evidence suggests that the plasma IL-6 response to exercise is 
attenuated following resistance (Izquierdo et al. 2009) and endurance (Akerstrom et 
al. 2009; Croft et al. 2009; Yfanti et al. 2012) training. Increases in basal levels of 
IL-1rα (Akerstrom et al. 2009; Keller et al. 2005) or an increase in antioxidant 
enzymes (Yfanti et al. 2012) may explain such reductions. Alternatively, a strong 
stimulus for IL-6 production by skeletal muscle fibres is muscle glycogen depletion 
(Keller et al. 2005; Steensberg et al. 2001), which is attenuated in trained muscle 
(Croft et al. 2009; Fischer et al. 2004b) secondary to training-induced increases in 
mitochondrial density (Hoppeler and Fluck 2003). IMT may elicit similar 
morphological adaptations in the inspiratory muscles (Brown et al. 2008; Brown et 
al. 2010; Brown et al. 2012; Ramirez-Sarmiento et al. 2002), and thus also attenuate 
the plasma IL-6 response to whole-body exercise and/or volitional hyperpnoea.   
Therefore, the aim of this study was to examine whether the respiratory 
muscles contribute to exercise-induced increases in plasma IL-6 concentration, if this 
is related to diaphragm fatigue, and whether IMT attenuates the plasma IL-6 
response to whole-body exercise and/or volitional hyperpnoea.  
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3.1 METHODS 
3.1.1 PARTICIPANTS 
Twelve non-smoking recreationally active males provided written, informed 
consent to participate in the study, which was approved by the Nottingham Trent 
University ethics committee (Appendix 1 and 2). Participants followed the pre-
experimental instructions outlined in Section 2.0. 
 
3.1.2 EXPERIMENTAL DESIGN 
Participants attended the laboratory on 5 separate occasions, before and after 
a 6 week intervention. Each laboratory visit was separated by 48 h and took place at 
the same time of day. During the first visit participants were familiarised with all 
testing procedures and pulmonary function and MIP were measured. During the 
second visit participants performed a cycling lactate minimum test to estimate MLSS 
power. Subsequent experimental trials lasted 1 h and comprised: (i) passive rest 
(PASSIVE); (ii) cycling exercise at the participants lactate minimum power (EX); 
and (iii) volitional hyperpnoea at rest whereby participants mimicked the breathing 
and respiratory muscle recruitment patterns achieved during EX (HYPEX). Since EX 
had to precede HYPEX, the experimental trials were only partially randomised. 
Following the final trial participants were randomly, and equally, divided into an 
IMT or placebo (PLA) group and completed a 6 week intervention. At least 48 h 
post-intervention, participants repeated the experimental trials in the same order as 
pre-intervention. All trials were performed on an electromagnetically braked cycle 
ergometer (Excalibur Sport; Lode). 
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3.1.3 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY MOUTH PRESSURE   
Pulmonary function and MIP were assessed according to the procedures 
stated in Sections 2.3 and 2.4, respectively.  
 
3.1.4 LACTATE MINIMUM TEST 
The lactate minimum test was performed following the procedures of 
Johnson et al. (2009) as stated in Section 2.16.  
 
3.1.5 EXPERIMENTAL TRIALS 
During experimental trials the configuration of the cycle ergometer and the 
body position adopted by each participant were identical to those adopted during the 
lactate minimum test. Each trial was preceded by a 5 min rest period and during 
PASSIVE participants remained seated on the cycle ergometer for the duration of the 
trial. During pre- and post-intervention EX trials participants cycled at their pre-
intervention lactate minimum power and each participant adopted the same cycling 
cadence during all trials. During HYPEX participants mimicked the breathing ( ̇E, fB 
and TI/TTOT) and respiratory muscle recruitment (Pdipeak) patterns attained during pre-
intervention EX. These variables were ensemble averaged into six 10 min blocks 
from the EX data and targets were updated during the HYPEX trial. During the post-
intervention HYPEX trial participants mimicked the breathing and respiratory 
muscle recruitment patterns performed during the pre-intervention HYPEX trial. An 
audio metronome paced fB and TI/TTOT, and real-time visual feedback of  ̇E and 
Pdipeak was provided throughout. All experimental trials were performed in an 
environmental chamber (Design Environmental WIR52-20HS; Design 
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Environmental, Gwent, UK) at 20ºC and 90% relative humidity to minimise mucosal 
drying of the airways during HYPEX. 
 
3.1.6 FLOW, PULMONARY GAS EXCHANGE AND PRESSURE MEASUREMENTS  
During all trials participants wore a facemask (model 7940; Hans Rudolph) 
connected to a pneumotachograph and ventilatory and pulmonary gas exchange 
responses were measured breath by breath (ZAN 600USB; Nspire Health). During 
experimental trials a two-way non re-breathing valve (model 2730; Hans Rudolph) 
was attached distally to the pneumotachograph and a 1.5 m length of wide-bore 
tubing was connected to the inspiratory port. During HYPEX CO2 was added into 
this tubing to increase FICO2 and retain end-tidal and, consequently, blood PCO2 at 
levels commensurate with rest (Brown et al. 2008; Johnson et al. 2006). On the 
expiratory port of the two-way valve a Fleisch no. 3 pneumotachograph was attached 
and connected to a differential pressure transducer ( 2.5 cmH2O) (TSD160A; 
BIOPAC Systems) and differential bridge amplifier (DA100C; BIOPAC Systems) to 
allow alignment of flow and pressure signals. Pe and Pg were measured according to 
the procedures stated in Section 2.6. Pdi was calculated by subtracting Pe from Pg. Pdi 
and Pe were integrated over the period of inspiratory flow and multiplied by fB and 
labelled the diaphragm pressure-time product (PTPdi) and the inspiratory muscle 
pressure-time product (PTPe), respectively. Non-physiological flows and pressures 
that resulted from swallowing, coughing and breath holding, were identified by 
visual inspection and removed. Breathing mechanics data were ensemble averaged 
into six 10 min blocks and used for subsequent analysis. 
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3.1.7 BILATERAL ANTERIOR MAGNETIC PHRENIC NERVE STIMULATION 
BAMPS was applied according to the procedures stated in Section 2.7. Non-
potentiated Pditw and potentiated Pditw was measured at baseline and within 15 (<15 
min), 35 (<35 min) and 60 (<60 min) min after each experimental trial. Diaphragm 
fatigue was defined as a >15% reduction in Pditw compared to the baseline value 
(Kufel et al. 2002).  
 
3.1.8 BLOOD ANALYSES AND ADDITIONAL MEASUREMENTS 
Arterialised venous blood was sampled from a dorsal hand vein via an 
indwelling 21-G cannula (McLoughlin et al. 1992). During the experimental trials 
blood samples were taken at rest, every 3 min for the initial 15 min, and every 5 min 
thereafter, and analysed immediately for PCO2 and pH (ABL520; Radiometer), 
which were corrected for changes in rectal temperature (Squirrel 2020; Grant 
Instruments, Cambridge, UK). At rest and every 10 min during each trial [La
-
]B was 
determined using an automated analyser (Biosen C_line Sport; EKF Diagnostics) and 
measurements were taken for fC using short range telemetry (Polar S610; Polar, 
Kempele, Finland), estimated arterial oxygen saturation (SpO2) using infrared 
fingertip pulse oximetry (Model 8600; Nonin, Minnesota, USA), and RPE for leg 
discomfort and dyspnoea using Borg’s modified CR10 scale (Borg 1982). At rest, 
immediately after (0 h) and 1 (+1 h), 2 (+2 h), and 24 h (+24 h) after each 
experimental trial, 5 mL blood samples were taken for the measurement of plasma 
IL-6 concentration. Participants were instructed to not undertake any physical 
activity between +2 h and + 24 h. Blood was transferred into pre-cooled tubes 
containing 1.6 mg·mL
-1
 of K3E EDTA (SARSTEDT) and immediately centrifuged 
for 15 min at 1000 x g and 5ºC. The plasma supernatant was subsequently removed 
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and stored at -80ºC until further analysis. Plasma IL-6 concentrations were measured 
in duplicate using a commercial solid phase sandwich ELISA (Quantikine HS; R&D 
Systems, Abingdon, UK). The assay has a detection limit of 0.039 pg·mL
-1
. To 
minimise the effect of inter-assay variation, pre- and post-intervention samples from 
both groups were measured during the same assay. The inter- and intra-assay CV for 
plasma IL-6 concentration was <10%. 
 
3.1.9 INSPIRATORY MUSCLE TRAINING AND PLACEBO INTERVENTIONS 
The IMT group performed training sessions according to the procedures 
stated in Section 2.15. The PLA group inhaled one puff twice daily for 6 weeks from 
a sham metered dose inhaler (Vitalograph). The inhaler contained compressed air 
only but was promoted to the participants as delivering a novel drug that reduces 
breathing-induced inflammation. During the post-intervention period the IMT and 
PLA groups performed their intervention 2 d·wk
-1
, which is sufficient to maintain 
improvements in inspiratory muscle function after IMT (Romer and McConnell 
2003). These maintenance sessions were performed 48 h before and 48 h after 
experimental trials. All participants completed a training diary throughout the study 
to record adherence to the prescribed intervention and whole-body training sessions. 
 
3.1.10 STATISTICAL ANALYSES 
Statistical analyses were performed using SPSS for Windows (IBM, Chicago, 
Illinois, USA). Groups were compared for pre-intervention
 
characteristics using 
independent t-tests. A two-way repeated measures analysis of variance (ANOVA) 
was used to test between-group effects due to ‘treatment’ (IMT vs. PLA) and within-
group effects due to ‘intervention’ (pre- vs. post-‘treatment’), ‘trial’ (EX vs. 
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HYPEX) or ‘time’ (10, 20, 30, 40, 50 and 60 min for physiological variables; 0 h, +1 
h , +2 h and +24 h for plasma IL-6 data or baseline, <15 min, <35 min and <60 min 
for Pditw data). Planned pairwise comparisons were made with repeated measures t-
tests and with Bonferroni adjustment. Plasma IL-6 and [La
-
]B responses were also 
analysed using a three-way repeated measures ANOVA (‘treatment’ x ‘intervention’ 
x ‘time’). Reliability was assessed using a CV calculated from a pooled mean of both 
groups and all trials. Statistical significance was set at P < 0.05. Results are presented 
as mean  SD. 
 
3.2 RESULTS  
Age (IMT vs. PLA: 27  7 vs. 22  3 yr), body mass (80  6 vs. 74  7 kg), 
height (181  5 vs. 177  4 cm) and  ̇O2peak (52  6.2 vs. 47  5.7 mL·kg
-1
·min
-1
) 
were not different between groups. Except for lactate minimum power, which was 
higher (P < 0.01) in the IMT group (199  8 W) compared to the PLA group (170  
19 W), all pre-intervention measurements were not different between groups. In both 
groups all responses remained unchanged from rest during PASSIVE trials (data not 
shown). 
 
3.2.1 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY PRESSURE 
Pre-intervention pulmonary function and MIP were within normal limits 
(Table 3.1). Compliance with the intervention was excellent in both IMT and PLA 
groups with 96  1 and 93  1% of sessions completed, respectively. Pulmonary 
function was unchanged in both groups post-intervention, whereas MIP increased by 
24  16% following IMT (P < 0.01). Inspection of training diaries revealed habitual 
whole-body training remained constant in both groups.  
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Table 3.1 Pulmonary function and maximal inspiratory pressure for IMT and PLA 
groups. Predicted values from Quanjer et al. (1993) and Wilson et al. (1984). Values 
are mean  SD.  
 
IMT PLA 
 
Pre-intervention Post-intervention Pre-intervention Post-intervention 
FVC (L) 5.58  0.44  5.65  0.47  5.61  0.67  5.49  0.62  
FVC (% Predicted) 104  7 105  5 105  9 103  8 
FEV1
 (L) 4.49  0.46  4.43  0.20  4.53  0.51  4.34  0.57  
FEV1
 (% Predicted) 100  8 102  7 100  10 96  12 
FEV1/FVC (%) 81  6  81  4  81  6  80  8  
FEV1/FVC (% Predicted) 99  6 99  5 98  7 96  9 
MVV10 (L·min
-1) 208  2  206  20  192  33  196  25  
MVV10 (% Predicted) 111  14 111  11 102  19 104  14 
MIP (cmH2O) 168  49  202  39
*  136  32  139  31  
MIP (% Predicted) 157  9 178  34* 113  26 115  25 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; MVV10, 
maximum voluntary ventilation in 10 s; MIP, maximal inspiratory pressure. 
Significant difference (from pre-intervention 
*
P < 0.01). 
 
3.2.2 BREATHING AND RESPIRATORY MUSCLE RECRUITMENT PATTERNS 
With the exception of PTPdi, which was higher during HYPEX compared to 
EX in IMT (main effect for trial, P < 0.05) and PLA (trial x time interaction, P < 
0.01) groups, the pre-intervention exercise hyperpnoea was successfully mimicked 
during HYPEX (Table 3.2 and Figure 3.1). In the IMT group, the higher PTPdi 
during HYPEX compared to EX resulted in a higher PTPdi/PTPe (main effect for 
trial, P < 0.05). Breathing and respiratory muscle recruitment patterns during EX and 
HYPEX were unchanged following both IMT and PLA. A representative breathing 
and respiratory muscle recruitment pattern trace is shown in Figure 3.2. The inter-
trial CV for Pdipeak at rest was <7%.  
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Table 3.2 Physiological and perceptual responses to EX and HYPEX for IMT and 
PLA groups. Values are mean  SD. 
  EX    
HYPEX     
 
Pre-
intervention   
Post-
intervention   
Pre-
intervention   
Post-
intervention  
IMT                
 ̇E (L·min
-1) 81.0  13.0 
 
75.1  6.1 
 
77.3  15.1 
 
77.0  15.9 
VT (L) 2.41  0.55  
2.40  0.51 
 
2.31  0.53 
 
2.31  0.52 
fB (breaths·min
-1) 36  8 
 
33  6 
 
35  7 
 
35  9 
TI/TTOT 0.47  0.01  
0.48  0.02 
 
0.49  0.04 
 
0.48  0.05 
[La-]B (mmol·L
-1) 4.21  1.88  2.74  1.08*‡  0.84  0.14§ 0.92  0.10 
pH 7.357  0.031  7.376  0.020*†  7.414  0.025§+  7.424  0.022 
PCO2 (mmHg) 41.8  3.5  
41.4  3.1 
 
41.9  3.8§§ 
 
40.9  2.4 
fC (beats·min
-1) 163  15 
 
159  14* 
 
68  9+§§ 
 
68  12 
SpO2 (%) 95  1  
95  1 
 
99  1+§§ 
 
99  1 
RPE (Leg)  5.8  1.3 
 
5.2  1.2**++ 
 
0.0  0.0+§ 
 
0.0  0.0 
RPE (Dyspnoea)  3.9  1.7 
 
2.0  1.5*++ 
 
2.8  1.6§ 
 
1.7  1.3 
 
               
PLA 
 ̇E (L·min
-1) 61.6  14.5 
 
59.6  12.5 
 
58.2  13.4 
 
59.1  14.6 
VT (L) 1.77  0.34  
1.78  0.27 
 
1.69  0.36 
 
1.72  0.40 
fB (breaths·min
-1) 36  7 
 
35  7 
 
35  7 
 
35  7 
TI/TTOT 0.48  0.01  
0.48  0.02 
 
0.49  0.03 
 
0.49  0.02 
[La-]B (mmol·L
-1) 4.20  1.19  4.00  1.13  0.98  0.18§++  0.93  0.39 
pH 7.358  0.017  7.359  0.022  7.400  0.03§++  7.395  0.03 
PCO2 (mmHg) 41.2  2.7  
41.1  2.6 
 
42.1  2.8§ 
 
42.5  3.2 
fC (beats·min
-1) 158  16 
 
153  14 
 
66  10+§§ 
 
63  7 
SpO2 (%) 96  1  
96  1 
 
99  1‡§ 
 
99  1 
RPE (Leg)  5.1  2.7 
 
5.2  3.4 
 
0.0  0.0+§ 
 
0.0  0.0 
RPE (Dyspnoea)  3.7  2.9 
 
3.2  4.4 
 
1.6  2.1+ 
 
1.3  1.7 
 
 ̇E, minute ventilation; VT, tidal volume; fB, breathing frequency; TI/TTOT, duty cycle; 
[La
-
]B, blood lactate concentration; PCO2, partial pressure carbon dioxide; fC cardiac 
frequency; SpO2, estimated arterial oxygen saturation; RPE, rating of perceived 
exertion. Significant difference [(from pre-intervention 
* 
P < 0.01,
 ** 
P < 0.05; 
intervention x time interaction 
† 
P < 0.01, 
†† 
P < 0.05); (between trial 
§ 
P < 0.01, 
§§ 
P 
< 0.05; trial x time interaction 
+ 
P < 0.01, 
++ 
P < 0.05); (treatment x intervention x 
time interaction 
‡
P < 0.05)]. 
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Figure 3.1 Peak transdiaphragmatic pressure (Pdipeak; A), diaphragm pressure-time 
product (PTPdi; B), inspiratory muscle pressure-time product (PTPe; C) and the 
relative contribution of diaphragm to the inspiratory muscle pressure-time product 
(PTPdi/PTPe; D) for IMT (left panels) and PLA (right panels) groups. Significant 
difference (between trial 
§ 
P < 0.01, 
§§
 P < 0.05). Values are mean  SD. 
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Figure 3.2 Representative trace of flow (A), oesophageal pressure (Pe; B), gastric 
pressure (Pg; C) and transdiaphragmatic pressure (Pdi; D) for EX and HYPEX. Note 
that only expiratory flow is shown because the pneumotachograph was located on the 
expiratory port of the two-way non re-breathing valve.    
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3.2.3 PLASMA INTERLEUKIN-6 CONCENTRATION 
Plasma IL-6 concentration peaked immediately after EX for both IMT and 
PLA groups and returned to resting values at +24 h (Figure 3.3). The plasma IL-6 
response to EX was reduced by 33% following IMT (main effect for intervention, P 
< 0.05). Compared to rest, plasma IL-6 concentration increased in both groups during 
HYPEX (main effect for time, P < 0.05) and returned to resting values at +24 h. 
Increases in  plasma IL-6 concentration during HYPEX were unchanged for both 
groups post-intervention, although there was a trend for an attenuated response 
following IMT (main effect for intervention, P = 0.083).  
 
Figure 3.3 Plasma interleukin-6 (IL-6) concentration for PLA (A) and IMT (B) 
groups. Significant difference (from pre-intervention 
* 
P < 0.05; main effect time 
during HYPEX, P < 0.01 for 
a
 pre and 
b
 post-intervention). Values are mean  SD. 
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3.2.4 BLOOD LACTATE CONCENTRATION AND BLOOD GASES 
[La
-
]B during EX was reduced by 35%, and pH was higher, following IMT 
(main effects for intervention, P < 0.01) (Table 3.2). Changes in PCO2 during EX 
were unchanged in both groups post-intervention (Table 3.2). At rest, pre-
intervention [La
-
]B was 0.57  0.11 and 0.76  0.12 mmol∙L
-1
 for IMT and PLA 
groups and increased during HYPEX for both groups (main effect for time, P < 
0.05), and responses were unchanged post-intervention. pH and PCO2 during 
HYPEX trials were maintained at rest for both groups.  
 
3.2.5 TRANSDIAPHRAGMATIC TWITCH PRESSURES 
A plateau (i.e., no significant increase in amplitude with increasing 
stimulation intensity) in M-wave and Pditw amplitude (Figure 3.4) was observed in 
response to supramaximal BAMPS, indicating maximal depolarisation of the phrenic 
nerves. Non-potentiated Pditw and potentiated Pditw were unchanged following EX and 
HYPEX in both groups pre- and post-intervention (see Table 3.3 for measures taken 
at baseline and <15 min after EX and HYPEX; Pditw and potentiated Pditw did not 
change after <15 min) indicating there was no evidence of diaphragm fatigue. The 
inter- and intra-trial CV for baseline Pditw and M-wave responses was <8%.  
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Figure 3.4 M-wave (A) and transdiaphragmatic twitch pressure (Pditw; B) responses 
to supramaximal BAMPS for IMT and PLA groups. Values are pooled mean of 
PASSIVE, EX and HYPEX trials. Significant difference (from values at 100% of 
stimulators power output (P < 0.05) 
a 
pre-intervention IMT, 
b 
post-intervention IMT; 
c 
pre-intervention PLA, 
d 
post-intervention PLA). Values are mean. 
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Table 3.3 Transdiaphragmatic twitch pressures (Pditw) at baseline and <15 min 
following EX and HYPEX for IMT and PLA groups. Values are mean  SD. 
  
  
EX 
     
HYPEX 
  
 
Baseline 
 
<15 min 
 
Baseline 
 
<15 min 
Pre-intervention IMT 
       
Pditw (cmH2O) 15.6  5.1  16.5  5.1  14.4  6.4  14.9  7.2 
Potentiated Pditw (cmH2O) 23.3  8.6 
 
24.7  9.4 
 
23.4  9.5 
 
21.3  9.2 
                Post-intervention IMT 
               
Pditw (cmH2O) 16.3  6.1 
 
16.6  5.0 
 
14.8  6.7 
 
15.7  6.2 
Potentiated Pditw (cmH2O) 24.6  8.4 
 
25.1  5.0 
 
24.8  9.3 
 
22.6  7.3 
                Pre-intervention PLA 
               
Pditw (cmH2O) 12.3  2.5 
 
14.0  3.2 
 
10.4  2.4 
 
10.1  2.1 
Potentiated Pditw (cmH2O) 18.7  5.3 
 
19.6  4.6 
 
16.9  5.1 
 
16.7  5.0 
                Post-intervention PLA 
               
Pditw (cmH2O) 12.2  2.3 
 
14.0  3.7 
 
11.2  2.6 
 
12.1  2.7 
Potentiated Pditw (cmH2O) 19.6  4.0 
 
21.2  3.7 
 
17.6  4.5 
 
18.3  4.9 
 
 
3.2.6 PERCEPTUAL RESPONSES, CARDIAC FREQUENCY AND ARTERIAL OXYGEN 
SATURATION  
 
Reductions in leg discomfort (main effect for intervention, P < 0.05) and 
dyspnoea (main effect for intervention, P < 0.01) were observed during EX after 
IMT (Table 3.2 and Figure 3.5). There was a trend for dyspnoea to be lower during 
HYPEX following IMT (main effect for intervention, P = 0.054). fC was lower 
during EX following IMT (main effect intervention, P < 0.05). fC and SPO2 responses 
during HYPEX were unchanged for both the IMT and PLA groups post-intervention 
(Table 3.2). 
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Figure 3.5 Rating of perceived exertion (RPE) for leg discomfort and dyspnoea for 
the IMT group during EX. Significant difference (from pre-intervention for leg (
*
P < 
0.01, 
** 
P < 0.05) and dyspnoea (
^
P < 0.01, 
^^ 
P < 0.05)). Values are mean  SD. 
 
3.3 DISCUSSION 
3.3.1 MAIN FINDINGS 
The main findings were that plasma IL-6 concentration increased following 
strenuous whole-body exercise (EX) and a volitional mimic of the breathing and 
respiratory muscle recruitment patterns achieved during EX (HYPEX), and that these 
increases occurred in the absence of diaphragm fatigue. Furthermore, IMT reduced 
the magnitude of the plasma IL-6 response to EX but not HYPEX.  
To the author’s knowledge, this is the first study to report an increase in 
plasma IL-6 concentration following a volitional mimic of the exercise hyperpnoea. 
The increase in IL-6 following HYPEX was of a similar magnitude to that reported 
following IRL at 75% MIP until task failure (Vassilakopoulos et al. 1999). However, 
the present experimental model provides a more ecologically valid approach to 
assess whether the respiratory muscles release IL-6 during whole-body exercise. 
Confidence that the increase in plasma IL-6 concentration observed during HYPEX 
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is not an artefact of the experimental conditions is evidenced by the PASSIVE trial, 
where plasma IL-6 concentration was unchanged. The present data therefore suggest 
that the respiratory muscles do indeed contribute to the increase in plasma IL-6 
concentration observed during whole-body exercise.  
 
3.3.2 STIMULI FOR INTERLEUKIN-6 
The stimuli responsible for the increase in plasma IL-6 following HYPEX 
could not be established from the present study. There was no evidence of diaphragm 
fatigue following HYPEX, and confidence in the data is supported by the 
demonstration of supramaximal stimulation in M-wave and Pditw amplitude and 
excellent inter/intra trial reliability in both. Therefore, the present data do not support 
the notion (Vassilakopoulos et al. 1999; Vassilakopoulos et al. 2002) that diaphragm 
fatigue is a likely trigger of IL-6 release.  
Oxidative stress due to enhanced generation of ROS and nitrogen species is 
an important regulator of IL-6 production. ROS can upregulate IL-6 in the 
diaphragms of rats exposed to IRL (Sigala et al. 2011) and antioxidants can attenuate 
the plasma IL-6 response to IRL in humans (Vassilakopoulos et al. 2002). ROS are 
also upregulated by respiratory acidosis (Arbogast and Reid 2004); however, in the 
present study, PCO2 was carefully maintained at resting levels. Upstream of ROS, 
NO production may be involved in the transcriptional signalling of IL-6 (Steensberg 
et al. 2007) and has been shown to regulate IL-6 production within the diaphragm of 
rats exposed to IRL (Sigala et al. 2012). A more likely mechanism for the production 
of IL-6 may be a reduction in respiratory muscle glycogen content. Muscle glycogen 
depletion during prolonged and strenuous lower-body exercise is a strong stimulus 
for enhanced IL-6 production by skeletal muscle fibres (Keller et al. 2005; 
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Steensberg et al. 2001). This notion is supported by the reduced diaphragm glycogen 
content of murines exposed to IRL (Ciufo et al. 2001) and whole-body exercise 
(Green et al. 1987; Ianuzzo et al. 1987).  
 
3.3.3 SOURCE OF PLASMA INTERLEUKIN-6 
Contracting skeletal muscle accounts for most (but not all) of the increase in 
plasma IL-6 observed during whole-body exercise (Steensberg et al. 2000). Thus, 
although the experimental model did not allow the source(s) of the increased plasma 
IL-6 during HYPEX to be established, the increase is attributed to, primarily, 
increased IL-6 release from contracting respiratory muscles. This notion is consistent 
with the increased IL-6 mRNA and protein expression in the diaphragm of rats 
exposed to IRL (Sigala et al. 2011; Sigala et al. 2012; Vassilakopoulos et al. 2004), 
and the higher IL-6 protein expression in the external intercostals of COPD patients 
compared to healthy controls (Casadevall et al. 2007).  
However, there may have been additional contributions from other sources to 
the increase in plasma IL-6 concentration during HYPEX. Excessive expiratory 
muscle contractions during HYPEX (as evidenced by a higher PTPdi) may have 
resulted in greater IL-6 release from expiratory muscles. Excessive expiratory muscle 
contractions have been previously observed by those mimicking the pressure/flow 
characteristics of exercise hyperpnoea (Klas and Dempsey 1989). Other sources may 
include the brain that has been shown to release small amounts of IL-6 (~60 pg·min
-
1
) following 60 min of cycling exercise (Nybo et al. 2002). Furthermore, IL-6 may be 
upregulated within the lungs and subsequently enter the systemic circulation from 
permeation of epithelial and endothelial barriers with increased transmural pressures 
(Uhlig 2002). This has been observed in murines exposed to negative or positive 
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pressure ventilated hyperventilation (von Bethmann et al. 1998) or IRL 
(Toumpanakis et al. 2010). However, this causes profound overdistension of the 
lung, which is unlikely during spontaneous hyperpnoea in humans due to self-
regulation of end-inspiratory and/or end-expiratory lung volumes.  
 
3.3.4 EFFECTS OF INSPIRATORY MUSCLE TRAINING ON PLASMA INTERLEUKIN-6 
CONCENTRATION 
 
This is the first study to show that IMT reduces the plasma IL-6 response to 
whole-body exercise. Reduced IL-6 production by respiratory muscles following 
IMT may result from increases in basal levels of IL-6 rα (Akerstrom et al. 2009; 
Keller et al. 2005) or antioxidant enzymes (Yfanti et al. 2012), or a reduction in 
muscle glycogen utilisation (Croft et al. 2009; Fischer et al. 2004b) secondary to 
training-induced increases in mitochondrial density (Hoppeler and Fluck 2003).  
However, the decrease in plasma IL-6 concentration during EX cannot be 
explained by this alone as: 1) plasma IL-6 concentration during HYPEX was not 
reduced; and 2) the reduction in plasma IL-6 concentration during EX following IMT 
was greater than the increase observed during HYPEX. Thus, an alternate 
explanation is that the decrease in fC during EX could be evidence of a reduction in 
the respiratory muscle metaboreflex (Witt et al. 2007) which may serve to improve 
blood flow to the leg muscles (McConnell and Lomax 2006) or potentially the liver 
(Febbraio et al. 2003). Additional blood flow to the legs would increase oxygen 
(Bailey et al. 2010) and/or glucose delivery (Ebeling et al. 1993) potentially reducing 
muscle glycogen utilisation and blood flow to the liver would increase 
hepatosplanchnic uptake of IL-6 (Febbraio et al. 2003).   
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3.4 CONCLUSION 
In conclusion, plasma IL-6 concentration is increased following strenuous 
whole-body exercise (EX) and a volitional mimic of the exercise hyperpnoea 
(HYPEX), and in the absence of diaphragm fatigue. Furthermore, IMT reduced the 
magnitude of the plasma IL-6 response to EX but not HYPEX. That the respiratory 
muscles may contribute to the increase in plasma IL-6 during whole-body exercise 
raises several key questions: what other inflammatory cytokines are released from 
respiratory muscles during exercise and what are the key regulators of this IL-6 
release? Are other cytokines increased / decreased following IMT and does this 
create a pro- or anti-inflammatory response during exercise or volitional 
hyperpnoea?    
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CHAPTER 4 ‒ INSPIRATORY MUSCLE TRAINING REDUCES PLASMA 
INTERLEUKIN-6 CONCENTRATION DURING A VOLITIONAL MIMIC 
OF HEAVY WHOLE-BODY EXERCISE HYPERPNOEA
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4.0 INTRODUCTION 
In Chapter 3 it was shown that the respiratory muscles can contribute to 
exercise-induced plasma IL-6 concentrations which occurred in the absence of 
diaphragm fatigue. What remains unknown from this finding is what other cytokines 
are released from the respiratory muscles during exercise, and what the key 
regulators of their release are.  
Only very prolonged exercise with primarily an eccentric component results 
in a small increase in the plasma concentration of the pro-inflammatory cytokine IL-
1β (Ostrowski et al. 1999). Therefore, it could be inferred that very prolonged and/or 
high levels of respiratory muscle work would be required to elicit a significant 
response in this cytokine; those similar to heavy whole-body exercise. The increase 
in plasma IL-6 concentration is also intensity dependent. With higher exercise 
intensities (thus more muscular work) there are greater increases in plasma IL-6 
concentration (Scott et al. 2011). Whether respiratory muscle IL-6 is also intensity 
dependent is unknown. One of the roles of IL-6 is to stimulate the anti-inflammatory 
cytokine IL-1ra (Steenberg et al. 2003). IL-1ra acts to restrict and limit the extent of 
the inflammatory response by inhibiting signalling transduction of IL-1 (α and β) 
through the IL-1 receptor complex (Dinarello 2000). IL-1β acts to reduce muscle 
contractility and mediate muscle injury (Paulsen et al. 2012) and therefore the 
appearance of plasma IL-1β could be linked to the induction of diaphragmatic 
fatigue. 
Oxidative stress also has a role in the aetiology of diaphragmatic fatigue. A 
decrease in muscle contractility has been observed in vitro by incubating unfatigued 
isolated diaphragm fibres with ROS (Lawler et al. 1997). Conversely, contractile 
performance is improved by administrating antioxidants (to scavenge ROS) before or 
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during fatiguing contractions in vitro (Diaz et al. 1994; Khawli and Reid 1994; 
Shindoh et al. 1992) and in vivo (Kelly et al. 2009b; Supinski et al. 1995; Supinski et 
al. 1997; Travaline et al. 1997b). In addition to playing a role in diaphragmatic 
fatigue, oxidative stress via ROS also upregulates the protein expression of IL-6 and 
IL-1β in the diaphragms of rats exposed to 6 h of IRL (Sigala et al. 2012).  
In Chapter 3 it was also shown that IMT attenuated plasma IL-6 
concentration during exercise but not a volitional mimic of the exercise hyperpnoea. 
Why this occurred is not known, but it was suggested that a change blood flow 
distribution (following IMT) during exercise played a role. It could also be 
speculated that the stimuli for the release of respiratory muscle IL-6 (i.e., oxidative 
stress, glycogen depletion) was not above a certain threshold to make any IMT-
mediated adaptations evident during volitional hyperpnoea. Indeed, if glycogen 
depletion is a stimulus for IL-6 release from respiratory muscles then the respiratory 
muscles may have to undergo a certain amount of work before this is evident. There 
is no glycogen depletion in the diaphragms of rats after treadmill running at 63  3% 
 ̇O2max whereas a 25% decrease is observed when they exercise at 84  2%  ̇O2max 
(Fregosi and Dempsey 1986). Therefore, only respiratory muscle work associated 
with heavy exercise hyperpnoea may elicit a significant reduction in diaphragm 
glycogen content. Whole-body exercise training attenuates glycogen depletion and 
plasma IL-6 concentration (Croft et al. 2009; Fischer et al. 2004b) secondary to 
training-induced increases in mitochondrial density (Hoppeler and Fluck 2003). IMT 
may elicit similar morphological adaptations in the inspiratory muscles (Brown et al. 
2008; Brown et al. 2010; Brown et al. 2012; Ramirez-Sarmiento et al. 2002), and 
thus also attenuate the plasma IL-6 response to the hyperpnoea associated with heavy 
whole-body exercise. 
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Therefore, the aim of this study was to use a volitional mimic of the breathing 
and respiratory muscle recruitment patterns associated with heavy whole-body 
exercise hyperpnoea and to examine whether the respiratory muscles contribute to 
exercise-induced increases in plasma IL-6, IL-1β and IL-1ra concentration and a 
systemic marker of oxidative stress (DNA damage levels in PBMC), if this release is 
related to diaphragm fatigue, and whether IMT attenuates the plasma IL-6 response 
associated with this higher level of respiratory muscle work.   
 
4.1 METHODS 
4.1.1 PARTICIPANTS 
Twelve non-smoking recreationally active young males provided written, 
informed consent to participate in the study, which was approved by the Nottingham 
Trent University ethics committee (Appendix 1 and 2). Participants followed the pre-
experimental instructions outlined in Section 2.0. 
 
4.1.2 EXPERIMENTAL DESIGN 
Participants attended the laboratory on 4 separate occasions, each separated 
by 48 h and at the same time of day, prior to a 6 week intervention. During the first 
visit participants were familiarised with all testing procedures and pulmonary 
function and MIP were measured. During the second visit participants performed a 
maximal incremental cycling test. The experimental trials were randomised, 1 h and 
comprised: (i) passive rest (PASSIVE) or (ii) volitional hyperpnoea at rest whereby 
participants mimicked the breathing and respiratory muscle recruitment patterns 
commensurate with heavy whole-body exercise (VH). Following the final trial 
participants were randomly, and equally, divided into an IMT or PLA group and 
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completed a 6 week intervention. At least 48 h after the intervention participants 
repeated the experimental trials in the same order as before the intervention. In all 
trials, participants either exercised or sat (in an identical position to the maximal 
incremental cycling test) on an electromagnetically braked cycle ergometer 
(Excalibur Sport; Lode). 
 
4.1.3 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY MOUTH PRESSURE  
Pulmonary function and MIP were assessed according to the procedures stated 
in Sections 2.3 and 2.4, respectively.  
 
4.1.4 MAXIMAL INCREMENTAL CYCLING TEST 
Cycling began at 0 W and power was subsequently increased by 10 W every 
15 s in order to result in exercise intolerance within ~10 min. This rapid incremental 
protocol was selected to maximise  ̇E at the cessation of the test and therefore reflect 
intense endurance exercise. The power at which exercise intolerance ensued defined 
 ̇max, and the highest  ̇O2 and  ̇E recorded in any 30 s period defined  ̇O2peak and 
 ̇Epeak, respectively. 
 
4.1.5 EXPERIMENTAL TRIALS 
Trials were preceded by a 5 min rest period and during PASSIVE participants 
remained seated on the cycle ergometer for the duration of the trial. During VH 
participants mimicked at rest the breathing pattern ( ̇E, fB and TI/TTOT) and 
respiratory muscle recruitment pattern (Pdipeak) commensurate with 70‒80% of the 
 ̇Epeak attained during the maximal incremental cycling test; which during pilot work 
was shown to represent the maximum square wave response that could be maintained 
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for 1 h. During the post-intervention VH trial participants mimicked the breathing 
and respiratory muscle recruitment patterns that were attained during the pre-
intervention trial. These variables were ensemble averaged into six 10 min blocks 
from the pre-intervention trial and targets were updated during the post-intervention 
trial. An audio metronome paced fB and TI/TTOT, and real-time visual feedback of  ̇E 
and Pdipeak was provided throughout. All experimental trials were performed in an 
environmental chamber (Design Environmental WIR52-20HS; Design 
Environmental) at 20°C and 90% relative humidity to minimise mucosal drying of 
the airways during VH. 
 
4.1.6 FLOW, PULMONARY GAS EXCHANGE AND PRESSURE MEASUREMENTS  
During all trials participants wore a facemask (model 7940; Hans Rudolph) 
connected to a pneumotachograph and ventilatory and pulmonary gas exchange 
responses were measured breath by breath (ZAN 600USB; Nspire Health). A two-
way non-rebreathing valve (model 2730; Hans Rudolph) was attached distally to the 
pneumotachograph and on the expiratory port a Fleisch no. 3 pneumotachograph was 
attached and connected to a differential pressure transducer ( 2.5 cmH2O) 
(TSD160A; BIOPAC Systems) and differential bridge amplifier (DA100C; BIOPAC 
Systems) to allow alignment of flow and pressure signals. Pe and Pg were measured 
according to the procedures stated in Section 2.6. Pdi was calculated by subtracting Pe 
from Pg. Pdi and Pe were integrated over the period of inspiratory flow and multiplied 
by fB and labelled PTPdi and PTPe, respectively. Non-physiological flows and 
pressures that resulted from swallowing, coughing and breath holding, were 
identified by visual inspection and removed.  
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4.1.7 BILATERAL ANTERIOR MAGNETIC PHRENIC NERVE STIMULATION 
BAMPS was applied according to the procedures stated in Section 2.7. Non-
potentiated Pditw and potentiated Pditw was measured at baseline and within 15 (<15 
min), 35 (<35 min) and 60 (<60 min) min after each experimental trial. Diaphragm 
fatigue was defined as a >15% reduction in Pditw compared to the baseline value 
(Kufel et al. 2002).  
  
4.1.8 BLOOD ANALYSES AND ADDITIONAL MEASUREMENTS 
Arterialised venous blood was sampled from a dorsal hand vein via an 
indwelling 21-G cannula (McLoughlin et al. 1992). During the experimental trials 
blood samples were taken at rest, every 3 min for the initial 15 min, and every 5 min 
thereafter, and analysed immediately for PCO2 and pH (ABL520; Radiometer), 
which were corrected for changes in rectal temperature (Squirrel 2020; Grant 
Instruments). At rest and every 10 min during each trial [La
-
]B was determined using 
an automated analyser (Biosen C_line Sport; EKF Diagnostics) and measurements 
were taken for fC using short range telemetry (Polar S610; Polar), SpO2 using 
infrared fingertip pulse oximetry (Model 8600; Nonin), and RPE for dyspnoea using 
Borg’s modified CR10 scale (Borg 1982). At rest, immediately after (0 h) and 1 (+1 
h), 2 (+2 h), and 24 (+24 h) h after each experimental trial, 3 x 5 mL blood samples 
were taken for the measurement of plasma cytokines. Participants were instructed to 
not undertake any physical activity between +2 h and + 24 h. Blood was transferred 
into pre-cooled tubes containing 1.6 mg·mL
-1
 of K3E EDTA (SARSTEDT, Leicester, 
UK) and immediately centrifuged for 15 min at 1000 x g and 5ºC. The plasma 
supernatant was subsequently removed and stored at -80ºC until further analysis. 
Commercial solid phase sandwich ELISA were used to measure plasma 
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concentrations in duplicate of IL-6, IL-1β (Quantikine HS; R&D Systems) and IL-
1ra (Quantikine; R&D Systems). The assays have a detection limit of 0.039 pg·mL
-1
 
(IL-6), 0.1 pg·mL
-1
 (IL-1β) and 22 pg·mL-1 (IL-1ra), respectively. To minimise the 
effect of inter-assay variation, pre- and post-intervention cytokines from both groups 
were measured during the same assay. The inter/intra assay CV for ELISA were 
<10%. 
 
4.1.9 MEASUREMENT OF SYSTEMIC OXIDATIVE STRESS 
The comet assay was used to measure systemic oxidative stress by measuring 
levels of DNA damage in PBMC. During the experimental trials blood samples were 
taken at rest, immediately following the experimental trial (0 h) and 1 day into 
recovery (+24 h). Blood was immediately transferred into pre-cooled tubes 
containing lithium heparin (SARSTEDT). PBMC were isolated using density 
gradient centrifugation as stated in Section 2.13.1. The alkaline comet assay (Singh 
et al. 1988) and the modified alkaline comet assay (Collins et al. 1993) was used to 
determine levels of DNA damage (DNA single strand breaks and alkali labile 
lesions) in PBMC as stated in Section 2.13.2. 
 
4.1.10 INSPIRATORY MUSCLE TRAINING AND PLACEBO INTERVENTIONS 
The IMT group performed training sessions according to the procedures stated 
in Section 2.15. The PLA group inhaled one puff twice daily for 6 weeks from a 
sham metered dose inhaler (Vitalograph). The inhaler contained compressed air only 
but was promoted to the participants as delivering a novel drug that reduces 
breathing-induced inflammation. During the post-intervention period the IMT and 
PLA groups performed their intervention 2 d·wk
-1
, which is sufficient to maintain 
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improvements in inspiratory muscle function after IMT (Romer and McConnell 
2003). These maintenance sessions were performed 48 h before and 48 h after 
experimental trials. All participants completed a training diary throughout the study 
to record adherence to the prescribed intervention and whole-body training sessions. 
 
4.1.11 STATISTICAL ANALYSES 
Statistical analyses were performed using SPSS for Windows (IBM). Groups 
were compared for pre-intervention
 
characteristics using independent t-tests. A two-
way repeated measures ANOVA was used to test between-group effects due to 
‘treatment’ (IMT vs. PLA) and within-group effects due to ‘intervention’ (pre- vs. 
post-‘treatment’), or ‘time’ (10, 20, 30, 40, 50 and 60 min for physiological 
variables; 0, +1 , +2 and +24 h for plasma cytokine data; 0 h and +24 h for DNA 
damage to PBMC data; or baseline, <15, <35 and <60 min for Pditw data). Planned 
pairwise comparisons were made with repeated measures t-tests and with Bonferroni 
adjustment. Plasma cytokine and [La
-
]B responses were also analysed using a three-
way repeated measures ANOVA (‘treatment’ x ‘intervention’ x ‘time’). Reliability 
was assessed using a CV calculated from a pooled mean of both groups and all trials. 
Pearson product-moment correlation coefficients were calculated to assess the 
relationship between selected variables. Statistical significance was set at P < 0.05. 
Results are presented as mean  SD. 
 
4.2 RESULTS 
Age (IMT vs. PLA: 27  7 vs. 22  3 yr), body mass (80  6 vs. 74  7 kg), 
height (181  5 vs. 177  4 cm) and  ̇O2peak (52  6.2 vs. 47  5.7 mL·kg
-1
·min
-1
) 
were not different between groups. ̇ max (378  21 vs. 336  23 W) and  ̇Epeak (154  
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19 vs. 120  27 L·min-1) were higher (P < 0.05) for the IMT group. All other pre-
intervention measurements were not different between groups. All responses 
remained unchanged from rest during PASSIVE trials. 
 
4.2.1 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY PRESSURE 
Pre-intervention pulmonary function and MIP were within normal limits 
(Table 4.1). Compliance with the intervention was excellent in both IMT and PLA 
groups with 96  1 and 93  1% of sessions completed, respectively. Pulmonary 
function was unchanged in both groups post-intervention, whereas MIP increased by 
24  16% following IMT (P < 0.01). Inspection of training diaries revealed habitual 
whole-body training remained constant in both groups.  
 
Table 4.1 Pulmonary function and maximal inspiratory pressure for IMT and PLA 
groups. Predicted values from Quanjer et al. (1993) and Wilson et al. (1984). Values 
are mean  SD.  
 
IMT PLA 
 
Pre-intervention Post-intervention Pre-intervention Post-intervention 
FVC (L) 5.58  0.44  5.65  0.47  5.61  0.67  5.49  0.62  
FVC (% Predicted) 104  7 105  5 105  9 103  8 
FEV1
 (L) 4.49  0.46  4.43  0.20  4.53  0.51  4.34  0.57  
FEV1
 (% Predicted) 100  8 102  7 100  10 96  12 
FEV1/FVC (%) 81  6  81  4  81  6  80  8  
FEV1/FVC (% 
Predicted) 
99 ± 6 99  5 98  7 96  9 
MVV10 (L·min
-1) 208  2  206  20  192  33  196  25  
MVV10 (% Predicted) 111  14 111  11 102  19 104  14 
MIP (cmH2O) 168  49  202  39
*  136  32  139  31  
MIP (% Predicted) 157  9 178  34* 113  26 115  25 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; MVV10, 
maximum voluntary ventilation in 10 s; MIP, maximal inspiratory pressure. 
Significant difference (from pre-intervention 
*
P < 0.01). 
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4.2.2 BREATHING AND RESPIRATORY MUSCLE RECRUITMENT PATTERN 
Both IMT and PLA participants were able to accurately mimic the breathing 
and respiratory muscle patterns commensurate with heavy whole-body exercise 
hyperpnoea and replicated this accurately in their respective post-intervention VH 
trials. A representative breathing and respiratory muscle recruitment pattern trace is 
shown in Figure 4.1 and the targets for VH in Table 4.2. There were no differences in 
the breathing pattern (Table 4.3; PASSIVE data not shown) and respiratory muscle 
recruitment pattern (Figure 4.2) before or after the intervention for both groups. The 
mean  ̇E during the pre-intervention VH trial represented 71  12 and 82  6% of the 
 ̇Epeak attained during the maximal incremental cycling test for IMT and PLA groups, 
respectively. The inter-trial CV for Pdipeak at rest was <7%. 
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Figure 4.1 Representative trace of flow (A), oesophageal pressure (Pe; B), gastric 
pressure (Pg; C) and transdiaphragmatic pressure (Pdi; D) for VH, PASSIVE and 
maximal incremental cycling (MAX). Note that only expiratory flow is shown 
because the pneumotachograph was located on the expiratory port of the two-way 
non re-breathing valve.    
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Table 4.2 Breathing and respiratory muscle recruitment pattern targets during VH 
for IMT and PLA groups. Values are mean  SD. 
 
IMT PLA 
   ̇ E (L·min
-1
) 126  17 104  17 
fB (breaths·min
-1
) 42  10 37  7 
TI/TTOT 0.50  0.02 0.51  0.02 
Pdipeak (cmH2O) 35  10 37  8 
 
 ̇E, minute ventilation; VT, tidal volume; fB, breathing frequency; TI/TTOT, duty cycle; 
Pdipeak, peak transdiaphragmatic pressure.  
  
 
 
Table 4.3 Physiological responses to VH for IMT and PLA groups.  
 
IMT PLA 
 
Pre-intervention 
 
Post-intervention Pre-intervention 
 
Post-intervention 
 ̇E (L·min
-1) 109  21 
 
109  16 99  20 
 
98  21 
VT (L) 2.75  0.73  
2.71  0.69 2.70  0.47 
 
2.66  0.44 
fB (breaths·min
-1) 42  11 
 
42  11 37  7 
 
37  6 
TI/TTOT 0.49  0.04  
0.48  0.05 0.50  0.03 
 
0.50  0.02 
[La-]B (mmol·L
-1) 1.37  0.58  1.21  0.40 1.29  0.43  1.19  0.47 
pH 7.399  0.043  7.409  0.035 7.407  0.028  7.408  0.033 
PCO2 (mmHg) 44.4  4.4  
43.8  4.2 41.3  4.0 
 
41.8  4.5 
fC (beats·min
-1) 84  9 
 
80  10† 74  6 
 
74  13 
SpO2 (%) 99  1  
99  1 99  1 
 
99  1 
               
 ̇E, minute ventilation; VT, tidal volume; fB, breathing frequency; TI/TTOT, duty cycle; 
[La
-
]B, blood lactate concentration; PCO2, partial pressure carbon dioxide; fC, cardiac 
frequency; SpO2, estimated arterial oxygen saturation. Significant difference 
(intervention x time interaction 
† 
P < 0.01). 
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Figure 4.2 Peak transdiaphragmatic pressure (Pdipeak; A), diaphragm pressure-time 
product (PTPdi; B), inspiratory muscle pressure-time product (PTPe; C) and the 
relative contribution of diaphragm to the inspiratory muscle pressure-time product 
(PTPdi/PTPe; D) for IMT and PLA groups. 
 
 
4.2.3 PLASMA CYTOKINE CONCENTRATIONS 
Compared to rest, plasma IL-6 and IL-1β concentrations increased over time 
(main effect for time, P < 0.05) during pre- and post-intervention VH trials for both 
groups and returned to resting values at +24 h (Figure 4.3). Pairwise comparisons did 
not reveal any significant effects for plasma IL-1β. The plasma IL-6 response to VH 
was reduced by 24% (main effect for intervention, P < 0.05) following IMT whereas 
no changes were observed following PLA. No changes in the plasma IL-1β response 
to VH were observed post-intervention for both groups. Compared to rest, plasma 
IL-1ra concentrations did not increase over time during VH trials for both groups. 
Resting IL-1ra concentrations during the pre-intervention VH trial were 157  46 and 
172  41 pg·mL-1 for the IMT and PLA groups, respectively.  
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Figure 4.3 Plasma interleukin-6 (IL-6; A) and interleukin-1β (IL-1β; B) for the IMT 
(left panels) and PLA (right panels) groups. Significant difference [(from pre-
intervention 
* 
P < 0.05); (main effect time during VH, P < 0.01 for 
a
 pre and 
b
 post-
intervention; main effect time during VH, P < 0.05 for 
c
 pre-intervention)]. Values 
are mean  SD. 
 
 
4.2.4 DNA DAMAGE LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS  
Compared to rest, the %DNA in Comet tail for the alkaline, FPG and ENDO 
III did not increase over time during VH trials before and after the intervention for 
both groups demonstrating that VH did not induce DNA damage in PBMC (Table 
4.4) and systemic oxidative stress was not evident using this marker.  
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Table 4.4 DNA damage levels in peripheral blood mononuclear cells during VH for 
IMT and PLA groups. 
 
 Rest 0 h +24 h 
Pre-intervention IMT    
Alkaline Comet (%DNA in Comet tail) 9.2  4.6 7.2  3.5 9.1  5.2 
FPG Comet (%DNA in Comet tail) 15.6  6.3 13.6  3.5 16.2  9.8 
ENDO III Comet (%DNA in Comet tail) 13.4  5.5 13.0  7.3 12.7  5.5 
       
Post-intervention IMT 
      
Alkaline Comet (%DNA in Comet tail) 7.3  1.2 8.2  3.3 8.8  5.0 
FPG Comet (%DNA in Comet tail) 16.9  2.8 17.8  7.3 17.3  5.4 
ENDO III Comet (%DNA in Comet tail) 11.4  1.2 10.8  2.0 9.8  1.7 
       
Pre-intervention PLA 
      
Alkaline Comet (%DNA in Comet tail) 14. 4  10.0 9.8  2.6 11.9  7.1 
FPG Comet (%DNA in Comet tail) 25.1  7.4 21.9  12.5 24.8  8.1 
ENDO III Comet (%DNA in Comet tail) 14.1  8.6 13.7  6.3 14.9  8.8 
       
Post-intervention PLA 
      
Alkaline Comet (%DNA in Comet tail) 11.2  8.1 15.7  9.0 11.8  7.7 
FPG Comet (%DNA in Comet tail) 21.6  7.2 16.6  11.7 25.0  11.7 
ENDO III Comet (%DNA in Comet tail) 15.6  7.7 15.3  7.9 15.1  7.2 
 
FPG, formamidopyrimidineglycosylase; ENDO III, endonuclease III.   
 
 
 
4.2.5 TRANSDIAPHRAGMATIC TWITCH PRESSURES 
A plateau (i.e., no significant increase in amplitude with increasing 
stimulation intensity) in M-wave and Pditw amplitude (Figure 4.4) was observed in 
response to supramaximal BAMPS, indicating maximal depolarisation of the phrenic 
nerves. Non-potentiated Pditw were unchanged following VH trials before and after 
the intervention for both groups. Compared to baseline responses, there was a 
reduction in potentiated Pditw by 15‒20% at <15 min post-VH (Figure 4.5), 
demonstrating evidence of diaphragm fatigue. This occurred in most VH trials, apart 
from post-intervention IMT trial, which was only 10%. Pairwise comparisons did 
not, however, reveal any significant effects. Pre-intervention increases in plasma IL-
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6 and IL-1β during VH did not correlate with the decrease in Pditw. The inter- and 
intra-trial CV for baseline Pditw and M-wave responses was <7%. 
 
Figure 4.4 M-wave (A) and transdiaphragmatic twitch pressure (Pditw; B) responses 
to supramaximal BAMPS for IMT and PLA groups. Values are pooled mean of VH 
and PASSIVE trials. Significant difference [from values at 100% of stimulators 
power output (P < 0.05 
a 
pre-intervention IMT, 
b 
post-intervention IMT; 
c 
pre-
intervention PLA, 
d 
post-intervention PLA)]. Values are mean. 
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Figure 4.5 Potentiated transdiaphragmatic twitch pressure (Pditw) responses to 
BAMPS at baseline and during recovery from VH for IMT and PLA groups. Values 
are mean  SD of percentage baseline responses. Dashed lines represent the baseline 
(0%) and diaphragmatic fatigue (>15% reduction in Pditw compared to the baseline 
values).  
 
 
4.2.6 ADDITIONAL MEASUREMENTS 
Compared to rest, [La
-
]B increased over time (main effect for time, P < 0.05) 
and PCO2, pH and SpO2 were maintained at rest during VH trials for both groups 
(Table 4.3). There was no effect of the intervention on these measures in both 
groups. RPE dyspnoea was lower during VH (main effect for intervention, P < 0.05) 
and changed differently over time (intervention x time interaction, P < 0.01) 
following IMT whereas no changes were observed following PLA (Figure 4.6). The 
response of fC was also different over time (intervention x time interaction, P < 0.01) 
following IMT whereas no changes were observed following PLA (Table 4.3).  
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Figure 4.6 Rating of perceived exertion (RPE) for dyspnoea during VH for IMT and 
PLA groups. Significant difference (from pre-intervention for IMT group 
**
P < 0.01, 
*
P < 0.05). 
 
4.3 DISCUSSION 
4.3.1 MAIN FINDINGS 
The main findings of this study were that plasma IL-6 and IL-1β 
concentrations increased following a volitional mimic of the breathing and 
respiratory muscle recruitment patterns achieved during heavy whole-body exercise 
(VH), and that these increases occurred with (but were not correlated to) 
diaphragmatic fatigue. There were no increases in the plasma IL-1ra concentration or 
DNA damage levels in PBMC after VH. Furthermore, IMT reduced the magnitude of 
the plasma IL-6 response to VH.  
To the author’s knowledge this is the first study the first to report an increase 
in plasma IL-6 and IL-1β concentration following a volitional mimic at rest of heavy 
exercise hyperpnoea. The increase in plasma IL-1β concentration following VH was 
of a similar magnitude to that reported following IRL at 75% MIP until task failure 
(Vassilakopoulos et al. 1999). The increase in plasma IL-6 concentration was, 
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however, much greater, and is similar to the peak concentrations observed after 
cycling exercise in Chapter 3. The increase in plasma IL-6 and IL-1β concentrations 
were not due to any methodological or environmental stresses since plasma IL-6 and 
IL-1β responses were unchanged from rest during PASSIVE.  
 
4.3.2 STIMULI FOR INTERLEUKIN-6 AND INTERLEUKIN-1Β 
The stimuli responsible for the increase in plasma IL-6 and IL-β 
concentration following VH could not be established from the present study. 
Although there was evidence of diaphragm fatigue following VH this was not 
correlated with these markers. Therefore, our data do not support the notion 
(Vassilakopoulos et al. 1999; Vassilakopoulos et al. 2002) that diaphragm fatigue is a 
likely trigger of IL-6 or IL-1β release.  
Oxidative stress due to enhanced generation of ROS and nitrogen species is 
an important regulator of IL-6 and IL-1β production. ROS can upregulate IL-6 and 
IL-1β in the diaphragms of rats exposed to IRL (Sigala et al. 2011) and antioxidants 
can attenuate the plasma IL-6 and IL-1β response to IRL in humans 
(Vassilakopoulos et al. 2002). ROS are also upregulated by respiratory acidosis 
(Arbogast and Reid 2004); however, PCO2 in the present study was maintained at 
resting levels. Upstream of ROS, NO production may be involved in the 
transcriptional signalling of IL-6 (Steensberg et al. 2007) and has been shown to 
regulate IL-6 and IL-1β production within the diaphragm of rats exposed to IRL 
(Sigala et al. 2012). Although a marker of systemic oxidative stress (DNA damage in 
PBMC) was not increased following VH, it cannot be excluded that there was a local 
increase within the respiratory muscles. Alternatively, although others have observed 
an increase in markers of oxidative stress within the diaphragms of rats following 
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whole-body endurance exercise (Lawler et al. 1997; Lawler and Hu 2000; Oh-ishi et 
al. 1997), the current finding might suggest that this local production does not spill 
out to cause sufficient DNA damage in systemic PBMC.  
A more likely mechanism for the production of IL-6 may be a reduction in 
respiratory muscle glycogen content. Muscle glycogen depletion during prolonged 
and strenuous lower-body exercise is a strong stimulus for enhanced IL-6 production 
by skeletal muscle fibres (Keller et al. 2005; Steensberg et al. 2001). This notion is 
supported by the reduced diaphragm glycogen content of murines exposed to IRL 
(Ciufo et al. 2001) and whole-body exercise (Green et al. 1987; Ianuzzo et al. 1987).  
 
4.3.3 SOURCE OF PLASMA INTERLEUKIN-6 AND INTERLEUKIN-1Β 
Although the current experimental model did not allow the source(s) of the 
increased plasma IL-6 and IL-1β concentration during VH to be established, this 
increase is attributed to, primarily, increased release from contracting respiratory 
muscles. This notion is consistent with the increased IL-6 and IL-1β mRNA and 
protein expression in the diaphragm of rats exposed to IRL (Sigala et al. 2011; Sigala 
et al. 2012; Vassilakopoulos et al. 2004), and the higher IL-6 and IL-1β protein 
expression in the external intercostals of COPD patients compared to healthy 
controls (Casadevall et al. 2007).  
However, there may have been additional contributions from other sources to 
the increase in plasma IL-6 and IL-1β concentration during VH. The brain has been 
shown to release small amounts of IL-6 (~60 pg·min
-1
) following 60 min of cycling 
exercise (Nybo et al. 2002). Furthermore, IL-6 and IL-1β may be upregulated within 
the lungs and subsequently enter the systemic circulation from permeation of 
epithelial and endothelial barriers with increased transmural pressures (Uhlig 2002). 
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This has been observed in murines exposed to negative or positive pressure 
ventilated hyperventilation (von Bethmann et al. 1998) or IRL (Toumpanakis et al. 
2010). However, this causes profound overdistension of the lung, which is unlikely 
during spontaneous hyperpnoea in humans due to self-regulation of end-inspiratory 
and/or end-expiratory lung volumes.  
 
4.3.4 ROLE OF DIAPHRAGM FATIGUE 
Low frequency diaphragm fatigue was observed following VH. This may 
have occurred because of the high levels of respiratory muscle work, causing 
amongst other things, an accumulation of metabolites, excessive production of ROS 
and/or glycogen depletion. Others have observed diaphragm fatigue following short-
duration and very intense volitional hyperpnoea (Babcock et al. 1995; Hamnegard et 
al. 1996; Mador et al. 1996). The induction of fatigue was not related to plasma IL-6 
or IL-β concentrations and it cannot be confirmed what the cause of it was. Based on 
the observation of the substantial increases in plasma IL-6 concentration, and the 
duration of VH, it is suggested that this may be due to glycogen depletion. 
Supplemented with the observation of an increase in plasma IL-1β, the findings may 
indicate that the diaphragm was injured in response to VH. Markers of respiratory 
muscle injury have been observed in humans following IRL at ~70% MIP for 1 h 
(Foster et al. 2012) which is another protocol performed at rest that significantly 
increases respiratory muscle work, and when strenuous enough can elicit 
diaphragmatic fatigue (Laghi et al. 1995; Laghi et al. 1996; Mador et al. 1996; 
Moxham et al. 1981; Sheel et al. 2001; Sheel et al. 2002; Travaline et al. 1997a; 
Travaline et al. 1997b).  
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4.3.5 PLASMA IL-1 RECEPTOR ANTAGONIST 
Why there was not an increase in plasma IL-1ra is unknown. The only known 
biological role of IL-1ra is to inhibit signalling transduction of IL-1 through the IL-1 
receptor complex (Dinarello 2000). It is has been suggested that IL-1ra is also 
upregulated by IL-6 and that acute exercise induces an anti-inflammatory 
environment in the post-exercise period (Steensberg et al. 2003). Therefore, 
theoretically, the increases in plasma IL-6 and IL-1β should lead to an increase in 
plasma IL-1ra. The likely explanation for this finding is the time course of plasma 
IL-6 and IL-1β in the present study. Following prolonged and strenuous whole-body 
exercise others have reported a plasma IL-1ra increase similar to the magnitude of 
the plasma IL-6 response, but with peak concentrations recorded between 2 to 4 h 
post-exercise (Ostrowski et al. 1999; Scott et al. 2011; Yfanti et al. 2012). The peak 
concentrations of plasma IL-6 and IL-1β in the present study were observed at +2 h 
and +1 h, respectively, which is consistent with IRL (Vassilakopoulos et al. 2002), 
but in contrast to whole-body exercise where these cytokines peak immediately post-
exercise (Ostrowski et al. 1999). It is probable that this delay, which was 
accompanied by relatively low concentrations of plasma IL-6 and IL-1β (compared 
to prolonged and strenuous exercise bouts such as a marathon) resulted in plasma IL-
1ra not being observed in the systemic circulation until ~2 h following this peak 
concentration; possibly at ~3 to 4 h post-VH and at a time point that was not 
measured.     
 
4.3.6 EFFECTS OF INSPIRATORY MUSCLE TRAINING ON PLASMA INTERLEUKIN-6 
CONCENTRATION 
 
This is the first study to show that IMT reduces the plasma IL-6 response to 
volitional hyperpnoea. Reduced IL-6 production by respiratory muscles following 
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IMT may result from increases in basal levels of IL-6 rα (Akerstrom et al. 2009; 
Keller et al. 2005) or antioxidant enzymes (Yfanti et al. 2012), or a reduction in 
muscle glycogen utilisation (Croft et al. 2009; Fischer et al. 2004b) secondary to 
training-induced increases in mitochondrial density (Hoppeler and Fluck 2003). The 
hypothesis that a certain level of glycogen depletion may be required in the 
respiratory muscles to make any IMT-mediated adaptations evident during volitional 
hyperpnoea would be supported by this study and infer that if glycogen depletion is a 
stimulus for IL-6 release from respiratory muscles, then the respiratory muscles may 
have to undergo a certain amount of work before the effect of IMT is evident. 
 
4.4 CONCLUSION 
In conclusion, plasma IL-6 and IL-1β concentrations are increased following a 
volitional mimic of the breathing and respiratory muscle recruitment patterns 
achieved during heavy whole-body exercise (VH), and these increases occurred with 
(but were not correlated to) diaphragm fatigue. There were no increases in plasma 
IL-1ra concentration or DNA damage levels in PBMC after VH. Furthermore, IMT 
reduced the magnitude of the plasma IL-6 response to VH.  
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CHAPTER 5 ‒ INSPIRATORY MUSCLE FUNCTION AND STRUCTURE 
ARE IMPROVED BUT RESTING SYSTEMIC MARKERS OF 
INFLAMMATION AND OXIDATIVE STRESS REMAIN UNCHANGED IN 
OLDER ADULTS FOLLOWING INSPIRATORY MUSCLE TRAINING
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5.0 INTRODUCTION 
In Chapters 3 and 4 it was shown that increased respiratory muscle work 
increases plasma cytokine concentrations. The respiratory muscles of older adults 
also experience increased workloads at rest. With healthy ageing there is a 
progressive decrease in total respiratory system compliance, which results in airflow 
limitation, air trapping, and an increase in residual volume (Vaz Fragoso and Gill 
2012). The increase in residual volume flattens the curvature of the diaphragm, 
shifting its length-tension relationship to a shorter length and placing the diaphragm 
at a mechanical disadvantage (Polkey et al. 1998). This contributes to a reduction in 
inspiratory muscle force and endurance whilst increasing the O2 cost of breathing 
(Harik-Khan et al. 1998; Johnson et al. 1997; Polkey et al. 1997; Takishima et al. 
1990). Functionally, this can increase dyspnoea during everyday tasks, limit exercise 
capacity, and lead to reduced PAL and QoL (Jensen et al. 2009; Renwick 2001).    
RMT in the forms of pressure-threshold IMT, combined pressure-threshold 
IMT/EMT and VIH have been promoted as a tool to attenuate the age-related decline 
in respiratory function. Manufacturers of devices have claimed that in older adults 
RMT can “increase resistance to fatigue”, “improve respiratory muscle efficiency” 
and “alleviate dyspnoea” all resulting in “improved exercise capacity” 
(http://www.powerbreathe.com/breathing-facts). Indeed, several studies have 
supported these claims and reported increases in respiratory muscle strength and 
endurance, pulmonary function, exercise capacity, PAL and QoL (Aznar-Lain et al. 
2007; Belman and Gaesser 1988; Huang et al. 2011; Watsford and Murphy 2008). 
Nevertheless, these studies have risked participant bias by failing to employ a 
placebo group (Belman and Gaesser 1988; Huang et al. 2011; Watsford and Murphy 
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2008) or are limited by a small sample size with insufficient statistical power  
(Aznar-Lain et al. 2007).  
Healthy ageing is also associated with systemic low-level inflammation due 
to enhanced production of pro-inflammatory cytokines (Bruunsgaard 2006; Kregel 
and Zhang 2007). Although a marker of systemic oxidative stress (DNA damage in 
PBMC) was not increased during elevated respiratory muscle work in Chapter 4, 
markers of oxidative stress are significantly higher in the external intercostals of 
older compared to younger adults (Barreiro et al. 2006), suggesting that the 
respiratory muscles of older adults may be prone to oxidatively mediated damage to 
biomolecules such as nucleic acids (Barnett and Barnett 1998; King and Barnett 
1995). Systemic inflammation may contribute to morbidity and mortality in ageing 
from hyperglycaemia, insulin resistance and increased gluconeogenesis (Beavers et 
al. 2010) and an elevation in bone reabsorbtion (Aris et al. 1998; Smith et al. 2008), 
dyslipidemia (Marik 2006), and proteolysis (Mitch and Goldberg 1996) whilst also 
increasing other parts of the inflammatory cascade that can have downstream 
biological effects. In Chapters 3 and 4 it was shown that IMT can attenuate plasma 
IL-6 concentrations during increased respiratory muscle work. In older adults, it has 
been reported that whole-body resistance or endurance training can decrease resting 
systemic cytokine concentrations (Kohut et al. 2006; Nicklas et al. 2008; Phillips et 
al. 2010; Prestes et al. 2009) and markers of oxidative stress (Fatouros et al. 2004; 
Parise et al. 2005; Takahashi et al. 2012), suggesting that regular conditioning of 
skeletal muscles may have a therapeutic benefit in attenuating these markers. 
Whether conditioning of the inspiratory muscles using IMT can have the same effect 
is unknown.  
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Therefore, the aim of this study was to examine the effects of IMT in older 
adults using a rigorous placebo controlled design, with an adequate sample size, on 
markers of systemic inflammation (plasma cytokines) and oxidative stress (DNA 
damage in PBMC) and to re-examine the claimed benefits of IMT on inspiratory 
muscle strength and endurance, pulmonary function, exercise capacity using the 
6MWT, PAL and QoL. A further aim was to evaluate the effects of IMT on 
diaphragm thickness and dynamic inspiratory muscle function which is shown to 
increase in younger adults following IMT (Downey et al. 2007; Romer and 
McConnell 2003).   
 
5.1 METHODS 
5.1.1 PARTICIPANTS 
A power analysis demonstrated that for the intervention to reduce a resting 
plasma IL-6 concentration of 2.5  0.5 pg·mL-1 by 0.5 pg·mL-1, 16 participants were 
required for each IMT and PLA group. The power analysis was based on the 
reductions observed following IMT in Chapters 3 and 4. Participants (65‒75 years) 
were recruited in response to local advertising according to the exclusion criteria 
used to define “healthy” (i.e., disease free non-smokers and not on any daily 
medication including antioxidants or supplements) older participants for exercise 
studies (Appendix 4; Greig et al. 1994). In total, 38 participants were screened for 
suitability and provided written, informed consent to participate in the study, which 
was approved by the Nottingham Trent University ethics committee (Appendix 5). 
Of these, one was excluded due to a FEV1 of <70% of predicted values (Falaschetti 
et al. 2004) and another developed bronchitis before commencement of the 
experimental trials. Each participant completed a 24 h estimated diet record prior to 
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their first experimental trial, which was then replicated prior to subsequent trials. 
Throughout the study, participants were instructed to adhere to their habitual training 
regimen and not to engage in any strenuous exercise the day preceding and the day of 
a trial. Participants arrived at the laboratory after an overnight fast (morning visits) or 
4 h postprandially (afternoon visits) having abstained from alcohol and caffeine in 
the 24 h before testing. 
 
5.1.2 EXPERIMENTAL DESIGN 
A randomised, placebo-controlled design was used. Prior to randomisation, 
all participants undertook a screening session, where a full 12-lead electrocardiogram 
was performed and subsequently interpreted by a trained cardiologist (Appendix 6). 
Height, body mass, blood pressure, pulmonary function and maximal mouth 
pressures were also measured. For the experimental trials, participants attended the 
laboratory on two separate occasions before and after an 8 week intervention, each 
separated by at least 1 week and at the same time of day. During the first visit, 
participants were familiarised with all testing procedures and pulmonary function 
and maximal mouth pressures were measured. Participants also completed a 
questionnaire to determine QoL and were given an accelerometer to measure 
quantitative PAL. During the second visit, participants returned the accelerometer 
and a blood sample was taken and body fat, diaphragm thickness, dynamic 
inspiratory muscle function and inspiratory muscle endurance were assessed and 
participants performed a 6MWT. In addition, participants completed a questionnaire 
to measure qualitative PAL. Participants were then randomly, and equally, divided 
into an IMT or PLA group. Following the intervention, participants repeated the 
experimental trials in the same order. Results from the experimental trials only were 
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used in the subsequent analysis. In addition to improving participants’ safety, the 
screening and familiarisation session(s) were used to minimise any learning effect 
and improve the reliability of the measurements (Eastwood et al. 1998; Kervio et al. 
2003; McConnell and Copestake 1999; Polkey and Moxham 2004). 
 
5.1.3 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY AND EXPIRATORY 
MOUTH PRESSURE 
 
Pulmonary function and maximal mouth pressures were assessed according to 
the procedures stated in Sections 2.3 and 2.4, respectively.  
 
5.1.4 DIAPHRAGM THICKNESS 
Diaphragm thickness (Tdi) was assessed using B-mode ultrasonography 
(Phillips ATL HDI 5000; ATL Ultrasound, Washington, USA) according to current 
recommendations (ATS/ERS 2002). Participants were semi-recumbent and the 
eighth and ninth intercostal spaces in the right midaxillary line were identified and 
marked with a wax pencil. The transducer (Linear array 5‒12 MHz probe; ATL 
Ultrasound) was held perpendicular to the chest wall and a two-dimensional coronal 
image of the diaphragm at the zone of apposition was identified by 2 clear parallel 
echodense lines (Figure 5.1). Tdi was measured from the middle of the pleural and 
peritoneal membranes. Images were recorded via a personal computer interfaced 
with the ultrasound scanner and subsequently digitised at 25 Hz and analysed using a 
public domain software package (ImageJ; National Institutes of Health, Maryland, 
USA).  
Measurements of Tdi were obtained in triplicate (Figure 5.1) at residual 
volume (Tdi.RV), functional residual capacity (Tdi.FRC), and total lung capacity (Tdi.TLC) 
and during a Müeller manoeuvre from residual volume (Tdi.CONT). The average value 
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from each measurement was used in the analysis. In order to standardise for any 
changes in lung volume post-intervention and, therefore, obtain measurements with 
the diaphragm in a more contracted state, the diaphragm thickening ratio (Tdi.TR) was 
determined using the formula: Tdi.RV / Tdi.CONT. Lung volumes were estimated from 
flow signals using the pneumotachograph setup described in Section 5.1.5. 
Ultrasound images were synchronised with flow signals using a custom-built trigger.  
To increase reproducibility and accuracy of the measurement, the same 
investigator completed each diaphragm assessment and was diligent in ensuring the 
probe was at the same alignment and internal markers were observed before and after 
the intervention. A semi-permanent mark was placed on each participant at the level 
of the probe and re-marked for each laboratory visit.  
 
 
 
Figure 5.1 Example of diaphragm thickness measurement at functional residual 
capacity (Tdi.FRC) in a male participant at pre-intervention. The red arrows mark both 
the peritoneal (top) and pleural (bottom) membranes of the diaphragm. Mean  SD 
of Tdi.FRC measurements was 2.3  0.1 mm.  
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5.1.4.1 REPRODUCIBILITY OF DIAPHRAGM THICKNESS MEASUREMENTS 
Five healthy males and one female with normal respiratory function visited 
the laboratory on two separate visits and Tdi measurements were undertaken using the 
procedure described above. Their age, body mass and height (mean  SD) were 36  
14 years, 75  12 kg and 174  10 cm, respectively. Reproducibility was assessed 
using the CV.  
The between-occasion reproducibility of the Tdi measurements is shown in 
Table 5.1 and apart from Tdi.TR was excellent for all other measures. The calculation 
of Tdi.TR uses a Müeller manoeuvre which is effort dependent and may hinder 
reproducibility.  
 
Table 5.1 Reproducibility of diaphragm thickness (Tdi) measurements. Values are 
mean  SD.   
 
Visit 1 Visit 2 CV 
Tdi.FRC (mm) 2.01  0.23 2.11  0.14 7.01 
Tdi.TLC (mm) 4.30  0.66 4.27  0.64 2.22 
Tdi.TR 2.46  0.47 2.0  0.44 14.2 
 
CV, coefficient of variation; Tdi.FRC, functional residual capacity; Tdi.TLC, total lung 
capacity; Tdi.TR, thickening ratio. 
 
5.1.5 MAXIMAL DYNAMIC INSPIRATORY MUSCLE FUNCTION 
Maximal dynamic inspiratory muscle function (Romer et al. 2002a; Romer 
and McConnell 2003) was assessed by performing maximal inspiratory efforts 
against a weighted plunger threshold device that housed two air-flow ports (Figure 
5.2; Johnson et al. 1996; Nickerson and Keens 1982). On the first air-flow port, a 
two-way non-rebreathing valve (model 500975; Harvard Apparatus, Kent, UK) was 
attached with a 1 m length of wide-bore tubing connected. Inspiratory mouth 
pressure was measured using 14-G needle blunt inserted through a 2 mm aperture 
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located near the mouthpiece that was attached to a differential pressure transducer ( 
400 cmH2O) (TSD104A; BIOPAC Systems) and a differential bridge amplifier 
(DA100C; BIOPAC Systems). Inspiratory flow was measured using a Fleisch no. 3 
pneumotachograph connected to a differential pressure transducer ( 2.5 cmH2O) 
(TSD160A; BIOPAC Systems) and differential bridge amplifier (DA100C; BIOPAC 
Systems) that was connected to the other air-flow port of the weighted plunger 
threshold device.  
Maximal inspiratory pressure at zero flow (P0max) was measured by placing a 
rubber bung distal to the pneumotachograph and exposing a 1 mm leak to prevent 
glottic closure. Subsequently, participants performed 3 inspiratory efforts separated 
by 30 s in random order at approximately 0, 20, 25, 35, 50 and 65% P0max. 
Participants wore a noseclip and manoeuvres were performed whilst standing, 
initiated from residual volume, and they received both visual and verbal feedback of 
voluntary efforts. Participants were encouraged to inspire as fast and as hard as 
possible. Pressure and flow fatigue is negligible following this protocol (Romer et al. 
2002a; Romer and McConnell 2003).  
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Figure 5.2 Weighted plunger inspiratory pressure-threshold device (Johnson et al. 
1996).  
 
The maximal value recorded for both inspiratory pressure (P0) and inspiratory 
flow ( ̇I) at each %P0 was used for analysis of which the product defined inspiratory 
muscle power ( ̇I). Maximal  ̇I ( ̇Imax) was calculated by extrapolation of a linear 
least squares representation of the P0 ‒  ̇I data. A 2
nd 
order polynominal was fitted to 
the  ̇I ‒  ̇I data and maximal  ̇I ( ̇Imax) was calculated by differentiation of the 
quadratic equation. Optimal inspiratory pressure (Popt and %P0 = Popt / P0) and 
optimal  ̇I ( ̇opt and % ̇max =  ̇opt / % ̇max) were defined as the pressure and flow 
values corresponding to the asymptote of the ̇ I curve ( ̇Imax) and the point at which 
this vertically transected the linear representation of the pressure-flow relationship. A 
schematic for the pressure-flow-work calculations for the IMT group at pre-
intervention is shown in Figure 5.3. Maximal rate of inspiratory pressure 
development (MRPD) was assessed during an inspiratory effort at P0max. MRPD was 
defined as the positive peak of the pressure derivative as a function of time or the 
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inspiratory pressure commensurate with the greatest ΔPressure (cmH2O) / ΔTime 
(ms).  
 
Figure 5.3 Pressure-flow-work calculations for the IMT group at pre-intervention. 
Values are mean only. SD are removed to improve clarity. A, maximal inspiratory 
flow at zero pressure ( ̇Imax); B, maximal inspiratory pressure at zero flow (P0max); C, 
maximal inspiratory muscle power ( ̇Imax); D, optimal inspiratory pressure (P0opt); E, 
optimal inspiratory flow ( ̇Iopt).  
 
 
5.1.6 INSPIRATORY MUSCLE ENDURANCE  
Inspiratory muscle endurance was assessed using the weighted plunger 
threshold loading device described in Section 5.1.5 using incremental pressure-
threshold loading (ITL). Participants were seated and wore a noseclip. Resistance 
started at 10 for male or 5 cmH2O for female participants and was increased by 5 
cmH2O by adding brass weights to the plunger every min until task failure. An audio 
metronome paced fB (15 breaths·min
-1
) and TI/TTOT (0.5). Participants were 
instructed to match resting inspiratory flow rates and VT which were displayed in 
real-time to the participant and investigator. The breathing pattern was chosen to 
reflect the same spontaneous breathing pattern adopted during incremental threshold 
loading using the same device (Johnson et al. 1997). Task failure (endurance time) 
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was defined as the inability to maintain the correct VT for three consecutive breaths 
despite verbal encouragement.  
 
5.1.7 SIX MINUTE WALK TEST 
Exercise capacity was assessed using a 6MWT according to published 
guidelines (ATS 2002), but modified to accommodate space considerations. 
Participants were instructed to walk as quickly as possible along a 15 m straight, flat, 
indoor running track and turned around a cone positioned at either end. Immediately 
after finishing the test measurements were obtained for fC using short range telemetry 
(Polar S610; Polar), SpO2 using infrared fingertip pulse oximetry (Model 8600; 
Nonin), and RPE for leg discomfort and dyspnoea using Borg’s modified CR10 scale 
(Borg 1982).  
 
5.1.8 ACCELEROMETRY 
Accelerometry was measured using the ActiGraph Model GT1M (ActiGraph 
Manufacturing Technology, Florida, USA) according to current recommendations 
(Murphy 2009). Participants were instructed to wear the ActiGraph unit on an elastic 
belt provided by the manufacturer as close to their centre of gravity as possible for 7 
days during waking hours and to remove it for sleep and bathing only. Activity was 
recorded using 5 s epochs and participants completed a log to record whole-body 
physical activity and when the accelerometer was worn.  
The data was downloaded (ActiGraph Lifestyle monitoring System Version 
3.3; ActiGraph Manufacturing Technology) and then uploaded to a public domain 
software package (Mahuffe; http://www.mrc-
epid.cam.ac.uk/Research/PA/Downloads.html). Recorded data files were viewed for 
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signs of malfunction or outliers and checked against participants logs. Based on a 
similar population (Davis and Fox 2007), data was reduced to provide bands of PAL: 
sedentary <200; light 200‒1999; moderate 2000‒3999; vigorous 4000‒5274; and 
very vigorous >5275 count·min
-1
.  
 
5.1.9 BODY COMPOSITION AND QUESTIONNAIRES 
Body composition was measured using bioelectrical impedance (Bodystat 
1500; Bodystat, Isle of Man, UK) according to published guidelines (Kyle et al. 
2004) to establish the percentage of body fat. PAL and QoL were administered via 
interview using the Physical Activity Scale for the Elderly (PASE; Washburn et al. 
1993) and Older People's Quality of Life Questionnaire (OPQOL-35; Bowling 
2009), respectively. Both PASE and OPQOL-35 are scored so that higher scores 
equal a higher PAL or QoL and scores can range from 0‒>400 and 35‒175, 
respectively.  
 
5.1.10 COLLECTION OF BLOOD FOR ASSAYS AND ISOLATION OF PERIPHERAL 
BLOOD MONONUCLEAR CELLS 
 
Whole blood samples (~10 mL) were taken at rest from an antecubital vein 
whilst participants were semi-recumbent. Blood was immediately transferred into 
pre-cooled tubes (SARSTEDT) containing either EDTA for plasma cytokines or 
lithium heparin for PBMC. Blood for plasma cytokines was immediately centrifuged 
for 15 min at 1000 x g and 5ºC. The plasma supernatant was subsequently removed 
and stored at -80ºC until further analysis. PBMC were isolated using density gradient 
centrifugation as stated in Section 2.13.1.  
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5.1.11 PLASMA CYTOKINE ASSAY 
Systemic inflammation was measured with a range of plasma cytokines and 
concentrations were measured in duplicate using an ultrasensitive 
electrochemiluminescence multiplex immunoassay which uses a solid-phase 
microspot assay based on ultra-low-noise charge-coupled device cameras (Meso 
Scale Discovery, Maryland, USA). To minimise the effect of inter-assay variation, 
pre- and post-intervention cytokines from both groups were measured during the 
same assay. The intra-assay (pooled mean of both groups at pre- and post-
intervention) and inter-assay CV were 14% and 18%, respectively. The lowest limit 
of detection (sensitivity) was: IL-1β, 1.44 pg·mL-1; interleukin-2, 0.56 pg·mL-1; IL-6, 
0.19 pg·mL
-1
; interleukin-8, 0.14 pg·mL
-1
; IL-10, 0.89 pg·mL
-1
; interleukin-12 p70, 
1.02 pg·mL
-1
; granulocyte macrophage colony-stimulating factor, 0.68 pg·mL
-1
; 
interferon-γ, 0.86 pg·mL-1; and TNF-α, 0.86 pg·mL-1. If the lowest limit of detection 
was not met, participant data (from pre- and post-intervention) was excluded from 
the analysis. All data for IL-1β was excluded.  
 
5.1.12 MEASUREMENT OF DNA DAMAGE IN PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
 
Systemic oxidative stress was measured using the alkaline comet assay 
(Singh et al. 1988) and the modified alkaline comet assay (Collins et al. 1993) to 
determine levels of DNA damage (DNA single strand breaks and alkali labile 
lesions) in PBMC as stated in Section 2.13.2. 
 
5.1.13 INSPIRATORY MUSCLE TRAINING AND PLACEBO INTERVENTIONS 
The IMT group performed training sessions according to the procedures 
stated in Section 2.15. The PLA group used a sham hypoxic trainer which was 
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identical to that used by the IMT group, except that the resistance spring was 
removed and the lower chamber was loosely packed with aquarium gravel, which 
was promoted to the participants as being O2 absorbent, thus reducing the O2 content 
of inspired air and mimicking altitude exposure (Johnson et al. 2007; Sonetti et al. 
2001). Participants were instructed to breathe normally for 30 consecutive breaths 
twice daily through the device and to not increase their normal breathing effort. 
Pulmonary function and maximal mouth pressure were assessed at 2 and 4 weeks 
during the intervention. During these visits, correct training technique was evaluated 
in both IMT and PLA groups and the “O2 absorbent” gravel in the PLA device was 
also replaced. All participants completed a training diary throughout the study to 
record adherence to the prescribed intervention and whole-body training sessions. 
Training sessions for IMT and PLA groups were not performed on the day of 
laboratory visits. 
 
5.1.14 STATISTICAL ANALYSES 
Statistical analyses were performed using SPSS for Windows (IBM). 
Pulmonary function and MIP / MEP data were analysed using a two-way repeated 
measures ANOVA to test between-group effects due to ‘treatment’ (IMT vs. PLA) 
and within-group effects due to ‘intervention’ (pre- vs. post-intervention)  or ‘time’ 
(2, 4 and 8 week). All other data were analysed with independent t-tests to test 
between group effects due to ‘treatment’ and paired t-tests for within group effects 
due to ‘intervention’. Pearson product-moment correlation coefficients were 
calculated to assess the relationship between selected variables. Reliability was 
assessed with the CV. Statistical significance was set at P < 0.05. Results are 
presented as mean  SD. 
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5.2 RESULTS 
One PLA participant withdrew during the intervention due to illness. One 
IMT participant was removed from the analysis because they completed <70% of the 
prescribed intervention. Results are therefore presented for 34 participants who 
completed the study. For the blood analyses, one IMT participant did not consent to 
blood sampling. For PAL, the accelerometer malfunctioned for one PLA participant 
during the post-intervention analysis. Therefore, for these variables, results are 
presented based on 16 participants in each group, respectively.      
 
5.2.1 PRE-INTERVENTION CHARACTERISTICS 
There were no significant differences between the groups in any pre-
intervention measures apart from Tdi.FRC which was lower (P < 0.01) for the IMT 
compared to the PLA group. There were no changes in any participant characteristics 
in both groups post-intervention (Table 5.2). Pre-intervention pulmonary function 
and maximal mouth pressures were all within normal limits (Table 5.3). 
 
Table 5.2 Participant characteristics for IMT and PLA groups. Values are mean  
SD.  
 
IMT PLA 
 
Pre-
intervention 
Post-
intervention 
Pre-
intervention 
Post-
intervention 
Age (years) 69  3 
 
68  3 
  
Sex (Male/Female) 9/8 
 
11/6 
  
Height (cm) 167  9 167  10 168  6 168  6 
Body mass (kg) 69  12 68  12 72  8 72  8 
BMI (kg·m
2
) 25  3 24  3 26  2 25  3 
Body fat (%) 31  7 31  8 31  6 31  7 
BP Systolic (mmHg) 135  13 131  13 144  18 140  19 
BP Diastolic (mmHg) 81  4 80  4 84  4 80  6 
 
BMI, body mass index; BP, blood pressure.  
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5.2.2 INTERVENTION 
Compliance with the intervention was excellent in both the IMT and PLA 
groups with 97  5 and 96  7% of the sessions completed resulting in a total of 113 
 25 and 104  17 individual sessions, respectively. Inspection of training diaries 
revealed habitual whole-body training remained constant in both groups. 
Measurements obtained at pre- and post-intervention in both groups are presented in 
Tables 5.2 to 5.7 and Figure 5.4 and the effects of the intervention are summarised as 
follows. 
 
5.2.3 PULMONARY FUNCTION AND MAXIMAL MOUTH PRESSURES 
Pulmonary function and maximal mouth pressures are shown in Table 5.3. 
There was a small decrease (3  4%, P < 0.01) in FVC in the PLA group, which 
resulted in a small increase (2  3%, P < 0.01) in FEV1/FVC. PIF increased in both 
the IMT (35  42%, P < 0.01) and PLA (17  29%, P < 0.05) groups. The increase 
from pre-intervention was greater for the IMT compared to the PLA group (time x 
intervention interaction, P < 0.05). MIP was unchanged in the PLA group. In 
contrast, MIP increased from 82  27 cmH2O at pre-intervention to 97  23, 100  
23, and 103  23 cmH2O (34  43%, P< 0.01) after 2, 4 and 8 weeks of IMT, 
respectively. No changes were observed in any other pulmonary function 
measurements or MEP during or post-intervention.  
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Table 5.3 Pulmonary function and maximal mouth pressures. Values in parentheses represent the percent of predicted values (Enright et al. 
1995; Falaschetti et al. 2004; Garcia-Rio et al. 2004). Values are mean  SD.  
 
 
IMT PLA 
 
Pre-intervention Post-intervention Pre-intervention Post-intervention 
FVC (L) 3.56  0.82 (107  12) 3.48  0.76 (105  10) 3.67  0.82 (106  12) 3.54  0.63 (102  8)* 
FEV1 (L) 2.63  0.53 (104  11) 2.64  0.53 (104  12) 2.83  0.53 (107  11) 2.79  0.50 (105  11) 
FEV1/FVC (%) 77  3 (98  3) 77  4 (99  5) 78  3 (100  3) 80  5 (102  6)
*
 
PEF (L·sec
-1
) 6.95  1.47 (102  11) 6.90  1.82 (101  16) 7.58  1.47 (105  11) 7.50  1.96 (104  19) 
PIF (L·sec
-1
) 4.15  1.26 (100  27) 5.22  1.11 (126  21)* 4.92  1.26 (111  27) 5.52  1.34 (126  22)** 
MVV10 (L·min
-1
) 103  27 105  30 124  27 121  36 
MIP (cmH2O) 82  27 (97  25) 103  23 (122  20)
*
 96  27 (107  25) 98  26 (110  23) 
MEP (cmH2O) 124  43 (88  23) 126  38 (90  23) 132  43 (86  23) 128  44 (84  22) 
     
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; PEF, peak expiratory flow; PIF, peak inspiratory flow; MVV10, maximum 
voluntary ventilation in 10 s; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure. Significant difference (from pre-
intervention 
*
P < 0.01,
 **
P < 0.05). 
 
 
 
 
 
 
 
 
 
192 
 
5.2.4 DYNAMIC INSPIRATORY MUSCLE FUNCTION AND INSPIRATORY MUSCLE 
ENDURANCE 
 
Dynamic inspiratory muscle function and inspiratory muscle endurance (ITL) 
is shown in Table 5.4. P0max increased in both the IMT (27  31%, P < 0.01) and 
PLA (20  45%, P < 0.05) groups. No other measurements changed post-intervention 
in the PLA group. There were increases (P < 0.05) in ̇ Imax (31  58%) and P0opt (62 
 151%) and increases (P < 0.01) in MRPD (59  84%) and ITL (87  127%) in the 
IMT group. The increase in  ̇Imax was positively correlated with the increase in P0opt 
(r = 0.96, P = 0.00) and ITL time (r = 0.79, P = 0.00). The increase in P0opt was 
positively correlated with the increase in ITL time (r = 0.77, P = 0.00). 
 
Table 5.4 Dynamic inspiratory muscle function and inspiratory muscle endurance for 
IMT and PLA groups. Values are mean  SD. 
 
IMT PLA 
 
Pre-
intervention 
Post-
intervention 
Pre-
intervention 
Post-
intervention 
P0max (cmH2O) 83  24 100  21
*
 89  29 97  26** 
 ̇Imax (L·s
-1
) 7.18  1.98 7.25  1.93 8.30  2.68 7.51  2.37 
 ̇Imax (cmH2O·L
-1
·s
-1
) 171  72 206  70** 216  106 217  104 
P0opt (cmH2O) 48  18 60  11
**
 56  19 58  16 
 ̇Iopt (L·s
-1
) 3.25  1.18 3.12  0.75 3.14  0.99 3.15  0.81 
P0opt / P0max (%) 58  14 60  5 66  12 60  8 
 ̇Iopt /  ̇Imax (%) 46  12 43  3 39  9 43  6 
MRPD (cmH2O·ms
-1
) 0.35  0.19 0.49  0.19* 0.36  0.15 0.44  0.17 
ITL (min) 5.03  2.60 7.50  2.73* 6.93  3.75 7.99  3.52 
 
P0max, maximal inspiratory pressure at zero flow;  ̇Imax, maximal inspiratory flow at 
zero pressure;  ̇Imax, maximal inspiratory muscle power; P0opt, optimal inspiratory 
pressure;  ̇Iopt, optimal inspiratory flow; MRPD, maximum rate of inspiratory 
pressure development; ITL, incremental pressure-threshold loading. Significant 
difference (from pre-intervention
 * 
P < 0.01,
 **
P < 0.05). 
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5.2.5 DIAPHRAGM THICKNESS 
There were increases (P < 0.05) in Tdi.RV (38  39%) and Tdi.FRC (28  22%), 
increase in Tdi.TLC (P < 0.01, 10  17%) and decrease in Tdi.TR (P < 0.01, 17  28%) 
in the IMT, whereas there were no changes in the PLA group (Table 5.5).  
 
Table 5.5 Diaphragm thickness (Tdi) measurements for IMT and PLA groups. Values 
are mean  SD.   
 
IMT PLA 
 
Pre-
intervention 
Post-
intervention 
Pre-
intervention 
Post-
intervention 
Tdi.RV (mm) 1.60  0.49 2.13  0.50
*
 1.85  0.53 2.02  0.56 
Tdi.FRC (mm) 1.93  0.50 2.42  0.48
*
 2.60  0.64† 2.37  0.60 
Tdi.TLC (mm) 3.38  0.57 3.65  0.51
**
 3.75  0.90 3.58  0.84 
Tdi.TR 1.84  0.64 1.41  0.25
**
 1.86  0.78 1.62  0.53 
 
Tdi.RV, residual volume; Tdi.FRC, functional residual capacity; Tdi.TLC, total lung 
capacity; Tdi.TR, thickening ratio. Significant difference (from pre-intervention 
* 
P < 
0.01,
 **
P < 0.05; between groups 
†
P < 0.01). 
 
 
 
5.2.6 SIX MINUTE WALK TEST 
There were no differences in the 6MWT distance in both groups post-
intervention (Table 5.6). No 6MWT measurements changed post-intervention in the 
IMT group, whereas there was a increase (P < 0.05) in fC (17  27%) and decrease in 
RPE for leg discomfort (40  61%) in the PLA group. No other measurements 
changed post-intervention in the PLA group. 
 
 
 
 
 
194 
 
Table 5.6 Six minute walk test for IMT and PLA groups. Values are mean  SD. 
Percent of predicted values from Troosters et al. (1999). 
 
IMT PLA 
 
Pre-
intervention 
Post-
intervention 
Pre-
intervention 
Post-
intervention 
6MWTD (m) 546  85 540  165 554  96 575  97 
6MWTD (%Predicted) 125  18 124  35 123  20 128  21 
fC (beats·min
-1
) 98  27 90  29 90  21 103  21** 
SpO2 (%) 97  4 97  2 97  3 98  2 
RPE Dyspnoea 1.15  1.32 0.87  1.76 1.43  1.71 0.89  1.26 
RPE Leg 0.94  1.54 0.77  1.77 1.38  1.23 0.74  1.30** 
 
6MWTD, six minute walk test distance; fC, cardiac frequency; SpO2, estimated 
arterial oxygen saturation; RPE, rating of perceived exertion. Significant difference 
(from pre-intervention
 **
P < 0.05). 
 
 
 
5.2.7 PHYSICAL ACTIVITY LEVELS AND QUALITY OF LIFE 
There were no differences in qualitative PAL (assessed by the PASE) or QoL 
(or in their subcategories) in both groups. For IMT and PLA groups at pre-
intervention
 
summed (all subcategories) PAL score was 174  56 and 181  69 and 
summed QoL score was 134  7 and 137  9, respectively. There were no differences 
in any quantative PAL (assessed by accelerometry) bands in both groups post-
intervention. For IMT and PLA groups pre-intervention
 
MVPA was 46  23 and 37  
17 count·min
-1
. 
 
5.2.8 PLASMA CYTOKINES AND DNA DAMAGE LEVELS IN PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
 
There were no differences in plasma cytokines (Table 5.7) and DNA damage 
levels in PBMC (Figure 5.4) in both groups post-intervention. 
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Table 5.7 Plasma cytokines for IMT and PLA groups. Values in parentheses 
represent the number of participants included in the analysis. Values are mean  SD. 
 
IMT PLA 
 
Pre-
intervention 
Post-
intervention 
Pre-
intervention 
Post-
intervention 
IL-2 (pg·mL
-1
) 0.50  0.42 0.48  0.41(9) 0.88  1.17 0.63  0.55(6) 
IL-6 (pg·mL
-1
) 1.13  0.38 0.98  0.41(15) 2.44  2.81 2.79  4.67(17) 
IL-8 (pg·mL
-1
) 5.72  4.42 5.15  3.30(16) 6.12  5.66 5.42  2.95(17) 
IL-10 (pg·mL
-1
) 2.11  1.23 1.78  1.06(12) 3.40  5.38 2.90  3.18(16) 
IL-12 p70 (pg·mL
-1
) 1.36  0.58 1.48  0.76(9) 2.26  1.63 2.19  1.67(10) 
GM-CSF (pg·mL
-1
) 2.05  3.24 1.90  2.76(6) 1.84  1.54 1.41  1.13(7) 
IFN-γ (pg·mL-1) 2.53  1.70 1.47  1.35(7) 2.94  3.36 2.49  2.13(12) 
TNF-α (pg·mL-1) 8.40  3.33 7.78  2.98(16) 9.56  6.62 8.79  4.79(17) 
 
IL-2, interleukin-2; IL-6, interleukin-6; IL-8, interleukin-8; IL-10, interleukin-10; IL-
12 p70, interleukin-12 p70; GM-CSF, granulocyte macrophage colony-stimulating 
factor; IFN-γ, interferon-γ; TNF-α, tumor necrosis factor-α.  
 
 
 
Figure 5.4 DNA damage levels in peripheral blood mononuclear cells for IMT and 
PLA groups. FPG, formamidopyrimidineglycosylase; ENDO III, endonuclease III 
for IMT and PLA groups. Values are mean  SD.  
 
 
5.3 DISCUSSION 
5.3.1 MAIN FINDINGS 
The main findings were that IMT increased inspiratory muscle function 
(strength, endurance and dynamic inspiratory muscle function), structure (Tdi) and 
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PIF, but did not change other measures of pulmonary function, resting markers of 
systemic inflammation (plasma cytokine concentrations) and oxidative stress (DNA 
damage levels in PBMC), exercise capacity (6MWT distance), quantative and 
qualitative PAL and QoL. This study is the first to examine the effects of IMT on 
markers of systemic inflammation and oxidative stress and inspiratory muscle 
function and structure in older adults. The effects of the intervention are summarised 
as follows.   
 
5.3.2 PULMONARY FUNCTION AND INSPIRATORY MUSCLE FUNCTION AND 
STRUCTURE 
 
Apart from PIF, pulmonary function was unchanged in the IMT group. This 
is in contrast with those who observed an increase in vital capacity after VIH 
(Belman and Gaesser 1988) and FVC and PEF after IMT/EMT (Watsford and 
Murphy 2008). In younger adults, the changes following VIH or IMT/EMT in these 
pulmonary function measures are equivocal (Griffiths and McConnell 2007; Leddy 
et al. 2007; Verges et al. 2007; Wells et al. 2005). In younger adults, FVC and PEF 
are never changed following IMT (Brown et al. 2008; Brown et al. 2010; Brown et 
al. 2012; Johnson et al. 2007). Belman and Gaesser (1988) and Watsford and 
Murphy (2008) failed to provide a mechanism for the changes in pulmonary 
function, but it is suggested that this may be a learning effect rather than an 
adaptation. It is well known that volitional techniques are dependent upon learning 
and motivation. Therefore, improvements in pulmonary function may be due to 
participants becoming better at undertaking the forced expiratory manoeuvres that 
are replicated during training (Polkey and Moxham 2004). This suggestion is 
supported by the finding in the present study of an increase in PIF and P0max in the 
PLA group, even with a rigorous familiarisation of the manoeuvres undertaken 
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before pre-intervention
 
measures. The increase in PIF was statistically greater for the 
IMT group. It could be suggested that this may be due to an increase in total 
respiratory system compliance. However, it cannot be ruled out that they also 
experienced a learning effect from undertaking dynamic inspiratory manoeuvres. 
Along with the increase in fC and decrease in RPE for leg discomfort during the 
6MWT in the PLA group, this highlights the requirement to employ a legitimate 
placebo group that will impact participant expectation and motivation.  
Inspiratory muscle strength (MIP and P0max) increased in the IMT group by 
34  43 and 27  31%, respectively. This is consistent with the increase of 21‒39% 
reported in similar ages (65‒71 years) following IMT (Aznar-Lain et al. 2007; 
Huang et al. 2011; Watsford and Murphy 2008). It is interesting to note that a rapid 
increase in MIP was observed from 82  27 to 97  23 cmH2O (+23  28%) within 
just 2 weeks of IMT. This has been reported previously in younger participants with 
14% and 28% increases in MIP observed after 1 and 2 weeks of IMT, respectively 
(Downey et al. 2007; Huang et al. 2003). Such rapid training-induced increases in 
limb muscle strength are usually ascribed to neural adaptations, with structural 
alterations becoming evident after about 6‒8 weeks of training (Kraemer et al. 1996). 
However, the signalling pathways that elicit structural alterations in inspiratory 
muscles might arise earlier than anticipated because of the greater training frequency 
with IMT (up to 14 sessions per wk
-1
) (Kraemer et al. 1996). In support, diaphragm 
thickness and type II fibre size in the external intercostals increased by 8‒12 and 
21%, respectively, following 4‒5 weeks of IMT (Downey et al. 2007; Enright et al. 
2006; Ramirez-Sarmiento et al. 2002). These diaphragm thickness findings were 
confirmed in the present study, but at all lung volumes. The stimuli for diaphragm 
hypertrophy with IMT are poorly understood but recently it has been shown that 
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growth hormone and cortisol are increased in young and healthy males immediately 
after a single 15 min VIH training session, performed 12 days after of similar 
training (Sartorio et al. 2012).  
An increase in the maximal power of the inspiratory muscles ( ̇Imax) was 
observed in the IMT group which was solely due to an increase in P0max and not 
maximal inspiratory flow rate ( ̇Imax). It may seem contradictory that a change in 
 ̇Imax was not observed but PIF increased (as they represent the same manoeuvre). 
This, however, can be explained by the type of measurement and analysis performed. 
PIF is calculated from the inspiratory limb of a flow-volume loop and represents 
unloaded shortening of the inspiratory muscles whereas  ̇Imax is calculated from 
extrapolation of a linear least squares representation of the pressure-flow data 
undertaken at six discrete resistances. Thus, the linear regression of  ̇Imax is 
dependent upon the inspiratory muscles contracting under loading. The increase in 
 ̇Imax is consistent with other reports in younger adults, but unlike the present 
finding, this is with a combination of an increase in P0max, and to a lesser extent an 
increase in  ̇Imax (Romer et al. 2002a; Romer and McConnell 2003). This finding 
suggests that in healthy older adults and with an initial training load of 50% MIP, 
P0max is only responsive to the training stimuli. This finding is supported by the 
observation that 5 weeks of IMT (with an initial training load of 40‒50% MIP) 
decreased fast twitch (type II) fibres by 15% in the external intercostals of 65 year 
old COPD patients (Ramirez-Sarmiento et al. 2002). These authors’ also observed a 
50% increase in inspiratory muscle endurance with the shift in fibre type. There was 
also an increase in inspiratory muscle endurance (ITL) in the IMT group which is 
consistent with Watsford and Murphy (2008). Several mechanisms, including the 
adaptations to inspiratory muscle morphology, may explain this finding. The increase 
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in optimal inspiratory pressure (P0opt) as a percentage of P0max (P0opt / P0max) would 
result in inspiratory muscle contractions being performed at a lower proportion of the 
maximum capacity at a given workload during ITL. This may reduce motor-unit 
recruitment and delay the onset of fatigue, thus enhancing endurance (McConnell 
and Romer 2004). There may also be a decrease in the O2 cost of breathing during 
ITL, which would improve inspiratory muscle efficiency at a given load (Turner et 
al. 2012).  
The increase in MRPD in the IMT group is consistent with the finding in 
younger adults (Romer et al. 2002a; Romer and McConnell 2003). The precise 
mechanism(s) for these increases are unknown, but may be explained by possible 
resistance training-induced adaptations to the firing frequency of motor units (Kamen 
2005). This suggestion is supported by the observation that motor unit firing 
frequency is higher in the rectus femoris of strength trained older adults than age-
matched untrained controls (Leong et al. 1999). Furthermore, motor unit firing 
frequency is increased in the vastus lateralis of untrained older adults following six 
weeks of lower-body resistance training (Kamen and Knight 2004). The functional 
benefits of the increase in MRPD are unclear, but it has been suggested that it would 
allow for a quicker inspiratory muscle contraction time and allow expiration to be 
prolonged, which may maintain end-expiratory lung volume, allowing the diaphragm 
to contract nearer its optimal length-tension relationship, and reduce the elastic recoil 
forces to be overcome (Romer et al. 2002a). 
  
5.3.3 EXERCISE CAPACITY, PHYSICAL ACTIVITY LEVELS AND QUALITY OF LIFE 
MEASURES 
 
There were no changes in exercise capacity (6MWT distance), qualitative and 
quantative PAL or QoL in the IMT group. The exercise capacity findings are in 
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contrast with others who have reported improvements in 6MWT distance (Huang et 
al. 2011) and endurance time during treadmill walking at the first ventilatory 
threshold following IMT (Aznar-Lain et al. 2007). The differences in the findings 
may be explained by baseline exercise training status. Huang et al. (2011) reported 
that 6MWT distance in participants at pre-intervention
 
were 90  16% of predicted 
values (Troosters et al. 1999), suggesting that the cardiorespiratory response to the 
6MWT may have been limited. In the present study 6MWT distance in participants 
at pre-intervention
 
was 123‒125% of predicted values (Troosters et al. 1999). If a 
functional consequence of IMT is to improve 6MWT distance in older adults then it 
may be those with a low baseline status who show the greatest improvement 
(Bouchard and Rankinen 2001). Alternatively, Huang et al. (2011) reported that they 
used American Thoracic Society guidelines for the 6MWT (ATS 2002). These 
guidelines do not, however, recommend a familiarisation session (Brooks et al. 2003) 
and Huang et al. (2011) did not report that one was undertaken. In older adults, at 
least two attempts of the 6MWT are required to obtain reliable measurements 
(Kervio et al. 2003) and this was undertaken in the present study.    
This is the first study to report qualitative PAL, but quantative PAL using 
accelerometry has demonstrated that MVPA is increased in six older adults following 
IMT (Aznar-Lain et al. 2007). Aznar-Lain et al. (2007) suggested this was due to an 
increase in the intensity of exercise performed, as no other accelerometry measure 
changed following IMT. The low sample size of this study makes the finding 
difficult to interpret.  
The QoL results disagree with Huang et al. (2011) who observed an increase 
in the physical subcategory of the SF-36 QoL questionnaire. Differences in the type 
of questionnaire used could explain the findings (SF-36 vs. OPQOL-35), or 
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alternatively, it could be suggested that baseline economical or health (mental and 
physical) status of participants could account for the differences. The SF-36 however 
is a generic measure as opposed to one that specifically examines the older adult like 
the OPQOL-35.  
 
5.3.4 PLASMA CYTOKINES AND DNA DAMAGE LEVELS TO PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
 
It was hypothesised that IMT may attenuate markers of systemic 
inflammation and/or oxidative stress in older adults. Systemic low-level 
inflammation can be defined as a 2‒4 fold increase in the resting concentration of 
inflammatory mediators (Bruunsgaard 2006). Although it is unreliable to compare 
cytokine concentrations from different assays, plasma IL-6 concentrations at rest in 
Chapters 3 and 4 were 0.5‒0.7 pg∙mL-1. In the present study, pre-intervention plasma 
IL-6 concentrations were 1.13 and 2.44 pg∙mL-1 for IMT and PLA groups, 
respectively. Therefore, the present findings suggest that systemic inflammation was 
evident in older adults. Furthermore, the plasma TNF-α concentrations reported in 
the present study compare well to Bruunsgaard (2006) (Figure 1.33). The present 
study also reported a large variance in plasma cytokines. This may relate to, in part, a 
lack of sensitivity in the assay used, and small differences in the age or health status 
of study participants (Bruunsgaard 2006).  
Whilst IMT did not change the resting plasma concentration of nine cytokines 
and DNA damage levels in PBMC, it cannot be excluded whether IMT attenuated 
local respiratory muscle cytokines and/or oxidative stress. A diaphragmatic or 
intercostal biopsy would allow this area to be explored. However, this is a very 
invasive measurement that requires open surgery or thoracscopy under general 
anaesthesia and thus for these healthy individuals this would not be ethical. It could 
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be that the improvement in inspiratory muscle structure and function did not reach a 
threshold necessary to achieve a potential systemic reduction in cytokines and/or 
DNA damage levels in PBMC. Previous studies have shown that whole-body 
resistance or endurance training can decrease resting systemic cytokine 
concentrations (Kohut et al. 2006; Nicklas et al. 2008; Phillips et al. 2010; Prestes et 
al. 2009) and markers of oxidative stress (Fatouros et al. 2004; Parise et al. 2005; 
Takahashi et al. 2012). However, the respiratory muscles only weigh ~960 g 
(Freedman et al. 1983) and represent ~3% of total body mass (Robertson et al. 1977). 
Thus, IMT only targets a small muscle group and although they do contribute to 
systemic cytokines concentrations through oxidative stress during increased 
respiratory muscle work, IMT does not attenuate this under resting conditions.   
 
5.4 CONCLUSIONS 
RMT has been promoted as a tool to attenuate the age-related decline in 
inspiratory muscle function and can “increase resistance to fatigue”, “improve 
respiratory muscle efficiency” and “alleviate dyspnoea” all resulting in “improved 
exercise performance”. It has been demonstrated that using a rigorous, placebo 
controlled design with an adequate sample size, IMT increases inspiratory muscle 
function (strength, endurance, dynamic inspiratory muscle function), structure (Tdi) 
and PIF, but does not change other measures of pulmonary function, resting markers 
of systemic inflammation (plasma cytokine concentrations) and oxidative stress 
(DNA damage levels in PBMC), exercise capacity (6MWT distance), quantative and 
qualitative PAL and QoL in older adults. Therefore, for healthy older adults without 
respiratory or cardiovascular limitations and with IMT as an RMT device, the present 
study supports the manufacturers’ claims that IMT can “increase resistance to 
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fatigue”, but not that RMT can “alleviate dyspnoea” or “improve exercise 
performance”.   
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CHAPTER 6 ‒ INSPIRATORY MUSCLE TRAINING DOES NOT CHANGE 
LACTATE MINIMUM CYCLING POWER OR RESPIRATORY MUSCLE 
RECRUITMENT PATTERNS DURING THE TEST
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6.0 INTRODUCTION 
In Chapter 3 the lactate minimum test was used to estimate MLSS intensity. 
The MLSS represents the highest exercise intensity at which [La
-
]B remains stable 
over time and is widely acknowledged as an important determinant of endurance 
exercise performance (Johnson et al. 2009; Johnson and Sharpe 2011; Jones and 
Doust 1998; MacIntosh et al. 2002). Unfortunately, direct MLSS estimation is 
laborious, requiring multiple constant intensity exercise tests (typically lasting 30 
min) over a range of exercise intensities. The lactate minimum test was originally 
developed by Tegtbur et al. (1993) to estimate MLSS running velocity. It has since 
been adapted for MLSS prediction in cycling with recent evidence suggesting a good 
agreement between the intensities of the lactate minimum test and MLSS (Johnson et 
al. 2009; Johnson and Sharpe 2011; Knoepfli-Lenzin and Boutellier 2011; MacIntosh 
et al. 2002; Simoes et al. 2009). The test comprises three consecutive exercise 
phases: 1) a lactate elevation phase; 2) a recovery phase; and 3) an incremental phase 
in which with increasing intensity [La
-
]B decreases (net lactate clearance) to a nadir 
(the lactate minimum) and then increases (net lactate appearance). The [La
-
]B is 
determined by rates of lactate release into the interstitium of circulation and 
consumption by adjacent or remote consuming oxidative muscle fibres or organs (the 
lactate shuttle; Brooks 2000).  
Two recent systematic reviews with meta-analyses have reported that RMT 
can improve endurance exercise performance (Hajghanbari et al. 2012; Illi et al. 
2012). While the mechanisms underlying such performance improvements remain 
speculative, a common observation after RMT is a reduction in [La
-
]B during 
maximal incremental cycling (Spengler et al. 1999), constant power exercise until the 
limit of tolerance (Bailey et al. 2010; Boutellier and Piwko 1992; Leddy et al. 2007; 
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Spengler et al. 1999), and exercise at MLSS (Chapter 3; McConnell and Sharpe 
2005). The mechanism(s) by which RMT reduces [La
-
]B remains equivocal, but may 
be due to either increased lactate uptake and metabolism or decreased efflux by the 
trained respiratory muscles (Spengler et al. 1999). While it is known that IMT does 
not change the cycling power at which MLSS corresponds to (McConnell and Sharpe 
2005) it is unknown whether it changes MLSS prediction from the lactate minimum 
test.   
During heavy constant load (Babcock et al. 1995; Babcock et al. 1995; 
Babcock et al. 1996; Babcock et al. 1998; Babcock et al. 2002; Johnson et al. 1993; 
Mador et al. 1993) and maximal incremental (Romer et al. 2007) exercise until the 
limit of tolerance there is a progressive increase in the contribution from the less 
efficient accessory inspiratory (and expiratory) muscles and a decrease in the 
contribution from the diaphragm to the ventilatory response. Less efficient accessory 
muscles may contribute more to the ventilatory response because the diaphragm is 
beginning to accumulate metabolites or fatigue which reflexly inhibits further 
diaphragm recruitment and triggers the recruitment of additional inspiratory (and 
expiratory) muscles (Jammes et al. 1986). It has been hypothesised that RMT may 
alter the breathing pattern and/or delay recruitment from fatiguing accessory muscles 
during exercise because of an increase in fatigue resistance and/or a desensitising of 
sensory afferents within the respiratory muscles (McConnell and Romer 2004). This 
hypothesis, however, remains untested.  
Therefore, the aim of this study was to examine the effects of IMT on an 
estimation of MLSS using the lactate minimum test, and to examine if the 
contribution of the respiratory muscles to the ventilatory response would change 
during the test. It was hypothesised that following IMT there would be a decrease in 
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[La
-
]B during the lactate minimum test which would change the estimated MLSS 
intensity and that there would be a delay in the recruitment of accessory respiratory 
muscles.  
 
6.1 METHODS 
6.1.1 PARTICIPANTS 
Twelve non-smoking recreationally active young males provided written, 
informed consent to participate in the study, which was approved by the Nottingham 
Trent University ethics committee (Appendix 1 and 2). Participants followed the pre-
experimental instructions outlined in Section 2.0. 
 
6.1.2 EXPERIMENTAL DESIGN 
Participants attended the laboratory on two separate occasions, each separated 
by 48 h and both took place at the same time of day, before and after a 6 week 
intervention where participants were randomly, and equally, divided into an IMT or 
PLA group. During the first and third visits, participants were familiarised or re-
familiarised with all testing procedures and pulmonary function and MIP were 
measured. During the second and fourth visits, participants performed a lactate 
minimum cycling test to estimate MLSS power.  
 
6.1.3 PULMONARY FUNCTION AND MAXIMAL INSPIRATORY MOUTH PRESSURE  
Pulmonary function and MIP were assessed according to the procedures stated 
in Sections 2.3 and 2.4, respectively. MIP was measured at 2 and 4 weeks during the 
intervention in both IMT and PLA groups.  
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6.1.4 LACTATE MINIMUM TEST 
The lactate minimum test was performed following the procedures of 
Johnson et al. (2009) as stated in Section 2.16. Each test was preceded by a 5 min 
rest period and comprised three consecutive phases: (i) lactate elevation phase (LEP) 
comprising maximal incremental exercise; (ii) 8 min recovery phase at 60 W (REC); 
and (iii) incremental phase (INC) comprising five consecutive 4 min stages at 
intensities of 45, 50, 55, 60, and 65% of the  ̇max achieved during the LEP. During 
the LEP power output was increased by 10 W every 15 s so that exercise intolerance 
(<60 revs·min
-1
) occurred in approximately 10 min. The final power defined  ̇max 
and the highest oxygen uptake recorded over any 30 s period defined  ̇O2peak. During 
the final seconds of each stage of the INC arterialised venous blood was sampled 
from a dorsal hand vein via an indwelling 21-G cannula (McLoughlin et al. 1992) for 
the measurement of [La
-
]B, which was determined using an automated analyser 
(Biosen C_line Sport; EKF Diagnostics). Arterialisation was ensured by immersing 
the hand in water at 40ºC for 10 min prior to cannulation and by warming the hand 
during trials using an infrared lamp. The lactate minimum power (i.e. estimated 
MLSS power) was calculated as the nadir of a 2
nd
 order polynomial fitting [La
-
]B 
against power of each increment. Measurements were taken for fC using short range 
telemetry (Polar S610; Polar) and SpO2 using infrared fingertip pulse oximetry 
(Model 8600; Nonin) at rest and at termination of the LEP (MAX). 
  
6.1.5 FLOW, PULMONARY GAS EXCHANGE AND PRESSURE MEASUREMENTS  
During all trials participants wore a facemask (model 7940; Hans Rudolph) 
connected to a pneumotachograph and ventilatory and pulmonary gas exchange 
responses were measured breath by breath (ZAN 600USB; Nspire Health). A two-
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way non-rebreathing valve (model 2730; Hans Rudolph) was attached distally to the 
pneumotachograph and on the expiratory port a Fleisch no. 3 pneumotachograph was 
attached and connected to a differential pressure transducer ( 2.5 cmH2O) 
(TSD160A; BIOPAC Systems) and differential bridge amplifier (DA100C; BIOPAC 
Systems) to allow alignment of flow and pressure signals. Pe and Pg were measured 
according to the procedures stated in Section 2.6. Pdi was calculated by subtracting Pe 
from Pg. Pdi and Pe were integrated over the period of inspiratory flow and multiplied 
by fB and labelled PTPdi and PTPe, respectively. Non-physiological flows and 
pressures that resulted from swallowing, coughing and breath holding, were 
identified by visual inspection and removed.  
 
6.1.6 INSPIRATORY MUSCLE TRAINING AND PLACEBO INTERVENTIONS 
The IMT group performed training sessions according to the procedures 
stated in Section 2.15. The PLA group inhaled one puff twice daily for 6 weeks from 
a sham metered dose inhaler (Vitalograph). The inhaler contained compressed air 
only but was promoted to the participants as delivering a novel drug that reduces 
breathing-induced inflammation. During the post-intervention period the IMT and 
PLA group reduced their training frequency to 2 d·wk
-1
. These maintenance sessions 
were performed 48 h before and 48 h after experimental trials. This has been shown 
to maintain improvements in inspiratory muscle function post-IMT (Romer and 
McConnell 2003). All participants completed a training diary throughout the study to 
record adherence to the prescribed intervention and whole-body training sessions. 
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6.1.7 STATISTICAL ANALYSES 
Data collected were aligned to fixed percentages of  ̇max during LEP and 
ensemble averaged for the final minute of REC and the final 30 s of INC. Statistical 
analyses were performed using SPSS for Windows (IBM). Groups were compared 
for pre-intervention
 
characteristics using independent t-tests. A two-way repeated 
measures ANOVA were used to test between-group effects due to ‘treatment’ (IMT 
vs. PLA) and within-group effects due to ‘intervention’ (pre- vs. post-‘treatment’) or 
‘time’ (10, 20, 30, 40, 50, 60, 70, 80, 90 and 100%  ̇max of LEP, REC and 45, 50, 
55, 60 and 65%  ̇max of INC). Planned pairwise comparisons were made with 
repeated measures t-tests and with Bonferroni adjustment. Statistical significance 
was set at P < 0.05. Results are presented as mean  SD. 
 
6.2 RESULTS 
Age, body mass, height, pulmonary function and  ̇O2peak were not different 
between IMT and PLA groups (Table 6.1).  ̇max and lactate minimum power were 
higher (P < 0.01) for the IMT compared to the PLA group (Table 6.1). For all other 
pre-intervention measurements there were no differences between the groups. 
Compliance with the intervention was excellent in both the IMT and PLA groups 
with 96  1 and 93  1% of sessions completed, respectively. Pre-intervention 
pulmonary function and MIP were all within normal limits (Table 6.1). MIP was 
unchanged post-intervention in the PLA group. In contrast, MIP was 168  49 
cmH2O at pre-intervention and increased to 183  41, 191  37, and 201  39 cmH2O 
(+24%) (P < 0.01) after 2, 4 and 6 wk of IMT, respectively. Pulmonary function, 
 ̇O2peak and ̇ max were unchanged in both groups post-intervention.  
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Table 6.1 Pre-intervention descriptive characteristics, pulmonary function and 
maximal inspiratory pressure for IMT and PLA groups. Values in parentheses are the 
percent of predicted values (Quanjer et al. 1993; Wilson et al. 1984). Values are 
mean  SD.   
 
IMT 
 
PLA 
Age (yr) 27  7 
 
22  3 
Body mass (kg) 80  6 
 
74  7 
Height (cm) 181  5 
 
177  4 
FVC (L) 5.58  0.44 (104  7) 
 
5.61  0.67 (105  9) 
FEV1 (L) 4.49  0.46 (100  8)  4.53  0.51 (100  10) 
FEV1/FVC (%) 81  6 (99  6)  81  6 (98  7) 
MVV10 (L·min
-1
) 210  2 (111  14)  192  33 (102  19) 
MIP (cmH2O) 168  49 (157  9)  136  32 (113  26) 
 ̇O2peak (mL·kg
-1
·min
-1
) 51.7  6.2 
 
47.0  5.7 
 ̇max (W) 378  22
*
 
 
342  21 
Lactate minimum power (W) 199  8* 
 
170  19 
 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; MVV10, 
maximum voluntary ventilation in 10 s; MIP, maximal inspiratory pressure;  ̇O2peak, 
peak oxygen uptake;  ̇max, maximum power output. Significant difference (between 
groups 
* 
P < 0.01).    
 
6.2.1 PHYSIOLOGICAL RESPONSES TO THE LACTATE MINIMUM TEST 
The [La
-
]B response to the lactate minimum test (Figure 6.1) and the lactate 
minimum power (Table 6.1) was unchanged post-intervention for both groups. Apart 
from PTPdi/PTPe, breathing and respiratory muscle recruitment pattern and 
pulmonary gas exchange variables all increased during the LEP, followed by a rapid 
decrease during REC and a progressive increase during INC (Figures 6.2 and 6.3 and 
Table 6.2). At the start of the test, PTPdi/PTPe gradually increased, but then 
progressively decreased through the duration of the test indicating a greater 
contribution from the accessory respiratory muscles, and a lesser contribution from 
the diaphragm to  ̇E.  
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Figure 6.1 Blood lactate concentration ([La
-
]B) at the termination of the lactate 
elevation phase (MAX), during the recovery phase (REC) and at 45, 50, 55, 60 and 
65% of the incremental phase for IMT and PLA groups.  
 
 
Figure 6.2 Minute ventilation ( ̇E; A), tidal volume (VT; B), breathing frequency (fB; 
C) and oxygen uptake ( ̇O2; D) for IMT and PLA groups. Dashed lines represent the 
start and finish of the lactate elevation phase (LEP), recovery phase (shaded area; 
REC) and incremental phase (INC). Significant difference (from pre-intervention 
* 
P 
< 0.05) for the IMT group. 
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Table 6.2 Pre-intervention physiological responses to the lactate minimum test at 
termination of the lactate elevation phase (MAX), during the recovery phase (REC) 
and at 65% of maximum power output during the incremental phase (INC) for IMT 
and PLA groups.   
 
MAX REC 65% of INC 
          Pre-intervention IMT    
 ̇CO2 (L·min
-1
) 5.5  0.5 1.7  0.5 4.1  0.5 
RER 1.4  0.1 1.0  0.2 1.2  0.2 
PETO2 (mmHg) 120  3 107  7 116  3 
PETCO2 (mmHg) 41  4 39  3 40  2 
TI/TTOT 0.50  0.01 0.47  0.02 0.49  0.01 
 
 
        
Pre-intervention PLA 
 
        
           ̇CO2 (L·min
-1
) 4.3  0.5 1.2  0.4 3.4  0.7 
RER 1.3  0.0 1.0  0.2 1.1  0.1 
PETO2 (mmHg) 115  6 106  8 116  5 
PETCO2 (mmHg) 41  4 38 ± 2 39  3 
TI/TTOT 0.50  0.01 0.46  0.02 0.50  0.02 
 
 ̇CO2, carbon dioxide production; RER, respiratory exchange ratio; PETO2, partial 
pressure of end tidal oxygen; PETCO2, partial pressure of end tidal carbon dioxide; 
TI/TTOT, duty cycle.  
 
 
Figure 6.3 Peak transdiaphragmatic pressure (Pdipeak; A), diaphragm pressure-time 
product (PTPdi; B), inspiratory muscle pressure-time product (PTPe; C) and the 
relative contribution of diaphragm to the inspiratory muscle pressure-time product 
(PTPdi/PTPe; D) for IMT and PLA groups. Dashed lines represent the start and finish 
of the lactate elevation phase (LEP), recovery phase (shaded area; REC) and 
incremental phase (INC).  
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6.2.2 EFFECTS OF THE INTERVENTION 
 ̇E was increased in the IMT group (main effect for intervention, P < 0.05), 
which was due to a strong trend for an increased VT (main effect for intervention, P 
= 0.051) (Figure 6.2). No other differences in breathing and respiratory muscle 
recruitment pattern or pulmonary gas exchange variables were observed post-
intervention in either group (Figures 6.2 and 6.3 and Table 6.2). For both IMT and 
PLA groups fC (174  13 vs. 178  10 and 167  12 vs. 170  10 beats·min
-1
) and 
SpO2 (98  2 vs. 96  3 and 97  3 vs. 96  2%) at MAX were not different post-
intervention. 
 
 
6.3 DISCUSSION 
6.3.1 MAIN FINDINGS 
The main findings are that in contrast to the hypothesis and following IMT 
there was no change to the estimation of MLSS using the lactate minimum test and 
there were no differences in the contribution of the respiratory muscles to the 
ventilatory response during the test.  
The lactate minimum test differs from other exercise protocols used to 
evaluate the effects of RMT and therefore it is difficult to compare the present 
findings. The lactate minimum test involves an incremental test performed until 
exhaustion (LEP), a short active recovery phase (REC) where the ventilatory 
response does not decrease to resting levels, and a sub-maximal incremental phase 
(INC) where ventilation progressively increases, but only reaches near-maximal 
levels in the final stage.  
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6.3.2 EFFECTS OF IMT ON [LA-]B AND MLSS ESTIMATION 
There was no effect of IMT on [La
-
]B during the lactate minimum test. During 
(or immediately following) maximal incremental exercise until the limit of volitional 
tolerance, [La
-
]B has been observed to either decrease (Spengler et al. 1999; 
Volianitis et al. 2001), decrease but not significantly (Boutellier et al. 1992; Romer et 
al. 2002a) or remain unchanged (McMahon et al. 2002). The differences cannot be 
explained by study protocol or training status as McMahon et al. (2002) and Spengler 
et al. (1999) utilised the same incremental protocol and participants that were 
endurance trained ( ̇O2peak > 60 mL·kg·min
-1
). The data from Volianitis et al. (2001) 
is questionable as following the intervention period the placebo group also 
demonstrated a similar reduction in [La
-
]B during exercise. 
[La
-
]B reflects both the rate of lactate release into, and removal from, the 
systemic circulation (Gladden 2004). Throughout the majority of maximal 
incremental exercise, net lactate production is probably negligible, as there is there is 
sufficient capacity for tissues (e.g., active skeletal muscle, the kidney and the liver 
(Brooks 2000)) to clear the lactate produced. Thus, any potential RMT-mediated 
increases in oxidative (Ramirez-Sarmiento et al. 2002) and/or lactate transport 
capacity of the inspiratory muscles (Brown et al. 2008; Brown et al. 2010; Brown et 
al. 2012) may not be evident on [La
-
]B until there is an increase in net lactate 
production. This probably occurs at higher workloads, where  ̇E is relatively high 
compared to MVV, and the respiratory muscles engage in net lactate production 
(Boutellier et al. 1992; Romer et al. 2002a; Spengler et al. 1999; Spengler et al. 
2000). This relatively small change in [La
-
]B may only by evident with larger (n = 20 
participants) sample sizes (Spengler et al. 1999). However, in the presnt study 
equivocal findings were observed for [La
-
]B at MAX, with both increases and 
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decreases following IMT. In contrast, most studies report a decrease in [La
-
]B during 
constant load exercise to the limit of tolerance (Bailey et al. 2010; Boutellier et al. 
1992; Leddy et al. 2007; Romer et al. 2002a; Spengler et al. 1999) or at MLSS 
(Chapter 3; McConnell and Sharpe 2005), where throughout the majority of exercise 
there is limited capacity to match further lactate appearance with an equal rate of 
lactate clearance. In this situation, RMT-mediated respiratory muscle adaptations 
may have the capacity to augment [La
-
]B. 
It was postulated that IMT may affect [La
-
]B and therefore change the MLSS 
estimation. This was based on evidence that IMT may reduce [La
-
]B and have less 
probable effects on ̇ max. Most well controlled studies have found no effect of RMT 
on  ̇max during maximal incremental exercise to the limit of volitional tolerance 
(Hajghanbari et al. 2012; Illi et al. 2012). Romer et al. (2002a) have observed that 
when the inspiratory muscles are unloaded using a PAV, there is no increase in  ̇max, 
even with significant reductions in whole-body  ̇O2 and perceptual (leg discomfort 
and dyspnoea) responses. Moreover, without inspiratory muscle unloading, maximal 
incremental exercise did not elicit substantial diaphragm fatigue. Taken together 
these findings suggest that neither inspiratory muscle work, nor diaphragm fatigue, 
limit maximal incremental exercise performance, two of the mechanisms by which 
RMT may exert an ergogenic effect upon performance (Table 1.1).  
 
6.3.3 EFFECTS OF IMT ON THE CONTRIBUTION OF THE RESPIRATORY MUSCLES 
TO VENTILATION 
 
During the lactate minimum test, PTPdi/PTPe gradually increased but 
progressively decreased through the duration of the test, indicating a greater 
contribution from the accessory inspiratory muscles, and a lesser contribution from 
the diaphragm to  ̇E. This has previously been observed during heavy constant load 
217 
 
exercise (Babcock et al. 1995; Babcock et al. 1995; Babcock et al. 1996; Babcock et 
al. 1998; Johnson et al. 1993; Mador et al. 1993) and to a lesser extent, maximal 
incremental exercise (Romer et al. 2007). Less efficient accessory muscles may 
contribute more to the ventilatory response because the diaphragm is beginning to 
accumulate metabolites or fatigue, which reflexly inhibits further diaphragm 
recruitment and triggers the recruitment of additional inspiratory (and expiratory) 
muscles (Jammes et al. 1986). It was hypothesised that IMT may alter the breathing 
pattern and/or delay recruitment from fatiguing accessory muscles during the lactate 
minimum test, because of an increase in respiratory muscle fatigue resistance and/or 
a desensitising of sensory afferents within the respiratory muscles (McConnell and 
Romer 2004). However, no change in respiratory muscle recruitment patterns 
following IMT was found. Why IMT did not alter this response may be due to the 
type of exercise performed. Indeed, when the inspiratory muscles are unloaded with 
a PAV, PTPdi/PTPe remains at resting values during heavy constant load exercise 
(Babcock et al. 2002), but PTPdi/PTPe still increases during maximal incremental 
exercise (Romer et al. 2007). These findings suggest that reducing the inspiratory 
WOB during maximal incremental exercise does not alter respiratory muscle 
recruitment patterns. It may be that during the lactate minimum test, there is an 
insufficient accumulation of metabolic stimuli and/or diaphragmatic fatigue to make 
any RMT-mediated adaptations evident.   
 
6.4 CONCLUSION 
In conclusion, IMT does not change the estimation of MLSS using the lactate 
minimum test and it does not change the contribution of the respiratory muscles to 
the ventilatory response during the test. Whether IMT may alter the respiratory 
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muscle contribution to ventilation during heavy constant load exercise warrants 
further investigation.   
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CHAPTER 7 – GENERAL DISCUSSION
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In younger adults the research aims were to evaluate whether: 
(I) The respiratory muscles contribute to exercise-induced increases in 
systemic cytokines and oxidative stress. 
(II) An increase in systemic cytokines and oxidative stress was related to 
diaphragmatic fatigue.  
(III) IMT attenuates systemic cytokines and/or oxidative stress during 
whole-body exercise or a volitional mimic at rest of steady-state 
(HYPEX) and heavy exercise (VH) hyperpnoea. 
(IV) IMT changes an estimation of the maximum lactate steady-state and 
respiratory muscle recruitment patterns during the lactate minimum 
test.  
In older adults the research aims were to evaluate whether: 
(V) IMT attenuates systemic cytokines and/or oxidative stress at rest. 
 
The primary findings in younger adults were: 
(I) Plasma IL-6 concentrations increased during EX, HYPEX and VH 
and plasma IL-1β increased during VH. Plasma interleukin-1 receptor 
antagonist concentration and oxidative DNA damage to PBMC 
remained unchanged during VH.  
(II) The increase in IL-6 and IL-1β during VH was not related to the 
induction of diaphragmatic fatigue.  
(III) Following IMT, plasma IL-6 concentrations were reduced by 33% 
during EX, 24% during VH, but were unchanged during HYPEX.  
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(IV) Following IMT, an estimation of the maximum lactate steady-state 
and respiratory muscle recruitment patterns remained unchanged 
during the lactate minimum test. 
 
The primary findings in younger adults were: 
(V) Following IMT, nine plasma cytokines and DNA damage to PBMC 
remained unchanged. 
 
7.0 CONTRIBUTION OF THE RESPIRATORY MUSCLES TO EXERCISE-INDUCED 
SYSTEMIC CYTOKINES  
 
Volitional hyperpnoea at rest was utilised to address the question of whether 
respiratory muscles release cytokines during exercise. In this model, validity is 
improved by mimicking the breathing and respiratory muscle recruitment patterns 
experienced during whole-body exercise (Babcock et al. 1995; Klas and Dempsey 
1989).  
Using this model, this thesis presents novel evidence that the respiratory 
muscles contribute to exercise-induced increases in plasma cytokines. There was an 
increase in plasma IL-6 concentration following a volitional mimic at rest of the 
breathing and respiratory muscle recruitment patterns experienced during steady-
state (Chapter 3) and heavy (Chapter 4) whole-body exercise. In Chapter 3 pre-
intervention peak plasma IL-6 concentration was 2‒3 pg∙mL-1 at 1 to 2 h after 
volitional hyperpnoea at rest that was commensurate with steady-state exercise. This 
change represented a 300 to 400% increase above resting values. The magnitude of 
this increase in plasma IL-6 concentration is comparable with Vassilakopoulos et al. 
(2002) who reported peak plasma concentrations of ~1.6 pg∙mL-1 30 to 120 min after 
IRL at ~75% MIP until task failure. In contrast, in Chapter 4 a much larger increase 
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in plasma IL-6 concentration was observed 2 h after volitional hyperpnoea. Pre-
intervention peak plasma IL-6 concentration was 4‒5 pg∙mL-1, representing a 600 to 
700% increase above resting values. This finding suggests that IL-6 production in the 
respiratory muscles is dependent upon the intensity of respiratory muscle work. In 
Chapter 3 mean pre-intervention PTPdi (diaphragmatic force output) during volitional 
hyperpnoea was 700‒800 cmH2O∙s∙min
-1
 and mean PTPe (total inspiratory muscle 
force output) was 400‒500 cmH2O∙s∙min
-1
. Contrastingly, in Chapter 4, PTPdi and 
PTPe were increased to 800‒900 and 600‒700 cmH2O∙s∙min
-1
, respectively. Figure 
7.1 shows a moderate to strong positive correlation for individual plasma IL-6 
increase during the volitional mimic of steady-state (Chapter 3; Volitional 
hyperpnoea A) and heavy (Chapter 4; Volitional hyperpnoea B) exercise hyperpnoea 
against respiratory muscle force output and ventilation.  
Since the duration of volitional hyperpnoea was the same in both chapters (1 
h), it demonstrates that with a greater amount of respiratory muscle work, there are 
larger increases in plasma IL-6 concentration. This has been previously shown with 
whole-body exercise. Scott et al. (2011) reported that plasma IL-6 concentration 
immediately after 1 h of treadmill running was higher at an intensity of 75%  ̇O2max 
compared to intensities of 65 or 55%  ̇O2max. Furthermore, although not statistically 
significant the plasma IL-6 concentration was higher at 65% compared to 55% 
 ̇O2max.  
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Figure 7.1 Multiple regression analyses for repeated observations within participants 
(Bland and Altman 1995) where plasma interleukin-6 (IL-6) concentration (peak 
percentage increase from resting values) was treated as the dependent variable, 
minute ventilation ( ̇E; A); diaphragmatic force output (PTPdi; B); and total 
inspiratory muscle force output (PTPe; C) during a volitional mimic of steady-state 
exercise hyperpnoea (Chapter 3; Volitional hyperpnoea A) and heavy exercise 
hyperpnoea (Chapter 4; Volitional hyperpnoea B) as the independent variables, and 
participant as the categorical variable. The regression lines are for group mean data.  
 
 
 Alternatively, it could be speculated that the greater increase in plasma IL-6 
concentration observed in Chapter 4 was due to a greater contribution of IL-6 from 
the less efficient accessory inspiratory muscles. Using the a–fv difference technique, 
Helge et al. (2011) observed that during 90 min of combined arm and leg exercise 
(60% of  ̇O2max) the arms produce greater amounts of IL-6 than the legs, even when 
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relative to the size of the muscle group used. No correlations were present between 
IL-6 release and exogenous substrate uptake suggesting that differences in muscle 
morphology may be the cause of the greater IL-6 release in the arms. In healthy 
males, there are a greater proportion of type II fibres in the vastus lateralis than the 
biceps brachii (Miller et al. 1993). The same can be observed in the diaphragm 
compared to the internal intercostals (Figure 1.6; Mizuno and Secher 1989).   
 Plasma IL-1β and IL-1ra concentrations were only measured in Chapter 4. 
The decision to only measure these cytokines after this breathing challenge was 
based on the observation that only very prolonged exercise with primarily an 
eccentric component results in a small increase in plasma IL-1β concentration 
(Ostrowski et al. 1999). Therefore, very high levels of respiratory muscle work 
would be required to elicit a significant response. In Chapter 4, although peak plasma 
IL-1β concentration was relatively low, it significantly increased from 0.1‒0.13 
pg∙mL-1 at rest to 0.27‒0.3 pg∙mL-1 at 1 h in recovery from volitional hyperpnoea. 
This increase represented a 120 to 130% increase above resting values which is 
comparable with Vassilakopoulos et al. (2002) who also observed an increase in the 
plasma IL-1β concentration from ~0.3 pg∙mL-1 at rest to ~0.8 pg∙mL-1 120 min in 
recovery from IRL at ~75% MIP until task failure (Figure 1.26).  
An increase in plasma IL-1ra concentration was not observed after volitional 
hyperpnoea in Chapter 4. The only known biological role of IL-1ra is to inhibit 
signalling transduction of IL-1 through the IL-1 receptor complex (Dinarello 2000). 
It has been reported that IL-1ra is also upregulated by IL-6 and that acute exercise 
induces an anti-inflammatory environment in the post-exercise period (Steensberg et 
al. 2003). Therefore, theoretically, the increases in plasma IL-6 and IL-1β 
concentration should lead to an increase in plasma IL-1ra concentration. The likely 
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explanation for this finding is the time course of plasma IL-6 and IL-1β 
concentration in Chapter 4. Following prolonged and strenuous whole-body exercise, 
others have reported an increase in plasma IL-1ra concentration similar to the 
magnitude of the plasma IL-6 response, but with peak concentrations recorded 
between 2‒4 h post-exercise (Ostrowski et al. 1999; Scott et al. 2011; Yfanti et al. 
2012). The peak concentrations of plasma IL-6 and IL-1β in Chapter 4 after the end 
of volitional hyperpnoea were observed at +2 and +1 h, respectively. This is 
consistent with IRL (Vassilakopoulos et al. 2002), but in contrast to whole-body 
exercise where the plasma concentrations of these cytokines peak immediately post-
exercise (Ostrowski et al. 1998; Ostrowski et al. 1999). It is probable that this delay, 
and the relatively low concentrations of plasma IL-6 and IL-1β (compared to 
prolonged and strenuous exercise), resulted in plasma IL-1ra not being observed in 
the systemic circulation until ~2 h following the peak concentration; possibly at ~3‒4 
h post volitional hyperpnoea, and at a time point was not measured.   
 
7.1 THE ROLE OF BREATHING-INDUCED CYTOKINES AND/OR OXIDATIVE STRESS 
IN DIAPHRAGM FATIGUE  
 
This thesis presents novel information regarding the role of breathing-induced 
cytokines and/or oxidative stress in the aetiology of diaphragm fatigue. The role of 
diaphragm fatigue was assessed because it was suggested that the increase in plasma 
cytokines may be due to inspiratory / diaphragmatic muscle fibre injury / fatigue 
since task failure also occurred following IRL (Vassilakopoulos et al. 1999; 
Vassilakopoulos et al. 2002). Furthermore, the stimuli for breathing-induced 
cytokines have been reported to be oxidative stress which can also contribute to 
diaphragmatic fatigue. Diaphragm fatigue was assessed using a non-volitional nerve 
stimulation technique in Chapters 3 and 4. Diaphragm fatigue was defined as a >15% 
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reduction in the Pditw response to BAMPS compared to the baseline value (Kufel et 
al. 2002). Diaphragm fatigue was evident following volitional hyperpnoea in Chapter 
4, but not in Chapter 3. In Chapter 4 it was shown that the increase in plasma IL-β 
concentration occurred with, but was not specifically related to the induction of 
diaphragmatic fatigue. This finding may indicate that inspiratory / diaphragmatic 
muscle fibre injury may have occurred after the high level of respiratory muscle 
work. The biological role of IL-β is poorly understood, but within the respiratory 
muscles IL-1β may reduce muscle contractility and mediate muscle injury. In both 
Chapters 3 and 4 there was an increase in plasma IL-6 concentration. IL-6 may be 
produced and released from the contracting muscles, signalling to the liver to 
increase its glucose output, and maintain substrate homeostasis. This should prevent 
an extreme fall in the blood glucose concentration. It could be speculated that the 
large increase in plasma IL-6 concentration observed in Chapter 4 suggests that there 
was a reduction in respiratory muscle glycogen content and this also contributed to 
diaphragmatic fatigue. 
Reports have demonstrated that respiratory muscle contractile properties are 
altered by oxidative stress. A decrease in muscle contractility has been observed in 
vitro by incubating unfatigued isolated muscle fibres with ROS (Lawler et al. 1997) 
and NO (Lawler and Hu 2000). Conversely, contractile performance is improved by 
administrating antioxidants during fatiguing contractions in vitro (Diaz et al. 1994; 
Khawli and Reid 1994; Shindoh et al. 1992) and in vivo (Kelly et al. 2009b; Supinski 
et al. 1995; Supinski et al. 1997; Travaline et al. 1997b). In Chapter 4 it was 
observed that the high level of respiratory muscle work did not alter a marker of 
systemic oxidative stress. The comet assay was used to determine levels of systemic 
oxidative stress to DNA damage in PBMC. The modified comet assay can measure 
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oxidative damage with the use of bacterial repair endonucleases with appropriate 
specificities that can readily be incorporated into the modified comet assay protocol. 
This finding suggests that in humans undertaking a high level of respiratory muscle 
work, systemic oxidative stress is not evident with diaphragm fatigue using this 
marker. Oxidative DNA damage to PBMC will occur if there is an excessive 
production of free radicals, inefficient antioxidant defences and/or DNA repair 
mechanisms. However, whether there was a local increase in diaphragmatic 
oxidative stress cannot be excluded. Alternatively, the finding in Chapter 4 might 
suggest that this local production does not spill out to cause sufficient systemic DNA 
damage in PBMC.   
 
7.2 THE EFFECT OF IMT ON PLASMA IL-6 DURING INCREASED RESPIRATORY 
MUSCLE WORK 
 
This thesis presents novel information that IMT attenuates plasma IL-6 
concentration during exercise (Chapter 3) and following a volitional hyperpnoea 
mimic at rest of the breathing and respiratory muscle recruitment patterns 
experienced during heavy (Chapter 4), but not steady-state (Chapter 3) whole-body 
exercise. Three questions are raised from this finding. Firstly, why is plasma IL-6 
concentration attenuated? Changes in inspiratory muscle morphology may explain, in 
part, the attenuated increase in plasma IL-6 concentration following IMT. There may 
be post-IMT increases in basal levels of IL-6rα (Akerstrom et al. 2009; Keller et al. 
2005), or an increase in antioxidant enzymes (Yfanti et al. 2012). More likely, IMT 
results in an increase in glycogen synthase within the respiratory muscles and the 
trained muscles will consequently store more muscle glycogen. It has been 
previously reported that endurance training in rats increases diaphragmatic muscle 
glycogen content (Green et al. 1988). Furthermore, muscle glycogen content is 
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associated with lower IL-6 mRNA expression during acute lower-body exercise 
(Fischer et al. 2004b). During high levels of respiratory muscle work the untrained 
muscle may be highly dependent on glycogen as a substrate whereas training leads to 
increased β-oxidating enzymes and an enhanced capability to oxidise fat and hence 
to use fat as a substrate during respiratory muscle work. The trained respiratory 
muscle therefore uses less glycogen during muscular contractions. The activation of 
muscle IL-6 is glycogen dependent. During prolonged and strenuous respiratory 
muscle work there is a decrease in respiratory muscle glycogen content, and IL-6 is 
upregulated at a faster rate. More IL-6 is produced at the same relative work 
compared with conditions with high muscle glycogen. During respiratory muscle 
work this results in a lower plasma IL-6 concentration for trained compared to 
untrained muscles.  
The second question regards why plasma IL-6 concentration is attenuated 
following IMT during exercise, but not a volitional mimic of the exercise 
hyperpnoea? This finding could be explained by the following hypothesis shown in 
Figure 7.2. During cycling exercise at an estimated MLSS (Chapter 3) the rate at 
which skeletal muscle (leg and respiratory) IL-6 is produced is low because skeletal 
muscle glycogen content is only slightly decreased. There is competition between the 
leg, respiratory muscles and the liver for blood flow. After IMT there is only a small 
decrease in the rate of IL-6 production within the respiratory muscles because 
respiratory muscle glycogen content is only slightly decreased. IMT possibly 
increases blood flow to the leg muscles (Bailey et al. 2010; Chiappa et al. 2008; 
McConnell and Lomax 2006; Witt et al. 2007) and/or potentially the liver. 
Additional blood flow to the legs would increase O2 (Bailey et al. 2010) and/or 
glucose delivery (Ebeling et al. 1993) potentially reducing muscle glycogen 
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utilisation, and blood flow to the liver would increase hepatosplanchnic uptake of IL-
6 (Febbraio et al. 2003). Therefore, plasma IL-6 concentration is decreased (Figure 
7.2A).  
During a volitional mimic at rest of the steady-state exercise hyperpnoea 
(Chapter 3) the rate at which respiratory muscle IL-6 is produced is low because 
skeletal muscle glycogen content is only slightly decreased. There is no competition 
between the leg, respiratory muscles and the liver for blood flow, and the rate of 
hepatosplanchnic uptake of IL-6 is maintained. After IMT there is only a small 
decrease in the rate of IL-6 production within the respiratory muscles because 
respiratory muscle glycogen content is only slightly reduced. Therefore, plasma IL-6 
concentration is unchanged (Figure 7.2B). 
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Figure 7.2 Interleukin-6 (IL-6) production and release during steady-state cycling 
exercise (A), a volitional mimic of steady-state exercise hyperpnoea (B) and a 
volitional mimic of heavy exercise hyperpnoea (C) before and after inspiratory 
muscle training (IMT). The activation of skeletal muscle IL-6 is glycogen dependent 
and during prolonged and strenuous respiratory muscle work there is a decrease in 
respiratory muscle glycogen content and IL-6 is upregulated. IL-6 is released in an 
endcocrine like manner into the systemic circulation and nearly half is cleared by the 
liver where glucose output is stimulated. Plasma IL-6 concentration is measured in 
the systemic circulation. After IMT there is an increase in β-oxidating enzymes 
within the respiratory muscles, an enhanced capability to oxidise fat, and to use fat as 
a substrate during respiratory muscle work. The trained respiratory muscles, 
therefore, uses less glycogen during muscular contractions. 
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The third question leads on from this point; why is a training effect revealed 
with a higher level of respiratory muscle work as plasma IL-6 concentration is 
attenuated during a volitional mimic at rest of the breathing and respiratory muscle 
recruitment patterns experienced during heavy whole-body exercise in Chapter 4? 
This suggests that there may be a threshold above which an effect of IMT is 
observed. During a volitional mimic of heavy exercise hyperpnoea (Chapter 4) the 
rate at which respiratory muscle IL-6 is produced is high because there is a 
significant reduction in respiratory muscle glycogen content. There is no competition 
between the leg, respiratory muscles and the liver for blood flow. However, at this 
point the capacity for hepatosplanchnic IL-6 uptake cannot match the rate of 
respiratory muscle IL-6 release (Febbraio et al. 2003). After IMT, there is large 
decrease in the rate of IL-6 production within the respiratory muscles because 
respiratory muscle glycogen content is only slightly reduced. Therefore, plasma IL-6 
concentration is decreased (Figure 7.2C).  
 
 
7.3 WIDER SIGNIFICANCE OF FINDINGS AND FUTURE PERSPECTIVES 
These findings demonstrate that the respiratory muscles contribute to 
exercise-induced increases in plasma cytokines. The first requirement for future work 
exploring this area is to determine whether decreased glycogen content is the 
stimulus for IL-6 production from respiratory muscles. This could be achieved by 
depleting respiratory muscle glycogen content using IRL and/or volitional 
hyperpnoea the day before replicating the experimental trials described in the 
experiment chapters of this thesis.  
The response of plasma IL-6 and TNF-α concentration from COPD patients 
during moderate intensity exercise is greater than the response observed in healthy 
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controls (Rabinovich et al. 2003). The inspiratory muscles of COPD patients 
experience increased workloads, due to airflow limitation, hyperinflation, and a 
reduction in inspiratory muscle contractile properties. Therefore, it could be 
speculated that the dysregulated cytokine response to exercise is due to a local 
production of respiratory muscle cytokines that then spill out into the systemic 
circulation. Thus, future perspective work would examine whether the respiratory 
muscles of COPD patients contribute to the dysregulated cytokine response to 
exercise that is observed.  
COPD patients also experience systemic inflammation which can account for 
a large part of the morbidity and mortality observed (Sin et al. 2006). There are two 
opposing views regarding the source of the systemic inflammation in COPD patients. 
Some suggest that inflammatory markers spill out from the lungs of patients into the 
systemic circulation whereas others have suggested that that multiple organs 
contribute (Barnes and Celli 2009). It is still unknown whether the respiratory 
muscles contribute to this systemic inflammation. However, Casadevall et al. (2007) 
reported that the external intercostals of COPD patients had higher mRNA and 
protein expression of TNF-α, IL-1β and IL-6 (although IL-6 mRNA was not 
significant) compared to aged-matched healthy controls. Thus, it could be speculated 
that they do. Future work would also examine whether IMT can attenuate local 
cytokine production within the inspiratory muscles of COPD patients.  
Lastly, the relationship between oxidative stress and cytokines on the 
aetiology of diaphragm fatigue are still poorly understood. The findings observed in 
Chapters 3 and 4 demonstrated that increases in plasma IL-6 and IL-1β 
concentrations can occur with, but are not related to, the induction of diaphragm 
fatigue. Furthermore, there were no effects of high levels of respiratory muscle work 
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on DNA damage in PBMC. Contractile performance is improved by administrating 
antioxidants before fatiguing contractions in vivo (Kelly et al. 2009b; Supinski et al. 
1995; Supinski et al. 1997; Travaline et al. 1997b). One study has utilised objective 
nerve stimulation techniques, but IRL was used as a model for a breathing challenge 
to induce diaphragm fatigue (Figure 30; Travaline et al. 1997a). Alternatively, Kelly 
et al. (2009b) used cycling exercise at 85%  ̇O2peak until volitional tolerance a more 
ecologically valid model, but diaphragm fatigue was assessed using a volitional 
measure of MIP. Thus, a future study would examine the effects of antioxidant 
administration on exercise tolerance and objectively measure diaphragm fatigue with 
bilateral phrenic nerve stimulation.  
 
7.4 THE EFFECT OF IMT ON SYSTEMIC PLASMA CYTOKINES AND/OR OXIDATIVE 
STRESS OBSERVED IN AGEING 
 
Chapter 5 provided novel evidence in older adults using a rigorous, placebo 
controlled design with an adequate sample size that IMT can increase diaphragm 
thickness and dynamic inspiratory muscle function, but does not change resting 
markers of systemic inflammation (plasma cytokines) and oxidative stress (DNA 
damage in PBMC). Whilst IMT did not change resting markers of systemic 
inflammation and oxidative stress, it cannot be excluded whether IMT attenuated 
local diaphragmatic cytokines and/or oxidative stress. A diaphragmatic or intercostal 
biopsy would allow this area to be explored. However, this is a very invasive 
measurement that requires open surgery or thoracscopy under general anaesthesia 
and for these healthy individuals this would not be ethical. It could be that the 
improvement in inspiratory muscle function and structure did not reach a threshold 
necessary to achieve a potential reduction in systemic cytokines and/or oxidative 
stress. Previous studies have shown that whole-body resistance or endurance training 
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can decrease resting systemic cytokine concentrations (Kohut et al. 2006; Nicklas et 
al. 2008; Phillips et al. 2010; Prestes et al. 2009) and markers of oxidative stress 
(Fatouros et al. 2004; Parise et al. 2005; Takahashi et al. 2012). However, the 
respiratory muscles only weigh ~960 g (Freedman et al. 1983) and represent ~3% of 
total body mass (Robertson et al. 1977). Thus, IMT only targets a small muscle 
group and although they do contribute to systemic cytokines concentrations during 
increased respiratory muscle work, this does not change under resting conditions.  
In contrast, the effects of IMT on the cytokine response to intense exercise 
and/or volitional hyperpnoea in older adults would be ethical. Older participants 
were unable to undertake intense exercise and/or volitional hyperpnoea in the present 
thesis as the study being the first of its type at the University. In future, this type of 
study may be available based on the outcomes of Chapter 5.   
 
7.5 THE EFFECT OF IMT ON THE LACTATE MINIMUM TEST AND ON THE 
CONTRIBUTION OF THE RESPIRATORY MUSCLES TO THE VENTILATORY 
RESPONSE  
 
Chapter 6 provided novel evidence that IMT does not change the estimation 
of MLSS using the lactate minimum test and it does not change the contribution of 
the respiratory muscles to the ventilatory response during the test. This type of test 
may not be suitable to demonstrate IMT-mediated adaptations in the contribution of 
the respiratory muscles to the ventilatory response. The lactate minimum test 
involves an incremental test performed until exhaustion, a short active recovery 
phase where the ventilatory response does not decrease to resting levels, and a sub-
maximal incremental phase where ventilation progressively increases, but only 
reaches near-maximal levels in the final stage. During constant load (Babcock et al. 
1995; Babcock et al. 1995; Babcock et al. 1996; Babcock et al. 1998; Babcock et al. 
235 
 
2002; Johnson et al. 1993; Mador et al. 1993) or maximal incremental (Romer et al. 
2007) exercise until the limit of tolerance there is a progressive increase in the 
contribution from the less efficient accessory inspiratory (and expiratory) muscles, 
and a decrease in the contribution from the diaphragm to the ventilatory response. 
When the inspiratory muscles are unloaded with a PAV respiratory muscle 
recruitment patterns remain at resting values during heavy constant load exercise 
(Babcock et al. 2002), but remain unchanged during maximal incremental exercise 
(Romer et al. 2007). These findings suggest that reducing the WOB of the inspiratory 
muscles during maximal incremental exercise does not alter respiratory muscle 
recruitment patterns. It may be that during the lactate minimum test there is an 
insufficient accumulation of metabolic stimuli and/or diaphragmatic fatigue to make 
any RMT-mediated adaptations evident. Future work would examine whether IMT 
may alter the respiratory muscle contribution to ventilation during heavy constant 
load exercise test until the limit of tolerance.  
 
7.6 CONCLUSION 
In conclusion, this thesis provides novel evidence in younger adults that the 
respiratory muscles contribute to exercise-induced increases in plasma IL-6 and IL-
1β concentrations and that this increase is not related to diaphragmatic fatigue. IMT 
attenuates plasma IL-6 concentration during exercise in younger adults, but not in a 
range of plasma cytokines at rest in older adults. It is attractive to speculate that the 
respiratory muscles contribute to the systemic inflammation observed in COPD 
patients and IMT may reduce the dysregulated cytokine response observed during 
exercise of COPD patients. 
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APPENDIX 1 ‒ YOUNGER PARTICIPANT SELF-REPORTING MEDICAL 
QUESTIONNAIRE 
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APPENDIX 2 – ETHICAL APPROVAL FOR EXPERIMENTAL CHAPTERS 3, 4 AND 6 
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APPENDIX 3 – AMENDMENT FOR ETHICAL APPROVAL FOR EXPERIMENTAL 
CHAPTERS 3, 4 AND 6 
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APPENDIX 4 – EXCLUSION CRITERIA USED TO DEFINE “HEALTHY” OLDER 
PARTICIPANTS FOR EXERCISE STUDIES (GREIG ET AL. 1994) 
 
 
 History of myocardial infarction within the previous 10 years. 
 Cardiac illness: e.g. symptoms of aortic stenosis, acute pericarditis, acute 
myocarditis, aneurysm, severe angina, clinically significant valvular disease, 
uncontrolled dysrrhythmia, claudication, within the previous 10 years 
 Thrombophlebitis or pulmonary embolus within the previous 10 years 
 History of cerebrovascular disease 
 Acute febrile illness within the previous 6 months 
 Moderate or severe airflow obstruction 
 Metabolic disease (e.g. diabetes, thyroid disease) whether controlled or 
uncontrolled 
 Major systemic disease diagnosed or active within the previous 20 years (e.g. 
cancer, rheumatoid arthritis) 
 Significant emotional distress, psychotic illness or anything worse than mild 
anxiety or depression, within the previous 10 years 
 Osteoarthritis, classified by inability to perform maximal contractions of 
upper and lower limbs without pain. 
 Bone fracture sustained within previous 2 years. 
 "Old person's fracture" after 40 years of age (wrist, hip, vertebral) 
 Non-arthroscopic joint surgery, ever, in the relevant limb part. 
 Any reason for loss of mobility for greater than 1 week in the previous 6 
months or greater than 2 weeks in the previous year 
 On daily medication (including daily aspirin or any medication with similar 
effects); on a oestrogen replacement therapy; antioxidants or supplements; on 
medication for hypertension, or with a diuretic for any other reason, even if 
not daily 
 Obese, i.e. a Quetelet index (wt.ht-2) greater than 29.9 
 Resting systolic blood pressure > 200mmHg, or resting diastolic blood 
pressure > 100mmHg 
 Unable to walk unsupported 
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APPENDIX 5 – ETHICAL APPROVAL FOR EXPERIMENTAL CHAPTER 5 
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APPENDIX 6 – COMMITMENT LETTER FROM TRAINED CARDIOLOGIST TO 
INTERPRET ELECTROCARDIOGRAMS 
 
 
 
 
